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RESÜMEE 
 
 
Glinus lotoides wird in Äthiopien traditionell als Anthelminthikum eingesetzt. Das Ziel 
der vorliegenden Arbeit ist es, Auszüge von G. lotoides herzustellen, diese zu 
charakterisieren und zu standardisieren. In einem weiteren Abschnitt sollen aus den 
Auszügen Arzneiformulierungen hergestellt werden. Um die Ziele der Arbeit zu 
erreichen, muss ein standardisiertes Extraktionsverfahren entwickelt werden. Des 
Weiteren ist ein umfangreiches Screening der Inhaltsstoffe durchzuführen, was die 
Isolierung und Identifizierung der pharmakologisch aktiven Substanzen einschließt. 
 
Die Isolierung und die Strukturaufklärung der Saponine und der Flavonoide als 
wirksame Inhaltsstoffgruppen von G. lotoides liefern vier neue Hopan-Saponine, die 
Glinuside F, G, H und K, das bekannte Succulentosid B sowie zwei bekannte 
Flavonoidglykoside; 5,7,4 '-trihydroxyflavon-6,8-di-C-glucosid (Vicenin-2) und 5,7,4 '-
trihydroxy-flavon-8-C-sophorosid (Vitexin-2"-O-glucosid). Die Strukturen der 
Saponine werden mittels NMR, HRESI Massenspektroskopie und Zucker-Analytik als 
3β-O-β-D-xylopyranosyl-6α-O-β-D-xylopyranosyl-16β-O-β-D-xylopyranosyl-22-
hydroxy-hopan (Glinusid F), 3β-O-α-L-rhamnopyranosyl-(1→2)-β-D-xylopyranosyl-
6α,16β-dihydroxy-22-O-α-L-rhamnopyranosyl-hopan (Glinusid G), 3β-O-α-L-
rhamnopyranosyl-(1→2)-β-D-xylopyranosyl-6α-O-β-D-xylopyranosyl-16β-hydroxy-22-
O-α-L-rhamnopyranosyl-hopan (Glinusid H) and 3β-O-α-L-rhamnopyranosyl-(1→2)-β-
D-xylopyranosyl-6α-O-β-D-xylopyranosyl-16β-O-β-D-xylopyranosyl-22-hopan 
(Glinusid I) aufgeklärt.  
 
Die Gesamtsaponin- und Favonidgehalte der Samen von G. lotoides werden mittels RP-
HPLC in den Extrakten und in den Tabletten bestimmt. Die quantitative Bestimmung 
der Saponine wird nach saurer Hydrolyse (3M HCl, 100 °C für 1 Stunde) durchgeführt, 
wobei  Mollugogenol B entstehen. Für die quantitative Bestimmung der Flavonoide 
wird Vicenin-2 als externer Standard eingesetzt. Mittels DC und HPLC unter 
verschiedenen Bedingungen wird eine mindestens 97 %ige Reinheit des isolierten 
Vicenin-2 und Mollugogenol B gefunden. Die Berechnung der Konzentrationen erfolgt 
über die Peakflächen von Vicenin-2 und von Mollugogenol B nach der Methode des 
externen Standards. Der Gesamtflavonoidgehalt und der Gesamtsaponingehalt von G. 
lotoides werden über die Gesamtpeakfläche des jeweiligen Chromatogramms ermittelt.  
 
Im Rahmen der Validierung der Gehaltsbestimmungsmethode erfolgt die Bestimmung 
von Selektivität, Widerfindung, System- und Methodepräzision, Bestimmungsgrenze 
und Nachweisgrenze. Als Sekundärstandard wird der aufgereinigte Extakt F 
charakterisiert. Der Flavonoid- und Saponingehalt der Tabletten beträgt zwischen 95 
und 103 % für die Flavonoide und zwischen 94 und 98 % für die Saponine. 
 
Eine zur Formulierung von Tabletten geeignete Extraktzubereitung wird durch 
Mischung des Extraktes mit  Aeroperl® 300 Pharma als Träger-Material hergestellt. Die 
benötigte Menge von Aeroperl® 300 Pharma wird durch Untersuchungen zur 
Wasseraufnahme und REM-Untersuchungen optimiert. Hierbei ergibt eine 
Extraktzubereitung mit 30% (m/m) Aeroperl® 300 Pharma die besten Eigenschaften im 
Hinblick auf die weiter Verarbeitung. Zusätzlich, durch Walzen-Kompaktierung der 
Extrakt-Aeroperl-Mischung wird die Fließfähigkeit der Tablettiermischung und den 
Zerfall der Tabletten verbessert. 
 
Eine geeignete Tablettenformulierung, die 947 mg Extraktzubereitung, 363 mg Avicel® 
PH101, und 90 mg Ac-Di-sol enthält, wird durch mehrere Optimierungsschritte 
entwickelt. Diese Tabletten zeigen einen Zerfall der Tabletten innerhalb von 2,4 
Minuten bei einer Härte von 73 N. 
 
Zusätzlich erhalten die Oblong-Tabletten einen Magensaftresistenten Überzog, der den 
Arzneibuchanforderungen entspricht. Dieser Überzug wird mittels der hier für 
geeigneten Filmbildner Eudragit® L 100/55 oder Kollicoat® MAE 100P hergestellt. Der 
Filmüberzug enthält Propylenglykol und Acetyltributylcitrat als Weichmacher. Durch 
die Prüfung der Zerfallzeit wird sichergestellt, dass die überzogenen Tabletten in 
künstlichen Magensaft Ph. Eur. (0,1 M Salzsäure, pH 1,0) innerhalb 2 Stunden nicht 
zufallen jedoch anschließend in künstlichen Darmsaft (Phosphat-Pufferlösung, pH 6,8) 
innerhalb von 15 Minuten zufallen.  
 
Zusammenfassend kann festgestellt werden, dass es gelungen ist, einen Auszug von G. 
lotoides herzustellen, dieser zu einer zur Formulierung von Tabletten geeigneten 
Extraktzubereitung zu verarbeiten, eine Tablettenformulierung zu entwickeln und die 
Tabletten mit einem magensaftresistenten Überzug zu versehen. 
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Chapter 1 
OBJECTIVE OF THE STUDY 
Herbal medicines are widely used in conventional as well as alternative medical 
practices in many countries, both developed and developing. Although herbal medicines 
have been used by the Ethiopian people for centuries, they have not yet been developed 
to a level as to serve as a substitute or complementary to synthetic drugs (Bishaw, 1991; 
Gedif and Hahn, 2003).   
 
However, incorporation of the traditional medicine into the health care system prior to 
systematic investigation, standardization and proper formulation may cause problems, 
such as inaccurate dosage, lack of proof of safety and efficacy and/or interaction risk 
with modern drugs. Standardization and formulation of traditional herbs into modern 
phytopharmaceuticals shall provide the solution to most of these problems of traditional 
medicine (Kroll, 2001; Gogtay et al., 2002).   
 
With this respect, the aim of this study is to standardize and formulate the extracts of the 
seeds of Glinus lotoides into enteric coated tablets. In order to achieve this goal, the 
following four major objectives were set and the experiments were carried out. 
 
1. Extraction, isolation and structural elucidation of saponins and flavonoids from the 
seeds of Glinus lotoides  
Qualitative and quantitative characterization of the extracts or the traditional 
preparations is indispensable to confirm the safety and efficacy of medicinal plants and 
formulations thereof. Hence, extraction, isolation and structural elucidation of the major 
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compounds of the seeds of G. lotoides are the first objective of the study. In this, the 
major saponins and flavonoids will be isolated using chromatographic methods such as 
open column chromatography, TLC and HPLC and their structures will be elucidated 
using spectral like UV, MS and NMR analyses. 
 
2. Quantitative determination of saponins and flavonoids of Glinus lotoides 
 
Quality control of raw materials, crude extracts, intermediate and finished products and 
manufacturing parameters require suitable quantitative determination methods. 
Accordingly, the second objective of the study is the development of HPLC methods 
for the quantitative determination of the total saponins and flavonoids of the seeds of G. 
lotoides using the isolated compounds as standards.  
 
3. Preparation and physicochemical characterization of the dry extract preparation for 
tablet formulations 
 
Preparation of the dry extract and characterization of its physicochemical properties are 
the third objective of the study. In this, the crude extract will be converted into a free 
flowing and less hygroscopic powder using Aeroperl® 300 pharma as an inert 
adsorbent. Physical and chemical characteristics of the dry extract preparations will be 
determined before embarking upon formulation. Various physicochemical properties 
such as, particle size and size distribution, densities, hygroscopicity, water content, 
flow properties, compatibility and stability of the saponins and flavonoids in the dry 
extract preparations at different storage conditions will be investigated.  
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4. Dry granulation by roller compaction, tablet preparation and enteric coating 
 
The fourth objective of the study is the granulation of the dry extract preparation and 
formulation into enteric coated tablets. Successful formulation of a stable and effective 
dosage form depends on appropriate selection of excipients and manufacturing 
processes. On this account, the effects of various excipients and manufacturing 
parameters, such as compression force will be investigated. Formulations of the core as 
well as enteric coated tablets will be optimized and characterized.  
Chapter 2 
GLINUS LOTOIDES- MOLLUGINACEAE 
 
2.1 Introduction and botanical description  
2.1.1  Introduction 
Glinus lotoides L. (Molluginaceae), locally known as “Mettere” is an annual or short-
living perennial prostrate herb (Edwards et al., 2000). It is found mostly in tropical and 
subtropical region such as Ethiopia, Sudan, Uganda, Egypt, India, Pakistan and South 
America. As it is found in different countries, its traditional uses also differ. In India 
and Pakistan, for instance, the plant is used as antifungal and antitumor agent and for 
fishing (Chopra et al., 1956; Kavimani et al., 1999). In Ethiopia, the seeds of G. lotoides 
are traditionally used as anthelminthic for the prevalent tapeworm infection. 
There are well over 25 plants in Ethiopia that are traditionally used against tapeworm 
infection (Kloos et al., 1978). However, literature reveals that most of them are toxic. 
For instance, several clinical symptoms and deaths have been attributed to the use of 
Embelia schimperi locally known as “Enkoko”, which contains embolic acid (Watt and 
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Breyer-Bandwijk, 1962). On the other hand, blurred vision and blindness, effects on the 
cardiovascular, respiratory and central nervous systems have been reported when people 
took overdoses of Hagenia abysinica locally known as “Kosso” (Rokos, 1969; Klitina, 
1965). H. abysinica was also found to be neurotoxic in mice (Tsega et al., 1978). Since 
G. lotoides is claimed to have little or no side effects, it enjoys a considerable reputation 
as a taenicide in the Ethiopian traditional medicine. 
2.1.2  Classification 
G. lotoides is classified under the family molluginaceae and order centrospermea. The 
order centrospermea contains 13 families, one of which is molluginaceae. The family 
molluginaceae contains 16 genera and about 100 species. The family molluginaceae 
was often included within the family Aizoaceae, but now it is generally accepted that 
the 16 genera of molluginaceae are not related to the other genera of Aizoaceae 
(Edwards et al., 2000). 
G. lotoides was known by different botanical synonyms such as Glinus dicatamoides, 
Glinus setiforous, Mollugo glinus, Mollugo hirta and Mollugo lotoides. 
 
2.1.3  Botanical description 
G. lotoides is widely distributed throughout the highlands and the banks of rivers and 
lakes of Ethiopia. The taxonomic features of the plant show that it is glabrous or 
densely short hairy. The leaves are opposite or clustered at nods and apparently 
verticillate, narrowly elliptic to subround. The plant contains stipules and the flowers 
are bisexual and clustered in axillary (Edwards et al., 2000).  
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2.2 Pharmacological activities of the seeds of Glinus lotoides 
The seeds of G. lotoides are traditionally used in Ethiopia for the treatment of prevalent 
tapeworm infection (Pankhurst, 1965; Kloos et al., 1978). The taenicidal activities have 
already been shown in vitro against Tenia saginata (Djote, 1978) and in vitro as well as 
in vivo against Hymenolepis nana worms (Endale et al., 1997; 1998). The ethanolic 
extract of the seeds of the plant has been shown to be highly active in vitro against H. 
nana worms with an approximate 50% effective dose (ED50) of 0.003 mg/ml. It has 
been shown that a concentration of 1 mg/ml of the extract exhibited comparable in vitro 
taenicidal activity with 0.05 and 0.01 mg/ml niclosamide and praziquantel, respectively 
(Endale et al., 1997). 
The in vivo anthelminthic activity of the extract has been determined in albino mice 
infested with H. nana worms and has been found to be active when given both as a 
single dose as well as multiple doses. In single dose treatment, higher concentrations of 
the extract (as much as 3.3 g per kg, i.e., 100 mg per 30 g mouse) were required to expel 
all the worms, whereas the total multiple dose that cured the mice completely amounted 
to only 0.6 g per kg (i.e., 3 mg a day for 6 days per 30 g mouse). In the control 
experiments, a single dose of praziquantel (0.6 mg per mouse) resulted in 100% cure 
within 48 hrs while a single dose of niclosamide (0.5 mg) had only 73.3% efficacy 
(Endale et al., 1998). 
 
The antitumor activity of the methanolic extract of G. lotoides has been evaluated 
against Dalton's ascitic lymphoma (DAL) in Swiss albino mice. A significant 
enhancement of mean survival time of tumor bearing mice and peritoneal cell count in 
normal mice was observed with respect to the control group receiving 5-Flourouracil 
(20 mg/kg). Tumor cell growth was inhibited in albino mice treated with extract of G. 
lotoides (50 mg/kg) after intra peritoneal inoculation with DAL cells. After 14 days of 
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inoculation, the extract of the plant is able to reverse the changes in the haemotological 
parameters, such as total white blood cells count, protein and packed cellular volume 
consequent to tumor inoculation (Kavimani et al., 1999). 
Preliminary pharmacological studies undertaken on the plant indicate that the extract 
does not affect the blood pressure, heart rate or the ECG of anaesthetized rabbits, bile 
production in guinea pigs, or contraction of frog isolated heart after oral administration 
(Arragie and Chernishov, 1977; Chernishov et al., 1978).  
2.3 Chemical constituents of the seeds of Glinus lotoides 
The pharmacological activities of the seeds of G. lotoides have been attributed to its 
saponins and flavonoids. (Pankhurst 1965; Kloos et al., 1978; Djote, 1978; Endale et al., 
1997; 1998; Kavimani et al., 1999). Abegaz and Tecle (1980) have isolated one 
triterpenoidal saponin with an oleanane skeleton. The chemical structure has been 
determined to be 3-O-[ß-D-glucopyranosyl-(1→4)-α-L-arabinopyranosyl]-oleanolic 
acid-(28→1)-ß-D-glucopyranosyl ester (Fig. 2.1). Acid hydrolysis of the saponin with 
8% methanolic HCl yielded oleanolic acid, D-glucose and L-arabinose and the ratio of 
glucose to arabinose has been found to be 2:1. 
COOR1
RO
 
R = glucose 1 → 4 arabinose; R1 = glucose 
Figure 2.1: Chemical structure of oleanolic saponin from the seeds of G. lotoides. 
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Five hopane triterpenoidal saponins (glinusides A – E) are known from the aerial parts 
of G. lotoides var. dictamnoides growing in Egypt (Hamed et al., 1996; Hamed and El-
Emary, 1999). The chemical structures of those saponins have been elucidated as (A) 3-
O-ß-L-arabinopyranosyl-22-O-ß-D-glucopyranosyl (4←1)-α-L-rhamnopyranosyl-15ß-
hydroxyhopan-6-one; (B) 3-O-ß-L-arabinopyranosyl-15-O-ß-D-glucopyranosyl-22ß-
hydroxyhopan-6-one; (C) 3-O-ß-D-glucopyranosyl-(4←1)-ß-L-arabinopyranosyl-22ß-
hydroxyhopan-6-one; (D) 3-O-ß-L-arabinopyranosyl-22-α-L-rhamnopyranosyl-(1→4)-
ß-D-glucopyranosyl-5ß-H-16-ß-hydroxyhopane; and (E) 3-O-ß-L-arabinopyranosyl-22-
O-ß-d-glucopyranosyl-(1→4)-ß-D-glucopyranosyl-5ß-H-16-ß-hydroxyhopane(Fig. 2.2). 
RO
OR1
OR2
O
HH
H
 
A:  R = arabinose; R1 = H  R2 = rhamnose 1→ 4 glucose 
B:  R = arabinose; R1 = glucose R2 = H 
RO
OR1
HH
H
OH
 
C:  R = arabinose 1→ 4 glucose 
RO
OR1
HH
H
OH
 
D:  R = arabinose  R1 = rhamnose 1 → 4 glucose 
E:  R = arabinose  R1 = glucose 1 → 4 glucose 
Figure 2.2: Chemical structure of glinuside A – E isolated from the seeds of G. lotoides. 
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Recently, seven hopane-type saponins (lotoideside A - F and succulentoside B) have 
been isolated from Glinus lotoides (Biswas et al., 2005) and the structures were 
elucidated using 1D and 2D NMR, ESIMS and chemical evidences as lotoideside (A) 3-
O-β-D-xylopyranosyl-(1 → 2)-α-L-rhamnopyranosyl-6α-O-β-D-xylopyranosyl-22-β-O-
β-D-glucopyranosyl-16β-hydroxyhopane; (B) 3-O-β-D-xylopyranosyl-(1 → 2)-α-L-
rhamnopyranosyl-22-β-O-β-D-glucopyranosyl-6α,16β-dihydroxyhopane; (C) 3-O-D-
xylopyranosyl-6α-O-β-D-xylopyranosyl-16β-O-β-D-xylopyranosyl-22β-hydroxyhopane; 
(D) 3-O-β-D-xylopyranosyl-16β-O-α-L-arabinopyranosyl-6α,22-β-dihydroxyhopane; 
(E) 3-O-β-D-xylopyranosyl-6α-O-β-D-xylopyranosyl-16 β,22-β-dihydroxyhopane; and 
(F) 3-O-β-D-xylopyranosyl-22-β-O-β-D-glucopyranosyl-16β-hydroxyhopan-6-one 
(Fig.2.3). The known compound succulentoside B has also been identified.  
RO
OR3
HH
OR2
OR1  
A:  R = xylose 1 → 2 rhamnose R1 = xylose R2 = H  R3 = glucose 
B:  R = xylose 1 → 2 rhamnose R1 = H R2 = H  R3 = glucose 
C:  R = xylose  R1 = xylose R2 = xylose R3 = H 
D:  R = xylose  R1 = H R2 = arabinose R3 = H 
E:  R = xylose  R1 = xylose R2 = H  R3 = H 
 
RO
OR1
HH
OH
O  
F:  R = xylose   R2 = glucose 
Figure 2.3: Chemical structures of lotoideside A – F isolated from G. lotoides. 
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Phytochemical investigation of G. lotoides growing in Egypt afforded three flavonoids 
which are identified as apigenin-7-O-glucoside, isovitexin, and luteolin-7-O-glucoside 
and three isoflavonoids namely 5,7,2',4'-tetrahydroxy-6-(3,3-dimethylallyl)isoflavone, 
5,7,4'-trihydroxy -6,3'-di-(3,3-dimethylallyl)isoflavone, and 5,7,2',4'-tetrahydroxy-6,3'-
di-(3,3-dimethylallyl) isoflavone. Moreover, ß-amyrin, campesterol, α-spinasterol, ß-
sitosterol and lupeol are isolated form the plant (Mohamed, 1998).   
O
OH
OOH
RO
R1
R2
 
Apigenin-7-O-glucoside: R = glucose R1 = H  R2 = H 
Isovitexin:   R = H  R1 = glucose R2 = H 
Lutenol-7-O-glucoside:   R = glucose R1 = H          R2 = OH 
O
OOH
OH
OHCH3
CH3
OH
 
5,7,2',4'-tetrahydroxy-6-(3,3-dimethylallyl)isoflavone 
O
OOH
OH
OHCH3
CH3
CH3
CH3
R
 
5,7,4'-trihydroxy -6,3'-di-(3,3-dimethylallyl)isoflavone R = H 
5,7,2',4'-tetrahydroxy-6,3'-di-(3,3-dimethylallyl) isoflavone R = OH 
Figure 2.3: Chemical structures of the flavonoids and isoflavonoids of G. lotoides. 
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Two phenylpropanoid glucosides, dictamnoside A (isolated for the first time), and the 
known compound, citrusin C have been isolated from a chloroform extract of G. 
lotoides L. var. dictamnoides (Hamed et al., 1997). The structures of the 
phenylpropanoid glucosides are shown in figure 2.4. 
CH2
R1
RO
R2
 
Dictamnoside A:  R = glucose  R1 = OCH3 R2 = OCH3 
Citrusin C:  R = glucose  R1 = OCH3 R2 = H 
Figure 2.4: Chemical structure of phenylpropanoid glucosides of G. lotoides 
 
The seeds of G. lotoides contain 14% oil. The etherial composition of the plant contains 
fatty acids, glycosides of sitosterols, stigmasterol and waxes (Biftu et al., 1979). On the 
other hand, from the saponifiable matter of the extract of G. lotoides, various fatty acids 
such as palmitic acid, stearic acid, behenic acid, linoleic acid, and oleic acid have been 
isolated (Mohamed, 1998). Singh, et al. (1982) have isolated fifteen alkanes and six 
isoalkanes from G. lotoides and Mollugo pentaphylla.   
 
The known C-glycoflavonoids, vicenin-2 and vitexin (Nair and Gunasegaran, 1983) and 
apigenin-7-rhamnoglucoside, pelargonidin-3-sophoroside-7-glucoside (Singh et al., 
1982) have been isolated from the fresh aerial parts of Mollugo hirta, which is a 
synonym of G. lotoides. Moreover, seven triterpenoidal sapogenins (mollugogenol A-
G) have been isolated from Mollugo hirta (Chakrabarti et. al., 1969; Chakrabarti, 1969; 
Chakrabarti and Sanyal, 1969; 1970; Chakrabarti and Choudhury, 1973; Barua et al., 
1976a; 1976b; 1989; Choudhury and Chakrabarti, 1975; 1976; 1979; Choudhury et al., 
1995). 
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In this study, four new hopane saponins and two C-glycoside flavones were isolated and 
the structures were elucidated. 
2.4 Traditional mode of application 
The traditional mode of administration of G. lotoides is to orally consume about 15-20 g 
of capsulated powdered seeds with some food to make it palatable or its “Tella” (a 
home-made beer) extract. This amount is believed to remove the tapeworms completely 
from the intestine (Pankhurst, 1965; Kloos et al., 1978). 
Based on the traditional mode of administration, a solvent system composed of 5% 
ethanol in water, that approximate the alcohol content of the home-made beer was 
utilized to estimate the traditional dose of the plant.  
Chapter 3 
 
EXTRACTION, ISOLATION AND STRUCTURAL ELUCIDATION OF THE 
SAPONINS AND FLAVONOIDS OF THE SEEDS OF GLINUS LOTOIDES 
 
3.1  Introduction 
The major constituents of the seeds of G. lotoides are hopane-type triterpenoidal 
saponins and C-glycoside flavones, which are the main bioactive components of the 
herb, contributing to the cestocidal and pharmacological activities (Pankhurst 1965, 
Kloos et al. 1978, Djote 1978, Endale et al. 1997, 1998, Arragie and Chernishov 1977, 
Chernishov et al. 1978). In this chapter, the extraction, isolation and structural 
elucidation of five hopane-type saponins (glinusides F, G, H, I, and succulentoside B) 
and two flavonoids (vicenin-2 and vitexin-2″-O-glucoside) from the seeds of the plant 
are described.  
 
3.2 Extraction of the seeds of Glinus lotoides  
The extraction and fractionation of the seeds of G. lotoides provided seven extracts (A–
G), Scheme 7.1. The saponins and flavonoids in extracts A – G were evaluated on thin 
layer chromatography (TLC) using different solvent systems. Figure 3.1 shows a typical 
RP-18 TLC of extracts A – G. Extracts A, D and F show a high concentration of 
saponins compared to extracts B, C and G. Moreover, as shown in figure 3.1, the seeds 
of G. lotoides contain a large number of saponins, which are well separated on the RP-
18 TLC plate. The presence of saponins in extract E indicated that the amount of 
methanol used to dissolve extract D was not sufficient (Scheme 7.1).  
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Figure 3.1: Typical RP-18 Thin Layer Chromatography of the extracts A–G of the seeds 
of G. lotoides [Solvent system: methanol: water (4:1); detection: 5% vanillin 
reagent]. *Saponins and flavonoids isolated in this work. 
 
In addition to saponins, the extracts of the seeds of the plant contain flavonoidal 
glycosides, which produce a fluorescent complex with the natural product-PEG reagent 
(NPR).  
 
3.3  Isolation of saponins and flavonoids 
3.3.1  Column chromatography fractionation 
Open-column chromatography is often used as a first fractionation step for a crude 
extract, which provides a partial separation of the different groups of the constituents. In 
order to simplify the isolation of saponins and flavonoids, extract F was fractionated 
using RP-18 and Sephadex LH-20 column.    
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Figure 3.2 depicts TLC of 14 fractions (Fr. I - XIV) of extract F using RP-18 column 
chromatography. As shown in the figure, fraction I and II contain flavonoids which 
were identified using NPR-reagent. 
 
 
 
 
 
Figure 3.2: TLC of the fractions of extract F collected from RP-18 column 
chromatography [TLC: RP-18; solvent system: methanol: water (4:1); 
detection: 5% vanillin reagent]. 
 
One of the major problems in column chromatography is the length of time required to 
perform the separations with large numbers of fractions to be analyzed. The RP-18 
column provided 280 fractions that were combined after TLC evaluation. Moreover, the 
yield of the saponins in the fractions was minimal. Hence, sephadex LH-20 column 
chromatography was used for the fractionation extract F. Unlike the RP-18 column, the 
sephadex LH-20 gel chromatography provides a small number of fractions and the 
separation was completed in a relatively short time. 
 
Figure 3.3 depicts the major fractions (6 out of the 20 fractions) containing the saponins 
and flavonoids. After TLC control, these fractions were combined into two major 
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fractions: Fr. 1 (yield, 352 mg) which contains mainly flavonoids and Fr. 2 (yield, 600 
mg) containing saponins. 
 
 
 
Figure 3.3: TLC of the major fractions of extract F collected from sephadex LH-20 
column chromatography [TLC: RP-18; solvent system: methanol: water 
(4:1); detection: 5% vanillin reagent]. 
 
3.3.2  High Performance Liquid Chromatography (HPLC) 
Fractions (Fr. 1 and Fr. 2) collected from the sephadex LH-20 column chromatography 
were further purified using reversed phase HPLC to isolate the saponins and flavonoids 
of G. lotoides.  
 
Figure 3.4 shows the analytical (Fig. 3.4 a) and preparative (Fig. 3.4 b) HPLC 
chromatogram of Fr. 1. The compounds at retention time of 8.2 min (F1/1) and 17.9 min 
(F1/2) were isolated and the structures were elucidated using spectral analysis including 
UV, MS and NMR as vicenin-2 and vitexin-2″-O-glucoside, respectively. The structural 
elucidation of F1/1 and F1/2 has been described under 3.4.2 
Fr. 1Fr. 2
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Figure 3.4: HPLC isolation of the flavonoids from Fraction 1. [Column: CC250/4 
Nucleosil 100-7 C18; mobile phase: 15% CH3CN; flow rate: 1 mL/min; 
detection: UV-360 nm; Injection volume: a) analytical, 20µL and b) 
preparative, 250µL]. 
 
Similarly, fraction 2 (480 mg) containing mixtures of saponins was separated by RP-18 
HPLC. Figure 3.5 a) shows the analytical HPLC separation of the saponins S1 and S2 
which after preparative scale up (Fig. 3.5 b) was used to isolate the major saponin 
b) 
a) 
3 EXTRACTION, ISOLATION AND STRUCTURAL ELUCIDATION  18 
fractions. The two major peaks at retention time of 18.8 (S1) and 23 (S2) min were 
isolated. 
 
 
 
Figure 3.5: HPLC isolation of the saponin fractions (S1 and S2) from fraction 2. 
[Column: CC250/4 Nucleosil 100-7 C18; mobile phase: 75% MeOH; flow 
rate: 1 mL/min; detection: RID; Injection volume: a) analytical, 20µL and b) 
preparative, 250µL]. 
 
However, TLC examination of the S1 and S2 (Fig. 3.6) showed that the isolated 
compounds were composed of a group of saponins, which were not separated by HPLC. 
As shown in figure 3.6 increasing the sample volume form 1 to 5 μL revealed the 
presence of additional minor components in S2 fraction. Isocratic elution was not 
satisfactory for such saponins due to a very similar polarity and gradient elution was not 
a) 
b) 
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possible due to the nature of the refractive index detector. Hence, preparative TLC was 
utilized to isolate the saponins as described below. 
 
 
 
 
Figure 3.6: TLC of S1, S2 and Extract F. [TLC: Silica gel 60; solvent system: CHCl3-
MeOH-H2O (70:50:4); detection: 5% vanillin reagent]. 
 
3.3.3  Preparative thin layer chromatography  
Preparative TLC of S1 afforded two fractions, S1/1 (Rf = 0.48) and S1/2 (Rf =0.41) and 
S2 gave two fractions S2/1 (Rf = 0.52) and S2/2 (Rf = 0.33) (Fig. 3.6) The structure of 
the isolated saponins has been elucidated using spectral analysis as described below. 
 
3.4     Structural elucidation of the saponins and flavonoids of Glinus lotoides 
3.4.1  Structural elucidation of the saponins 
The structure of the isolated saponin S1/1 was elucidated as 3ß-O-ß-D-xylopyranosyl-
6α-O-ß-D-xylopyranosyl-16ß-O-ß-D-xylopyranosyl-22-hydroxyhopane, which is 
referred to as glinuside F. S1/2, was identified as 6α-O-α-L-arabinopyranosyl-3ß-O-ß-D-
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xylopyranosyl-16ß-O-ß-D-xylopyranosyl-22-hydroxyhopane, succulentoside B, a 
saponin that was isolated from Polycarpon succulentum (Meselhy and Aboutabl, 1997). 
The structure of S2/1 was elucidated as 3ß-O-α-L-rhamnopyranosyl-(1→2)-ß-D-
xylopyranosyl-6α,16ß-dihydroxy-22-O-α-L-rhamnopyranosyl-hopane (glinuside G). 
S2/2 provided two saponins and their structures were elucidated in a mixture as 3β-O-α-
L-rhamnopyranosyl-(1→2)-β-D-xylopyranosyl-6α-O-β-D-xylopyranosyl-16β-hydroxy-
22-O-α-L-rhamnopyranosyl-hopane (glinuside H) and as 3β-O-α-L-rhamno-pyranosyl-
(1→2)-β-D-xylopyranosyl-6α-O-β-D-xylopyranosyl-16β-O-β-D-xylopyranosyl-22-
hopane (glinuside I). Figure 3.7 depicts the chemical structures of the glinusides F, G, 
H, I and succulentoside B. The structural elucidation of the glinusides F, G, H and I 
using spectral analysis has been described below.  
 
3.4.1.1  General introduction 
Saponins are high-molecular weight glycosides, consisting of a sugar moiety linked to a 
triterpene or steroid aglycon. Saponins exhibit a wide spectrum of biological activities 
and they are constituents of many herbal drugs and folk medicines (Wagner et al., 1985; 
Bader and Hiller 1987; Bader et al., 1995; Bialy et al., 1999; Liou and Wu, 2002). Of 
these, the most important include: Saponariae radix, Hippocastani semen, Primulae 
radix, Hederae helices herba, Senegae radix, Liquiritiae radix and Ginseng radix. The 
cestocidal and pharmacological activities of the seeds of G. lotoides are probably due to 
its saponins. Anthelmintic activity has been demonstrated for other triterpene saponins 
(Carpani et al., 1989; Enwerem et al., 2001). 
 
The triterpene saponins could be mono-, bi- or tridesmosidic. As monosaccharide units, 
D-glucose, L-rhamnose, L-arabinose and D-xylose occur widely and D-apiose, D-ribose, 
D-quinovose and D-allose occur rarely (Hostettmann and Marston, 1995). 
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Saponins/Aglycon R R1 R2 R3 Formula Mol. Weight 
Mollugogenol A H H H H C30H49O4   473 
Glinuside F Xyl Xyl Xyl H C45H76O16   872 
Glinuside G Rha-Xyl H H Rha C47H80O16   900 
Glinuside H Rha-Xyl Xyl H Rha  C52H88O20 1032 
Glinuside I Rha-Xyl Xyl Xyl  H C51H86O20 1018 
Succulentoside B Xyl Ara Xyl H C45H76O16   872 
Abbreviations: Xyl, xylose; Rha, rhamnose and Ara, arabinose. 
 
Figure 3.7: Chemical structures of the saponins of Glinus lotoides and the aglycon, 
mollugogenol A.  
 
Mass Spectrometry (MS) 
The choice of ionization method in MS depends on the polarity, liability and molecular 
weight of the saponin to be analyzed. The so-called ‘soft’ ionization techniques are 
employed to obtain molecular weight and sugar sequence information. (Wolfender et al, 
1992; Schöpke et al, 1996). ESIMS and HRESIMS methods have been used to 
characterize the molecular weight and formula as well as information on the sugar 
nature.  
 
3 EXTRACTION, ISOLATION AND STRUCTURAL ELUCIDATION  22 
Nuclear Magnetic Resonance (NMR) 
The 1H NMR spectra of saponins are complex and tedious to analyze. The vast majority 
of proton resonances of the sugar moiety appear in a very small spectral width of 3.0 – 
4.2 ppm, with subsequent problems of overlapping. 2-D NMR analysis provides a 
method of overcoming the problem of spectral crowding in these regions, thus 
simplifying the assignment of saccharide protons. Under favorable conditions, all the 
protons present in a given sugar residue can be identified.  
 
The methyl peaks of triterpenes are readily discernible and informative. Some useful 
data can also be obtained from 1H NMR spectra for the anomeric configurations and 
linkages of the sugar chain. The coupling constant of the C-1 proton of α-linked sugar 
units is approximately 3 Hz, while β-linked units have a coupling constant of 6-7 Hz 
(Agrawal, 1992). 
 
The number of anomeric carbons in saponin is readily determined by 13C NMR, 
defining the number of individual sugar residues present. By comparing the chemical 
shifts with appropriate model sugars, the ring size (furanose or pyranose form) and type 
of each monosaccharide can be established (Seo et al., 1978; Bock and Pedersen, 1974; 
1983). The anomeric carbon atoms in pyranoses resonate at 90-110 ppm, while carbon 
atoms bearing secondary hydroxy groups in pyranoses give signals at 65-85 ppm; 
carbon atoms carrying primary hydroxy groups are found at 60-64 ppm (Bock and 
Pedersen, 1983).  
 
13C NMR, DEPT, HMQC, and long-range COSY were applied to the structural 
elucidation of the saponins in order to resolve the problems caused by overcrowding of 
proton spectrum. 
 
3 EXTRACTION, ISOLATION AND STRUCTURAL ELUCIDATION 23
Sugar analysis 
NMR and MS information may sometimes not be confirmatory. In this case, additional 
sugar analysis is necessary. One of the most important procedures for the determination 
of interglycosidic linkages is to carry out GC-MS analysis of the alditol acetates of the 
sugars from the premethylated saponins. The premethylated saponin was hydrolyzed, 
reduced and subsequently acetylated, giving the corresponding monosaccharide 
derivatives, which were analyzed and compared with the data from authentic samples 
(Plock et al., 2001). 
 
Microhydrolysis of saponins using a hydrochloric acid vapor on TLC was also used to 
identify the monosaccharides (Meselhy and Aboutabl, 1997; Meselhy, 1998). Authentic 
sugars such as arabinose, xylose and rhamnose were utilized as reference 
monosaccharides.  
 
3.4.1.2  Glinuside F  
Glinuside F was isolated as a white amorphous powder. The TLC analysis of glinuside 
F using a solvent system composed of CHCl3-MeOH-H2O (70:50:4) provided a spot at 
Rf –value of 0.48. 
 
The electrospray ionization mass spectrometry (ESIMS) of glinuside F (Fig. 3.8 a and 
b) in the positive and negative mode showed quasimolecular ion peaks at m/z 872.7 
[M+H]+ and 871.6 [M-H]-, respectively, consistent with the molecular formula, 
C45H76O16. This was confirmed by its HRESIMS, which showed a [M+Na]+ at m/z 
895.507 (calculated for C45H76O16+Na, 895.5031).  
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Figure 3.8: ESIMS collision induced dissociation spectra of glinuside F in a) positive 
mode and b) negative mode. 
 
The 1H NMR spectrum (CD3OD) showed signals characteristic for eight tertiary methyl 
groups as singlets at δ 0.88, 0.96, 1.10, 1.11, 1.13, 1.15, 1.30 and 1.42, and three 
anomeric protons at δ4.30 (d, J = 7.8 Hz), 4.45 (d, J = 7.8 Hz), and 4.50 (d, J = 7.8 Hz) 
(Table 3.1) demonstrating the presence of ß-anomers of three sugar units.  
 
The 13C NMR spectrum of glinuside F (CD3OD) analyzed by the aid of distortionless 
enhancement by polarization transfer (DEPT) and 1H-detected heteronuclear one-bond 
spectroscopy (HMQC) revealed the presence of 45 carbon atoms in the molecule (Table 
a) 
b) 
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3.2). DEPT was used for the determination of carbon multiplicities in the 13C NMR. 
Thirty carbon signals were indicated for the aglycon part with signals characteristic for 
eight tertiary methyls, eight methylenes, eight methines and six saturated quaternary 
carbons, including a carbon signal at δ 74.6 for a quaternary carbinol carbon.  
 
From the above data and by comparing the 13C NMR data of glinuside F with literature 
reports for triterpenoids, the aglycon was identified as mollugogenol A, a triterpene 
from the hopane type isolated form Mollugo pentaphylla L (Hamburger et al., 1989; 
Mahato and Kundu 1994).  
 
Fifteen carbon signals were left for the sugar moieties including three anomeric carbons 
at δ 107.6, 106.0, and 104.1, (Table 3.2) from which the presence of three pentose-
monosaccharide moieties was indicated. Accordingly, the ESIMS of glinuside F in the 
positive mode showed fragment ion peaks at m/z 740 [(M+H)-132]+, 608 [(M+H)-
2(132)]+, and 476 [(M+H)-3(132)]+ (Fig. 3.8 a), due to subsequent loss of three pentose 
units. Consequently, the spectra in the negative mode produced fragment ions at m/z 
739 [(M-H)-132]-, 607 [(M-H)-2(132)]-, 475 [(M-H)-3(132)]- (Fig. 3.8 b). 
 
Acid hydrolysis of glinuside F on TLC plate in a hydrochloric acid vapor afforded only 
xylose, which was supported by GC-MS analysis of the partially methylated alditol 
acetates as described by Plock et al (2001). The identities of the monosaccharides were 
confirmed by a detailed inspection of 1D and 2D NMR experiments (1H–1H COSY and 
HMQC) where information of the respective sugar residues and the anomeric 
configurations could be obtained.  
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As shown in Table 3.2, the downfield shift of three oxygen-bearing methines C-3 (δ 
90.9), C-6 (δ 81.1) and C-16 (δ 80.8), indicated the sites of glycosylation (Hamburger et 
al, 1989; Mahato and Kundu 1994). 
 
The above proposed interglycosidic linkages were further substantiated by the long-
range correlation observed in the 1H-detected heteronuclear multiple-bond spectroscopy 
(HMBC) spectra of glinuside F. Cross peaks between H-1'/C-1' (δ 4.30/ δ 107.6) of one 
xylose unit and C-3/H-3 (δ 90.9/ δ 3.10) of the aglycon showed one xylose to be bound 
to C-3 of the aglycon. Similarly, H-1''/C-1'' (δ 4.45/ δ 106.0) of the second xylose unit 
correlated with C-6/H-6 (δ 81.1/ δ 4.05), and H-1'''/C-1''' (δ 4.50/ δ 104.1) of the third 
xylose correlated with C-16/H-16 (δ 80.8/ δ 4.30) of the aglycon.  
 
The 1H and 13C NMR data (Table 3.1 and 3.2) indicated the ß-configuration at the 
anomeric positions for the xylose units (3JH1,H2 = 7.8 Hz) (Hamburger et al, 1989). The 
multiplicities and coupling constants of the axial protons at C-3 (J2a,3α = 12.0; J2e,3α = 
4.5 Hz), C-6 (J5a,6ß = 12.0; J5e,6ß = 4.5 Hz) and C-16 (J15a,16α = 10.0; J15e,16α = 4.0; J17a,16α 
= 10.0 Hz), confirmed the equatorial orientation of all three substitutents in the aglycon 
part (Hamburger et al, 1989; Breitmaier 1993).  
 
Further analysis of the HMBC spectrum provided independent confirmatory evidence 
for the nature of the aglycon and allowed unambiguous assignment of both the 13C and 
1H NMR chemical shifts of most of the relevant signals (Plock et al, 2001). On the basis 
of the above evidence, the structure of glinuside F was characterized as 3ß-O-ß-D-
xylopyranosyl-6α-O-ß-D-xylopyranosyl-16ß-O-ß-D-xylopyranosyl-22-hydroxyhopane. 
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3.4.1.3  Glinuside G 
Glinuside G was isolated as a white amorphous powder. The TLC analysis of glinuside 
G using a solvent system composed of CHCl3-MeOH-H2O (70:50:4) provided a spot at 
Rf –value of 0.52 (Fig. 3.6). 
 
The ESIMS of glinuside G (Fig. 3.9) in the negative mode showed quasimolecular ion 
peaks at m/z 899 [M-H]-. The molecular formula of glinuside G was calculated as 
C47H80O16 from its HRESIMS, which showed a [M+Na]+ at m/z 923.538 (calculated for 
C47H80O16+Na, 923.5344).  
 
 
Figure 3.9: ESIMS collision induced dissociation spectra of glinuside G in the negative 
mode. 
 
The 1H, 1H COSY, 13C, DEPT and HMBC spectra suggested the aglycon to be 
mollugogenol A, the same moiety as in glinuside F. The only differences were changes 
in the chemical shifts associated with differences in the glycosylation pattern at C-6, C-
16, and C-22.  
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Sugar analysis of glinuside G revealed two rhamnose moieties and one xylose moiety as 
sugar components. The occurrence of these sugars was further supported by the 
fragmentation pattern in the ESIMS of glinuside G, taken in the negative mode, which 
showed fragment ions at m/z 753 [(M–H)-146]–, 607 [(M–H)-(146+146)]–, and 475 
[(M–H)-(146+146+132)]–, due to the subsequent loss of rhamnose, and two molecules 
of rhamnose and xylose, respectively (Fig. 3.9). Additionally, the presence of these 
sugars was confirmed from their 1H and 13C NMR data as shown in Table 3.1 and 3.2 
(Breitmaier, 1993). 
 
Glycosylation at C-3 with xylose was deduced from the correlation in the HMBC 
spectrum between the signals at δC 106.5/ δH 4.42 of xylose and the signal at δC 90.2/ δH 
3.09 (C-3) of the aglycon moiety. The downfield shift of C-2 of xylose at δC 78.6 and δH 
3.47 suggested further glycosylation at this position. Long-range correlations between 
C-2 (δ 78.6) of xylose and H-1IV (δ 5.36) of rhamnose confirmed the linkage at this 
position. The second rhamnose moiety was attached to C-22 which is deduced from the 
long-range correlation between the signals at δC 97.0/ δH 5.21 from C-1 of rhamnose 
and δC 84.5 of the aglycon at C-22. 
 
Analysis of the HMBC spectrum afforded confirmatory evidence of the structure and 
allowed assignment of the 13C and 1H NMR data (Plock et al., 2001). Accordingly, 
glinuside G was identified as 3ß-O-α-L-rhamnopyranosyl-(1→2)-ß-D-xylopyranosyl-
6α,16ß-dihydroxy-22-O-α-L-rhamnopyranosyl-hopane. 
 
3.4.1.4  Glinuside H  
S2/2 provided a mixture of two saponins (glinuside H and I) and their structures were 
elucidated in this mixture due to the small amount obtained. The presence of a mixture 
was confirmed from inspection of the 1D 1H NMR spectrum where the intensities of the 
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signals for the anomeric protons indicated a 2:1 mixture of glinuside H and I, 
respectively. This difference in the proportion of the two saponins in the mixture made 
possible the identification of the saponins in a mixture. The TLC analysis of the mixture 
using a solvent system composed of CHCl3-MeOH-H2O (70:50:4) provided Rf values 
of 0.33 and 0.25 for glinuside H and I, respectively. 
  
The HRESIMS of the major component (glinuside H) showed a [M + Na]+ at m/z 
1055.581, with the molecular formula of C52H88O20 (calculated for C52H88O20+Na, 
1055.5766) indicating the presence of two rhamnose and two pentose sugar moieties. 
Sugar analysis of the mixture revealed the presence of rhamnose and xylose.  
 
Inspection of the 1D and 2D COSY spectra of the anomeric protons indicated that 
glinuside H possessed two rhamnose units from signals at δH 5.53 and 5.21 and two 
xylose units at δH 4.41 and 4.36 (Table 3.1). Comparison of the data with glinuside G 
suggested that glinuside H had a rhamnose (1→2) xylose unit at C-3 of the aglycon 
while analogous comparison with glinuside F suggested a β-xylopyranosyl unit at C-6.  
 
Long-range C-H correlations in the 2D HMBC spectrum provided further evidence for 
the substitution pattern of the aglycon. Thus, in glinuside H, H-1 of the xylose moiety at 
δH 4.41 correlated with C-3 (δC 91.1) of the aglycon as identified from its correlations 
with H-23 (δH 1.42) and H-24 (δH 1.10).  
 
Similarly, H-1 of the xylose at δH 4.36 correlated with C-6 at δC 81.4 as in glinuside F, 
and the rhamnose moiety at δH 5.53 correlated with a carbon signal at δC 77.9 attributed 
to C-2 of the same xylose moiety as shown for glinuside G. H-1 of the rhamnose moiety 
at δH 5.21 correlated with C-22 (δC 84.4) of the aglycon as determined from its 
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correlations with H-30 (δH 1.43), H-29 (δH 1.36), H-17 (δH 1.52), and H-21 (δH 2.59). 
Form the above data, glinuside H was identified as 3β-O-α-L-rhamnopyranosyl-(1→2)-
β-D-xylopyranosyl-6α-O-β-D-xylopyranosyl-16β-hydroxy-22-O-α-L-rhamnopyranosyl-
hopane.  
 
3.4.1.5  Glinuside I  
The HRESIMS of the minor component of the mixture (glinuside I) showed a [M+Na]+ 
at m/z 1041.565 indicating a molecular formula of C51H86O20 (calculated for 
C51H86O20+Na, 1041.5610) with three pentose and one rhamnose sugar units. Sugar 
analysis revealed rhamnose and xylose in the mixture. 
 
The integrals of the 1D and 2D COSY signals of glinuside I had only one rhamnose 
signal at δH 5.53 and two separate signals for xylose units at δH 4.39 and 4.37 (Table 
3.1). According to the integration, a third xylose signal overlapped with that of the 
major compound (glinuside H) at δH 4.41.  
 
Comparison of the data with glinuside G suggested that glinuside I had a rhamnose 
(1→2) xylose unit at C-3 of the aglycon and similar comparison with glinuside F 
suggested a β-xylopyranosyl unit at C-6. Long-range C-H correlations in the 2D HMBC 
spectrum provided further evidence for the substitution pattern of the aglycon. Thus, in 
glinuside I, H-1 of the xylose moiety at δH 4.41 correlated with C-3 (δC 91.1) of the 
aglycon as identified from its correlations with H-23 (δH 1.42) and H-24 (δH 1.10). 
Similarly, H-1 of the xylose at δH 4.36 correlated with C-6 at δC 81.4 as in glinuside F 
and the rhamnose moiety at δH 5.53 correlated with a carbon signal at δC 77.9 attributed 
to C-2 of the same xylose moiety as shown for glinuside G. 
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The remaining signal for glinuside I of H-1 of the xylose moiety at δH 4.39 correlated 
with a carbon signal at δC 80.7, compatible to C-16 of the aglycon compared with 
glinuside F. Hence, glinuside I was identified as 3β-O-α-L-rhamnopyranosyl-(1→2)-β-
D-xylopyranosyl-6α-O-β-D-xylopyranosyl-16β-O-β-D-xylopyranosyl-22-hopane. 
 
Table 3.1: 1H NMR spectral data of glinuside F, G, H and I in CD3OD 
Aglycon F G H* I*
1 1.00 m; 1.70 m 1.01 m; 1.70 m  
2 1.84 m; 1.70 m 1.86 m; 1.70 m 1.87 m; 1.71 m  
3 3.10 dd (12, 4.5) 3.09 dd (12, 4.5) 3.06 dd (11.6, 4.5)  
5 0.95 d (10.5) 0.94 d (10.5) 1.12 d  
6 4.05 ddd (10, 10, 4) 4.03 ddd (11, 10.5, 4) 4.01 m  
7 1.62 m; 1.95 m 1.70 m; 1.58 m 1.62 m; 1.95 m  
9 1.30 m 1.30 m  
11 1.65 m; 1.65 m 1.65 m; 1.65 m  
12 1.60 m; 1.60 m 1.60 m; 1.60 m  
13 1.45 dd (12, 4) 1.43 dd (12, 4)  
15 1.75 m; 1.90 m 1.72 m; 1.33 m 1.29 m; 1.71 m 1.45 m; 1.91 m
16 4.30 ddd (10, 10, 4) 4.14 ddd (10, 10, 4) 4.14 ddd  
(11.6, 9.3, 4.1) 
4.30 ddd  
(11.6, 9.3, 4.1) 
17 1.45 dd (10, 10) 1.55 dd (10, 10) 1.52 m  
19 1.10 m; 1.60 m 1.10 m; 1.60 m  
20 1.90 m; 1.60 m 1.90 m; 1.60 m 1.56 m; 1.92 m  
21 2.60 ddd (10, 10, 9) 2.60 ddd (10, 10, 9) 2.59 m  
23 1.41 s 1.38 s 1.42 s  
24 1.10 s 1.07 s 1.10 s  
25 0.98 s 0.96 s 0.98 s 0.98 s 
26 1.13 s 1.14 s 1.14 s  
27 1.11 s 1.13 s 1.11 s  
28 0.87 s 0.88 s 0.88 s 0.87 s 
29 1.15 s 1.37 s 1.36 s 1.15 s 
30 1.29 s 1.42 s 1.43 s 1.29 s 
* Only the signals that could be ambiguously assigned are given. 
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Table 3.1: 1H NMR spectral data of glinuside F, G, H and I in CD3OD (cont’d) 
Sugars F G H I 
Xyl C-3     
1′ 4.30 d (7.8) 4.42 d (6.6) 4.41 d (7.5) 4.41 d (7.5) 
2′ 3.25 m 3.46 m 3.51 m  3.51 m 
3′ 3.39–3.34m 3.47 m 3.51–3.47 m 3.51–3.47 m 
4′ 3.52–3.48 m 3.52 m 3.48a m 3.48a m 
5′ A 3.91–3.85 m 3.90 dd (5.0, 11.4) 3.82b m 3.82b m 
5′ B 3.26–3.20 m 3.22 dd (9.3, 11.4) 3.22c m 3.22c m 
     
Xyl C-6     
1′′ 4.45 d (7.8)  4.36 d (7.5) 4.37 d (7.5) 
2′′ 3.25 m  3.28 m 3.28 m 
3′′ 3.39–3.34 m  3.34 m 3.34 m 
4′′ 3.52–3.48 m  3.49a m 3.49a m 
5′′ A 3.91–3.85 m  3.88b m 3.88b m 
5′′ B 3.26–3.20 m  3.22c m 3.22c m 
     
Xyl C-16     
1′′′ 4.50 d (7.8)   4.39 d (7.5) 
2′′′ 3.25 m   3.20 m 
3′′′ 3.39–3.34 m   3.35 m 
4′′′ 3.52–3.48 m   3.49a m 
5′′′ A 3.91–3.85 m   3.88b m 
5′′′ B 3.26–3.20 m   3.22c m 
     
Rha (1-2)     
1 IV  5.36 d (2) 5.53 d (2) 5.53 d (2) 
2 IV  3.98 m 3.93 m 3.93 m 
3 IV  3.79 m 3.78 m 3.78 m 
4 IV  3.43 dd (9, 9) 3.44 m 3.44 m 
5 IV  3.77 dq (9, 6.5) 4.09 m 4.09 m 
6 IV  1.29 d (6.5) 1.26 d (6.5) 1.26 d (6.5) 
     
Rha C-22     
1 V  5.21 d (2) 5.21 d (2)  
2 V  3.78 m 3.77 m  
3 V  3.67 dd (9, 3.5) 3.67 dd (9; 3.5)  
4 V  3.42 dd (9, 9) 3.41 dd (9; 9)  
5 V  4.00 dq (9, 6.5) 3.77 m  
6 V  1.26 d (6.5) 1.28 d (6.5)  
a, b, c Assignments of values with the same superscript may be interchanged;  
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Table 3.2: 13C NMR spectral data of glinuside F, G, H and I in CD3OD 
Aglycon F G Hb Ic 
1 40.1 t 40.1 t 40.0 t  
2 26.8 t 26.9  (26.9) t  
3 90.9 d 90.2  91.1 d 91.1 d 
4 40.8 s 40.9 s 40.8 s  
5 61.3 d 61.9 d 61.8 d  
6 81.1 d 69.0 d 81.4 d 81.4 d 
7 45.1 t 46.1 t (44.9) t  
8 44.0 s 44.8 s (43.9) s  
9 49.9a d 50.6 d 50.7 d  
10 39.9 s 39.9 s 40.0 s  
11 22.0 t 22.0 t (22.1) t  
12 24.6 t 24.7 t (24.7) t  
13 50.6a d 50.0 d 50.2 d  
14 44.0 s 43.9 s (43.9) s  
15 43.4 t 44.2 t (44.0) t  
16 80.8 d 67.8 d (67.9) d 80.7 d 
17 59.9 d 62.7 d 62.7 d 59.9 d 
18 47.5 s 46.6 s 46.7 s 47.4 s 
19 42.6 t 42.7 t 42.6 t  
20 29.1 t 28.7 t (28.7) t  
21 53.4 d 51.5 d 51.5 d 53.5 d 
22 74.6 s 84.5 s 84.5 s 74.6 s 
23 31.2 q 31.2 q 31.3 q  
24 16.8 q 17.0 q 16.8 q  
25 17.6 q 17.6 q (17.7) q  
26 17.6 q 17.8 q (17.7) q  
27 18.5 q 18.7 q (18.7) q  
28 18.7 q 18.7 q (18.8) q  
29 30.7 q 25.5 q 25.4 q 30.6 q 
30 27.1 q 26.1 q 26.0 q 27.1 q 
a Assignments with the same superscript may be interchanged.  
b The shifts in parentheses were assigned from the 1D 13C spectrum by comparison 
with F and G. 
c Only the signals that could be unambiguously assigned are given.  It is assumed 
the other signals overlap with those of the major component, glinuside H, in the 
mixture. 
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Table 3.2: 13C NMR spectral data of glinuside F, G, H and I in CD3OD (cont’d) 
Sugars F G H I 
Xyl C-3     
1′ 107.6 d  106.5 d 106.8 d 106.8 d 
2′ 75.5a d 78.6 d 77.9 d 77.9 d
3′ 78.3b d 78.9 d 79.4 d 79.4 d
4′ 71.3c d 71.6 d 71.8 d 71.8 d  
5′ 66.7d d 66.3 d 66.6 d 66.6 d
Xyl C-6   
1′′ 106.0 d   106.6 d 106.6 d 
2′′ 75.0a d  75.0a d 75.0a d 
3′′ 77.9b d  78.5 d 78.5 d
4′′ 71.0c d  71.1 d 71.1 d  
5′′ 66.8d d  66.6 d 66.6d
Xyl C-16   
1′′′ 104.1 d   104.1 d 
2′′′ 75.2a d  75.1a d 
3′′′ 78.0b d  78.3 d
4′′′ 71.1c d  71.0 d
5′′′ 67.2d d  66.6 d
Rha (1-2)   
1IV  102.0 d 101.4 d 101.4 d 
2IV  72.1 d 72.4 d 72.4 d
3IV  73.1 d 71.8 d 71.8 d
4IV  74.0 d 74.3 d 74.3 d
5IV  70.4 d 69.7 d 69.7 d
6IV  18.0 q 18.0 q 18.0 q
Rha C-22   
1V  97.0 d 96.9 d
2V  73.9 d 73.1 d
3V  72.2 d 72.3 d
4V  74.0 d 73.9 d
5V  70.1 d 70.5 d
6V  18.0 q 18.0 q
a-d Assignments with the same superscript may be interchanged.  
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3.4.2  Structural elucidation of the flavonoids  
3.4.2.1  General introduction 
Flavonoids are polyphenolic compounds that are ubiquitous in nature and are 
categorized, according to chemical structure, into flavonols, flavones, flavanones, 
isoflavones, catechins, anthocyanidins and chalcones (Harborne, 1988; Markham and 
Geiger, 1994). Over 4,000 flavonoids have been identified, many of which occur in 
fruits, vegetables and beverages (tea, coffee, beer, wine and fruit drinks). The 
flavonoids have aroused considerable interest because of their potential beneficial 
effects on human health as antiviral, anti-allergic, antiplatelet, anti-inflammatory, 
antitumor and antioxidant (Tsai et al., 1996; Kuti and Konuru, 2004; Lombardi-Boccia, 
2004; Wei et al., 2004; Hsiao et al., 2005).  
 
The structures of the two isolated flavonoids, F1/1 and F1/2, were elucidated using 
spectral analysis including UV, MS and NMR as 5,7,4′-trihydroxyflavone-6,8-di-C-
glucoside (vicenin-2) and 5,7,4′-trihydroxy-flavone-8-C-sophoroside (vitexin-2″-O-
glucoside), respectively. The chemical structure of vicenin-2 and vitexin-2″-O-
glucoside are shown in Figure 3.10.  
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Figure 3.10: Chemical structures of the flavonoids of Glinus lotoides.  
The structural elucidations of F1/1 and F1/2 are described below. 
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3.4.2.2  Ultraviolet Spectroscopy (UV) 
Figure 3.11 depicts the methanol spectra of F1/1 and F1/2 in the region 240-400 nm, 
showing two major absorption peaks at 272 and 330 nm for F1/1 and 270 and 331 for 
F1/2. These peaks are characteristics for flavones and flavonols (Fig. 3.12) which show 
two major absorption peaks in the region 240-400 nm. These two peaks are commonly 
referred to as band I (300-380 nm) and band II (240-280 nm) (Mabry et al, 1970). 
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Figure 3.11: The UV spectra of F1/1 and F1/2 in methanol.  
 
Band I is considered to be associated with the absorption due to the B-ring (cinnamoyl 
system) and band II with the absorption involving the A-ring, benzoyl system (Fig. 
3.12). Particularly, the position of band I in the methanol spectrum provides information 
about the type of flavonoid as well as its oxidation pattern. The position of band I 
distinguish between flavones and flavonols (3-hydroxyflavones). Band I of flavones 
occurs in the range 304-350 nm whereas band I of flavonols appears at a longer 
wavelength (352-385 nm). 
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Figure 3.12: Flavone and flavonol skeletons with benzoyl and cinnamoyl moieties. 
 
As shown in Figure 3.11, the maximum of band I absorption in methanol UV spectra of 
F1/1 and F1/2 appear at 330 and 331 nm, respectively, indicating that F1/1 and F1/2 
may belong to flavone groups. However, in flavonols with a substituted 3-hydroxy 
group (methylated or glycosylated), band I appears in the range 328-357 nm which 
overlaps the region of band I in flavones, and the general shape of the spectral curves 
approach those of flavones. 
 
Oxidation pattern of the B-ring in flavones could be identified from the nature of the 
peaks. In this, 3´, 4´- or 3´, 4´, 5´- oxygenated flavones usually exhibit two absorption 
peaks (or one maximum with a shoulder) between 250-275 nm, while the 4´-oxygenated 
equivalents have only one peak in this range. The methanol UV spectra of F1/1 and 
F1/2 (Fig. 3.11) showed a single peak at 272 and 270 nm, respectively, indicating that 
the B-rings contain only 4´-OH group. 
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The UV spectra of flavones and flavonols in the presence of sodium methoxide 
(NaOMe) provide information on the hydroxylation pattern of the flavonoid. Sodium 
methoxide is a strong base and ionizes to some extent all hydroxy groups of the 
flavonoid nucleus. The addition of NaOMe to flavones in methanol usually produces 
bathochromic shifts in all absorption bands. However, a large bathochromic shift of 
band I of about 40-65 nm, with an increase in intensity, is diagnostic for the presence of 
a free 4´-hydroxy group.  
 
As shown in Figure 3.13 the addition of NaOMe to methanol solution of F1/1 produced 
bathochromic shift of band I by 69 nm (from 330 to 399) with an increase in the 
intensity of absorption, confirming the presence of free 4´-hydroxy group in F1/1. 
Similar result was obtained for flavonoid F1/2, which showed a bathochromic shift of 
band I by 65 nm. The NaOMe spectra of F1/1 and F1/2 were stable for 5 min 
confirming the absence of free 3-OH group. 
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Figure 3.13: Bathochromic shift of the methanol spectrum of F1/1 due to sodium 
methoxide.  
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Sodium acetate is a weaker base than NaOMe, and as such ionizes only the more acidic 
hydroxy groups in flavones and flavonols, i.e., the 3-, 7- and 4´-hydroxy groups. The 
ionization of the 7-hydroxy group mainly affects band II, whereas the ionization of the 
3- and/or 4´-hydroxy groups mainly affects band I. Particularly, NaOAc is a useful 
diagnostic reagent for the specific detection of 7-hydroxy groups. The UV spectra of 
flavones containing free 7-hydroxy groups exhibit a diagnostic 5-20 nm bathochromic 
shift of band II in the presence of NaOAc. However, when 6 and 8 oxygen substituted, 
the bathochromic shift with NaOAc is often smaller presumably because of the reduced 
acidity of the 7-hydroxy group. Certain 3´, 4´-dioxygenated derivatives without the 7-
OH group showed bathochromic shifts of 20-25 nm. 
 
The NaOAc UV spectra of F1/1 and F1/2 showed bathochromic shift of band II by 10 
nm (from 272 to 282) and (from 270 to 280), respectively indicating the presence of 
free 7-hydroxy group. Figure 3.14 depicts the bathochromic effect of NaOAc on the UV 
spectrum of F1/1 in methanol. 
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Figure 3.14: The effect of NaOAc on the MeOH UV spectrum of F1/1. 
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The presence or absence of an ortho-dihydroxy group at all locations of the flavonoid 
nucleus could be detected from the effect of NaOAc/H3BO3 in the UV spectrum.  In the 
presence of NaOAc, boric acid forms chelate complexes with ortho-dihydroxy groups. 
Flavones containing a B-ring ortho-dihydroxy group show a consistent 12-30 nm 
bathochromic shift of band I in the presence of NaOAc/H3BO3, whereas a bathochromic 
shift of about 5-10 nm in band I in the presence of NaOAC/H3BO3 is diagnostic for the 
presence of an ortho-dihydroxy group (at C-6, 7 or C-7, 8) in the A-ring. In F1/1 and 
F1/2, the NaOAc spectra reduced the intensity without bathochromic shifts on addition 
of boric acid. The disappearance of band I peak in NaOAc/H3BO3 spectra of F1/1 and 
F1/2 indicated the absence of ortho-dihydroxy groups in A- and B-rings. 
 
Flavones and flavonols which contain hydroxy groups at C-3 or C-5 form acid stable 
complexes with aluminum chloride, whereas the aluminum chloride complexes with 
ortho-dihydroxy groups are not stable. The presence of an ortho-dihydroxy group in the 
B-ring of flavones and flavonols can be detected by comparison of the spectrum of the 
flavonoid in the presence of AlCl3 with that obtained in AlCl3/HCl. 30-40 nm 
hypsochromic shift observed in band I of the AlCl3 spectrum on the addition of acid 
results form the decomposition of the complex of AlCl3 with the ortho-dihydroxy group. 
The presence of three adjacent hydroxy groups in the B-ring gives only a 20 nm 
hypsochromic shift on the addition of acid to the AlCl3 solution. 
 
Figure 3.15 illustrates the AlCl3 and AlCl3/HCl spectra of F1/1. As shown in the figure, 
the addition of acid to the AlCl3 containing flavonoid solutions produced no significant 
hypsochromic shift of band IIb indicating that there is no ortho-dihydroxy group in 
F1/1. Similar results were obtained for F1/2.  
3 EXTRACTION, ISOLATION AND STRUCTURAL ELUCIDATION 41
27
9
30
5
35
1
38
72
80
30
4
34
4
38
3
0
0,1
0,2
0,3
0,4
200 250 300 350 400 450
Wavelength (nm)
A
bs
or
ba
nc
e
F1/1 in MeOH + AlCl3
F1/1 in MeOH + AlCl3 + HCl
Figure 3.15: The UV Spectra of F1/1 in MeOH in the presence of AlCl3 and AlCl3/HCl. 
 
The addition of acid to a methanolic solution of flavones or flavonols which already 
contain AlCl3 decomposes the complexes between AlCl3 and ortho-dihydroxy groups. 
Hence, any shift still remaining in band I or band II relative to the methanolic spectrum 
will be due to the presence of free 3- and/or 5-hydroxy groups in the flavonoid. 
Regeneration of the methanol spectrum on the addition of acid indicates that both the 3- 
and 5-hydroxy groups are either absent or substituted. 
 
The AlCl3/HCl spectrum of a 5-hydroxyflavone typically consists of four major 
absorption peaks, band Ia, Ib, IIa and IIb, which are all bathochromically shifted relative 
to their band of origin (presumably Ia and Ib originate from I; and IIa and IIb from II). 
As shown in Figure 3.15, the AlCl3/HCl spectra of F1/1 depict four major peaks which 
are bathochromically shifted relative to their respective band in the MeOH spectrum 
(Fig. 3.11).  
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The two major flavonoids of G. lotoides (F1/1 and F1/2) belong to the family of flavone 
glycosides with free 4´-, 5- and 7-hydroxy groups. F1/1 and F1/2 do not have ortho-
dihydroxy and 3´- or 5´-OH groups. Table 3.3 summarizes the UV spectral data of F1/1 
and F1/2. 
 
Table 3.3: UV spectral data of F1/1 and F1/2 in methanol and with diagnostic reagents 
Diagnostic reagents F1/1 (λmax nm) F1/2 (λmax nm) 
MeOH 272, 330 270, 331 
MeOH + NaOMe 282, 334, 399 280, 331, 396 
MeOH + NaOAc 282, 395 280, 310s, 389 
MeOH + NaOAc + H3BO3 284, 320, 406 272, 322 
MeOH + AlCl3 279, 305, 351, 387 276, 304, 350, 382 
MeOH + AlCl3 + HCl 280, 304, 344, 383 277, 302, 342, 378 
 
 
3.4.2.3  Mass Spectroscopy (MS) 
Mass spectroscopy has been successfully employed for the structure determination of 
flavonoids (Frański, et al., 1999). ESIMS of F1/1 and F1/2 were recorded on a Thermo 
Finnigan TSQ Quantum triple-quadrupole mass spectrometer. 
 
ESIMS full-scan spectra of F1/1 showed quasimolecular ions at m/z 594.9 [M+H]+ (Fig. 
3.16 a) and 593.2 [M-H]- (Fig. 3.16 c) with positive and negative modes, respectively. 
The collision induced dissociation spectra of the flavonoid provided further 
characteristic fragmentation patterns at m/z 475[(M+H)-120]+, 433[(M+H)-162)]+, 
355[(M+H)-2(120)]+, 313[(M+H)-(120+162)]+, 271[(M+H)-2(162)]+ in the positive 
mode (Fig. 3.16 b) and m/z 473[M–H–120]-, 383[M–H–120–90]-, 353[M–H–2(120)]- in 
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the negative mode (Fig. 3.16 d) indicating the presence of two hexose sugars, which are 
C-glycosides at C-6 and C-8 (Qimin et al, 1991).  
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Figure 3.16 a): The ESI-mass spectra of F1/1 [full scan positive mode].  
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Figure 3.16 b): The ESIMS collision induced dissociation (CID) spectrum of F 1/1 at 
m/z 595. 
a) 
b) 
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 Figure 3.16 c): The mass spectra of F1/1 [full scan negative mode].  
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Figure 3.16 d): The ESIMS collision induced dissociation (CID) spectrum of F 1/1 at 
m/z 593. 
ESIMS of F1/2 provided quasimolecular ions at m/z 595 [M+H]+ and 593 [M-H]- (Fig. 
3.17 a) with positive and negative modes, respectively. The ESIMS CID spectra of F1/2 
in negative mode provided additional fragment ions at m/z 413[M-H-180]- and 293 [M-
H-180-120]-, indicating the presence of two hexose sugar moieties (Fig. 3.17 b).  
c) 
d) 
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Similarly, the ESIMS CID in the positive mode provided fragment ions at m/z 595 
[M+H]+; 433 [M+H-162]+; 415 [M+H-180)]+; 313[M+H-(120+162)]+; 271[M+H-
2(162)]+ (Fig. 3.17 c). The removal of a fragment of 180 depicted that one of the hexose 
is attached to another sugar molecule. The difference of 120 and 162 showed that the 
second hexose is C-glycoside.  
 
Figure 3.17: The mass spectra of F1/2 a) full scan negative mode; b) CID-fragmentation 
at m/z 593 and c) CID-fragmentation at m/z 595. 
a) 
b) 
c) 
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3.4.2.4  Nuclear Magnetic Resonance Spectroscopy (NMR) 
 
1H NMR 
The 1H NMR spectrum of flavonoids appears predominantly in the range 0-10 ppm 
downfield. The chemical shift establishes the nature of the hydrogen, and coupling 
constants determine the presence of the ortho, meta and vicinal protons. The ortho and 
meta couplings have ranges of 6.5-9.0 Hz and 1.5-2.5 Hz, respectively and are of value 
in establishing the aromatic substitution pattern. 
As shown in Figure 3.18, the 1H NMR of F1/1 in (DMSO-d6) showed signals at δH 6.78 
(s) characteristic for H-3 as well as 6.88 (d) and 7.97 (d) indicating ring B contains 
para-hydroxy group (4'-OH). The signals at δH 6.88 and 7.97 were assigned to H-3'/H-5' 
and H-2'/H-6', respectively. The broad singlet at δH 13.7 was due to the -OH groups 
which forms hydrogen bonding. The anomeric proton signals of the sugars of F1/1 
appeared at δH 4.66 (d) and 4.83 (d). 
 
Figure 3.18: 1H NMR of F1/1 
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1H-1H COSY of F1/1 showed correlations between the signals at δH 6.88 and 7.97, 
indicating ring B contains para-hydroxy group (Fig. 3.19). There was no correlation 
between these signals and the signal at δH 6.78, due to H-3. The 1H NMR results 
obtained were identical to the published data for the C-flavone glycoside, vicenin-2 
(Österdahl 1979). 
 
Figure 3.19: 1H-1H COSY of F1/1 
The 1H NMR (DMSO-d6) of F1/2 showed signals at δH 6.69 (singlet) due to H-3. 
Comparison of the signals with F1/1 indicated the presence of 4'-OH group in F1/2 due 
to the signals at δH 6.90 for H-3'/H-5' and δH 7.91 for H-2'/H-6'. As shown in Figure 
3.20, the 1H NMR of F1/2 showed an additional signal at δH 6.17 (singlet) for either H-6 
or H-8 of ring A, indicating that the C-glycoside linkage in F1/2 in only in one position. 
Moreover, only one anomeric proton signal was observed. The NMR result was in good 
agreement with the MS which indicated that the two hexose sugars are attached to one 
another. 
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Figure 3.20: 1H NMR of F1/2 
 
13C NMR 
In general, 13C NMR spectra are recorded in the proton-noise (broad band) decoupled 
mode in order to avoid the extensive signal overlap which can occur due to the large 
one bond carbon hydrogen coupling constants (ca. 120-250 Hz). The multiplets are thus 
reduced to single lines and it is possible to determine the number of carbons. 
 
Usually, the carbon resonances representing the A- and C-rings are not superimposed 
and give rise to independent signals. However, the six B-ring carbons can give rise to 
fewer than six signals when the B-ring is unsubstituted or possesses symmetrical 
substitution.  
Table 3.4 depicted the 13C NMR data of F1/1 and F1/2. Based on the above results and 
comparing with published data for vicenin-2 (Österdahl, 1979; Sakakibara et al., 1977), 
F1/1 was identified as 5,7,4'-trihydroxyflavone-6,8-di-C-glucoside (vicenin-2). 
Similarly, the NMR data obtained for F1/2 were identical with published data for 
vitexin-2''-O-glucoside (Markham et al., 1984). Hence, F1/2 was identified as 5,7,4'-
trihydroxy-flavone-8-C-sophoroside. 
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Table 3.4: 13C NMR of F1/1 and F1/2. 
C F1/1 F1/2 
2 162.72 163.43
3 101.64 102.42
4 181.11 181.62
5 160.78a 160.49a
6 108.32 98.52
7 160.77a 161.11a
8 102.03 103.75
9 155.01 156.21
10 104.45 103.17
1′ 121.70 121.64
2′ 128.35 128.71
3′ 115.65 115.81
4′ 159.25a 160.49
5′ 115.65 115.81
6′ 128.35 128.71
Sugars Glucose at C-6 Glucose at C-8 
1′′ 74.00 71.50
2′′ 71.10 81.15
3′′ 78.77 78.26
4′′ 70.39 70.15
5′′ 81.47 81.65
6′′ 61.08 60.38b
 Glucose at C-8 Glucose at C-2′′ 
1′′′ 74.27 104.89
2′′′ 71.43 74.31
3′′′ 78.77 75.95
4′′′ 69.86 69.46
5′′′ 80.87 76.23
6′′′ 60.60 60.98b
a, b Assignments with the same superscript may be interchanged. 
 
3.4.2.5  Acid isomerization of the flavonoids 
The acid isomerization gives one or more by products owing to the superposition of 
Wessely-Moser transposition and sugar ring isomerization (Besson and Chopin, 1983). 
This chemical method, associated with suitable chromatographic systems, remains an 
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important technique for distinguishing mono-C-glycosylflavones, di-C-glycosylflavones 
and O-glycosyl-C-glycosylflavones (Maurice, 1994). 
F1/1 was stable in acid indicating that it is a di-C-glycosylflavones. Acid hydrolysis of 
F1/2 yielded vitexin accompanied by small amounts of its Wessely-Moser isomer 
(isovitexin) that are identified by HPLC with spiking the sample with authentic 
standards of vitexin and isovitexin (Extrasynthese) (Fig. 3.21). The result confirmed 
that F1/2 contains an O-glycoside linkage (Tomczyk et al. 2002).  
 
Figure 3.21: HPLC of the acid hydrolysis product of F1/2. [Column: CC250/4 Nucleosil 
100-7 C18; mobile phase: 15% CH3CN; flow rate: 1 mL/min; detection: 
UV 360 nm] Peaks at retention time of 18.95 and 21.55 min were 
identified as vitexin and isovitexin, respectively. 
 
Chapter 4 
QUANTITATIVE DETERMINATION OF THE SAPONINS AND FLAVONOIDS OF 
GLINUS LOTOIDES 
4.1 General introduction 
 
The determination of the phytochemical constituents of plant extracts is essential in 
order to ensure the reliability and repeatability of pharmacological and clinical research, 
to understand their bioactivities and possible side effects of active compounds and to 
enhance product quality control. High-performance liquid chromatographic (HPLC) and 
thin-layer chromatographic (TLC) fingerprints have been applied for this kind of 
documentation (Gurfinkel and Rao, 2002; Zhang et al., 2005; Ji et al., 2005). 
HPLC and TLC methods are generally used for the analysis and identification of 
pharmaceuticals based on their chromatographic retention data. However, identification 
problems arise when standards are not available, which is the case for most 
phytopharmaceutical preparations. In an effort to standardize the crude extract of the 
seeds of G. lotoides, colorimetric and UV-spectrophotometric methods have been 
developed for quantitative determination of total saponins in the crude extracts using a 
purified extract and β-escin, a mixture of triterpenoidic saponins obtained from 
Aesculus hippocastanum, as standards (Endale et al., 2000). 
In this work, separate HPLC methods were developed for the quantitative routine 
analysis of the saponins and flavonoids of G. lotoides.  
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4.2 Quantitative determination of the saponins 
Different methods have been employed for the qualitative and quantitative 
determination of saponins. The classical methods like haemolysis, surface activity, fish 
toxicity have been replaced by chromatographic and photometric methods such as TLC-
densitometry and HPLC. High performance liquid chromatography on reversed-phase 
columns remains the best technique for saponin determination and is the most-widely 
used method for this group of compounds (Park et al., 2000; Li and Fitzloff, 2001). 
However, the lack of chromophore allowing detection in UV, limits the choice of 
gradient and detection method (Oleszek, 2002). Hence, the saponins of G. lotoides were 
quantified after acid hydrolysis using mollugogenol B as an external standard. Ireland 
and Dziedzic (1985) have described a method for estimation of the total saponin of 
soybean by HPLC after hydrolysis of the triterpene glycosides. 
Due to the absence of commercial standards, mollugogenol B was isolated and used as 
reference substance for the aglycons of the saponins of G. lotoides. The identity of the 
isolated standard was confirmed with UV and NMR spectral analyses. 
4.2.1  Preparation of a standard 
Triterpene saponins isolated from the seeds of G. lotoides are derivatives of the same 
aglycon, mollugogenol A, differing only in their sugar moieties and position of 
substitution (Fig. 3.7, page 21). Therefore, they were quantified after acid hydrolysis 
using mollugogenol B as an external standard. Unlike the native saponins of G. lotoides, 
mollugogenol B is UV-active due to the formation of a diene chromophore in ring D 
and E (Fig. 4.1). The isolation and structural confirmation of mollugogenol B are 
described below. 
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Figure 4.1: Chemical structure of mollugogenol B. 
 
4.2.1.1  Isolation of mollugogenol B 
The acid hydrolysis of the saponins of the seeds of G. lotoides provided aglycons which 
are UV-active. Scheme 4.1 shows the acid hydrolysis and extraction of the aglycons 
from the purified extract of the seeds of G. lotoides (Extract F). Similarly, saponin 
fractions (S1 and S2) were hydrolyzed to identify the hydrolysis products from the 
major saponins of G. lotoides. The optimal acid hydrolysis conditions were determined 
as described under 4.2.2.  
Scheme 4.1: Acid hydrolysis and extraction of the aglycons of the saponins of G. 
lotoides 
Extract F
3M HCl, 100° C, 1 hour
Hydrolysis products
cooled 
3 X 50 ml Ether
Ether layer Aqueous part
Aglycons
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As shown in the scheme 4.1, the purified extract was hydrolyzed with 3M HCl at 100°C 
for 1 h and the aglycons of the saponins were extracted three times with diethyl ether.  
 
The major hydrolysis product was isolated by RP-HPLC. Figures 4.2 a) and b) depict 
the HPLC chromatograms of the aglycons from extract F (Fig. 4.2 a) and from the 
saponin fraction, S1 (Fig. 4.2 b). A similar HPLC chromatogram was obtained after acid 
hydrolysis of S2.  
 
The acid hydrolysis of extract F gave two major hydrolysis products, aglycons A1 and 
A2 at retention times of about 13 and 15 minutes, respectively. However, the saponin 
fractions (S1 and S2) provided only one major aglycon at retention time of 13 min 
indicating that the major saponins of G. lotoides provided only one aglycon, A1. S1 and 
S2 are HPLC fractions of saponins which provided the five hopane-saponins, glinuside 
F – I and succulentoside B (Fig. 3.7; Chapter 3).  
 
The acid hydrolysis product at retention time of 13 min was isolated after preparative 
HPLC scale-up of the injection volume to 250 µL. The structure of aglycon A1 was 
identified as mollugogenol B by NMR spectral analysis.  The isolation and structural 
identification of aglycon A1 are described below. 
 
TLC analysis of the hydrolysis products of extract F, S1 and S2 as well as the isolated 
aglycons A1 and A2 also confirmed that aglycon A1 is the major hydrolysis product of 
the saponins of G. lotoides (Fig. 4.3). 
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Figure 4.2: HPLC chromatograms of the acid hydrolysis products from a) extract F and 
b) saponin fraction, S1 [Column: CC250/4 Nucleosil 100-7 C18; mobile 
phase: acetonitrile; detection: UV-254 nm; flow rate: 1.0 ml/min; injection 
volume: 20 µL].  
a) 
b) 
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Figure 4.3: TLC analysis of the acid hydrolysis products of Extract F, S1 and S2 and the 
isolated aglycons A1 and A2. [RP-18 F254s TLC, Merck; solvent system: 
methanol: water (9:1); detection: 5% vanillin in EtOH with H2SO4; 
mollugogenol B: Rf = 0.43] 
 
4.2.1.2  Structural confirmation of mollugogenol B 
The structure of the isolated aglycon A1 was confirmed with NMR spectral analysis and 
by comparison with published data as mollugogenol B. Table 4.1 provides the 1H and 
13C NMR data of mollugogenol B which is in good agreement with previous report 
(Hamburger et al., 1989). 
 
4.2.1.3  Determination of the purity of mollugogenol B 
The purity of the isolated mollugogenol B was determined by TLC, HPLC and UV-
spectrophotometry.  
 
S1
 
S2
 
A
1 
A
2 E
xt
. F
 
Mollugogenol B 
4 QUANTITATIVE DETERMINATION 
 
57
Table 4.1: 1H and 13C NMR of mollugogenol B 
 1H 13C
1  41.3a t
2  27.8 t
3 3.15 dd (10.5, 6) 79.6 d
4  40.5 s
5  61.8 d
6 4.04 ddd (10, 10, 4) 69.1 d
7  46.0 t
8  47.2 s
9  51.3 d
10  39.9 s
11  22.8 t
12  23.4 t
13  49.0 d
14  43.5 s
15 5.68 d (10) 136.0 d
16 6.28 d (10) 120.7 d
17  140.3 s
18  49.0 s
19  41.3a t
20 2.42 ddd (16, 10.5, 6);  
2.25 dd (16, 9) 
29.0 t 
21  141.7 s
22 2.82 qq 28.0 d
23 1.33 s 31.5 q
24 0.98 s 16.1 q
25 0.92 s 17.2 q
26 1.03  18.7 q
27 1.24 s 18.0 q
28 0.93 s 19.2 q
29 1.02 d (7) 22.0 q
30 1.04 d (7) 21.6 q
a Assignments with the same superscript may be interchanged.  
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Thin Layer Chromatography (TLC) 
Figure 4.4 depicts a typical TLC plate of mollugogenol B with only one major spot at Rf 
value of 0.56. The purity of the standard was evaluated qualitatively with the absence of 
another major spots.  
 
 
 
Figure 4.4: TLC of mollugogenol B [RP-18 F254s TLC, Merck; solvent system: 
methanol; detection: 5% Vanillin in EtOH with H2SO4; sample solution: 
237 mg/100 ml]. 
 
High Performance Liquid Chromatography (HPLC) 
A high concentration of mollugogenol B (237 mg/100mL) was injected into HPLC and 
developed using various solvent systems. A typical HPLC is depicted in Figure 4.5. 
Peak area of mollugogenol B at retention time of 8.12 min (Fig. 4.5) was compared to 
the total peak area of the chromatogram and the purity of mollugogenol B was 
calculated as 98%. As shown in the chromatogram, except for a minor peak at retention 
time of 14.56 min there is only a peak for mollugogenol B.   
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Figure 4.5: HPLC chromatogram of mollugogenol B [Column: CC250/4.6 Nucleosil 
100-5 C18; mobile phase: methanol-water gradient system (see under 4.2.3); 
detection: UV-254 nm; flow rate: 1.0 ml/min; injection volume: 20 µL of 
237 mg/100ml].  
 
Ultraviolet Spectroscopy (UV) 
Figure 4.6 depicts the UV spectrum of mollugogenol B. The molar absorptivity (log ε) 
of the methanol solution of mollugogenol B at concentration of 0.948 mg/100ml was 
found to be  3.98, 4.16 and 4.12 at λmax of 260sh, 251 and 243 nm, respectively, which is 
in good agreement with literature values (Hamburger et al. 1989), indicating the purity 
of mollugogenol B. 
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Figure 4.6: UV spectrum of mollugogenol B [0.948 mg/100ml MeOH]. 
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4.2.2  Optimization of the acid hydrolysis of the saponins 
During acid hydrolysis, a number of saponins generate not only the genuine aglycon but 
also artifacts, which can influence the final results. Acid-catalyzed double-bound 
migration, epimerization and dehydration are often observed during hydrolysis (Potterat 
et al. 1992). Besides, structurally different saponins show different rates of hydrolysis 
(Ireland and Dziedzic, 1986).  Hence, optimization of the acid hydrolysis conditions is 
indispensable before development of quantification method. As shown in Figure 4.7, the 
acid hydrolysis of the saponins using 3M HCl at 100°C for 1 hour provided the 
maximum yield of mollugogenol B.  
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Figure 4.7: Effect of time a) and temperature b) of acid hydrolysis of the saponins of 
G. lotoides on the mollugogenol B yield. Hydrolysis conditions: a) 3M 
HCl at 100 °C; b) 3M HCl for 1 h. 
b) 
a) 
4 QUANTITATIVE DETERMINATION 
 
61
The optimum time of hydrolysis was determined by analyzing the hydrolysis products 
at different time intervals (Fig. 4.7 a). As shown in the figure, the formation of 
mollugogenol B reached the maximum after 1 hour and subsequent heating under the 
hydrolysis conditions resulted in a loss of mollugogenol B.  
 
The maximum amount of mollugogenol B was obtained using a hydrolysis temperature 
of 100°C (Fig. 4.7 b). Lower acid concentrations (0.5; 1 and 2M HCl) required longer 
time to achieve the maximum concentration of mollugogenol B, whereas higher acid 
concentrations (4 and 5 M HCl) produced artifacts, which reduced the yield of 
mollugogenol B.  
 
4.2.3  HPLC analysis of the aglycons of the saponins 
 
Figure 4.8 shows typical HPLC chromatograms of mollugogenol B as external standard 
(Fig. 4.8 a); acid hydrolysis products of extract A (crude extract of the seeds of G. 
lotoides) (Fig. 4.8 b) and tablet formulation of extract A after acid hydrolysis (Fig. 4.8 
c). As shown in the figures, separation of the aglycons was completed within 25 min 
and the major peak at 8 min belongs to mollugogenol B. The other peaks were not 
identified. 
 
The crude extract of the seeds of G. lotoides (extract A) was used for the formulation of 
tablets. Hence, the analytical method developed should determine the total saponins the 
extract as well as the tablet formulations thereof. The preparation of the dry extract and 
the tablet formulations thereof are described under Chapter 5 and 6, respectively. 
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Figure 4.8: HPLC Chromatogram of a) mollugogenol B as external standard, b) acid 
hydrolysis products of the crude extract of the seeds of G. lotoides and c) 
tablet formulation of the extract after acid hydrolysis. [Column: CC 250/4.6 
Nucleosil 100-5 C18; mobile phase: see under 7.5.1.5 (Table 7.8); flow rate 
1.0 mL/min; detection: 254 nm; sample volume: 20 µL].  
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4.2.4  Preparation of the calibration curve 
The calibration curve of mollugogenol B provided a linear relationship between the 
peak area (Y) and the concentrations of mollugogenol B injected (X) in mg/100ml with 
a regression equation of Y = 376738 X – 703.7 (r² = 0.9998) in the concentration range 
of 0.237 to 2.37 mg/100mL (Fig. 4.9). As shown in Figure 4.10 the residuals points of 
the calibration points were well distributed within acceptable limits.  
 
The total amounts of saponins of the crude extract and tablet formulation were 
determined as glinuside G equivalent. The molecular weight of glinuside G (900) 
approximates the average molecular weight of the saponins of G. lotoides (Fig. 3.7). 
Before determination of the total saponins, an equimolecular mollugogenol A 
(molecular weight = 476) was calculated from mollugogenol B (molecular weight = 
440).  
 
4.2.5  Method validation 
Validity of an analytical method can be verified by establishing several analytical and 
statistical parameters (Table 4.2). The linearity of the detector response for 
mollugogenol B was confirmed between 0.237 – 2.37 mg/100ml. The calibration curves 
(Fig. 4.9), residuals (Fig. 4.10) and standardized residuals were inspected to assess 
linearity. The calibration curves were analyzed using a linear regression model and 
correlation coefficients (Table 4.2).  
 
The intra- and inter-day repeatability of the method was evaluated using multiple 
preparations of the sample with relative standard deviation of 0.5 and 1.17%, 
respectively. The limits of detection (LOD) and limits of quantification (LOQ) were 
calculated according Gottwald (2000) and were found to be 0.027 and 0.082 
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mg/100mL, respectively, which were confirmed with serial dilutions. 
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Figure 4.9:  HPLC calibration curve of mollugogenol B [ ■  Data points;  Linear 
regression;  95% Confidence interval (10 times)]. 
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Figure 4.10: Residual plots of the HPLC calibration curve of mollugogenol B 
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Table 4.2: Statistical validation of the calibration data for quantitative determination of 
mollugogenol B 
 
Parameter Mollugogenol B 
Concentration range [mg/100ml] 0.237 – 2.37  
Number of concentration 6 
Average values x = 1.225           y = 460 807.222 
Correlation coefficient 0.9998 
Relative standard deviation (%) 0.90  
Calibration equation f(x) = 376 738x – 703.66 
LOD [mg/100ml] 0.027  
LOQ [mg/100ml] 0.082  
System precision 1.17% (n = 6) 
Method precision 0.50% (n = 9) 
 
 
4.3 Quantitative determination of the flavonoids 
Several liquid chromatographic (LC) methods with UV-Vis absorption (Gil et al., 1995; 
Hertog et al., 1992; Blouin and Zarins, 1988) or diode-array ultraviolet (DAD-UV) 
(Mouly, 1998; Mateos, et al., 2001; Bramati, et al., 2002), fluorescence (Hollman et al., 
1998) and mass spectrometric (Raffaelli et al., 1997; Justesen, 1998) have been 
developed for the analysis of flavonoids. Merken und Beecher (2000) have reviewed the 
various HPLC and sample preparation methods that have been employed to detect and 
quantify flavonoids. 
 
Quantitative determination of individual flavonoid glycosides is difficult because most 
reference compounds are not commercially available. Hence, the total flavonoids of the 
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seeds of G. lotoides in the crude extract as well as in tablet formulations were 
determined by HPLC using vicenin-2 as an external standard.  
4.3.1  Preparation of a standard 
The isolation and structural confirmation of vicenin-2 from the purified extract of the 
seeds of G. lotoides have been described under section 3.3.2 and 3.4.2, respectively.  
 
4.3.2  Determination of the purity of vicenin-2 
The purity of the isolated vicenin-2 was determined using TLC and HPLC methods as 
described below. The TLC and HPLC were loaded with high concentrations of vicenin-
2 to evaluate the degree of purity. 
 
4.3.2.1  Thin layer chromatography 
Figure 4.11 shows a TLC plate of vicenin-2. Overloading the TLC plates up to 39 μg 
showed no major impurity. However, due to the overloading, the spots at high 
concentration of vicenin-2 (19.5 and 39 μg,) were diffused. 
 
 
Figure 4.11:  TLC of vicenin-2 [RP-18 TLC plates; solvent system CH3CN:H20 (15:85); 
sample concentration: 130 mg/100 ml; detection: NPR (1% Diphenyl-
boryloxyethylamin/ MeOH and 5% PEG 400 in EtOH), UV-366nm]. 
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4.3.2.2  High performance liquid chromatography 
As shown in Figure 4.12, the HPLC of vicenin-2 provided only one major peak at 
retention time of about 20 min. The purity of vicenin-2 was calculated from the peak 
area as 97%.  
 
Figure 4.12: HPLC chromatogram [CC 250/4.6 Nucleosil 100-5 C18; mobile phase: 
CH3CN:H2O (1:9); flow rate 1.0 mL/min; detection: UV-360 nm; sample 
volume: 20 µL of 130 mg/100ml] 
 
 
4.3.3   HPLC analysis of the flavonoids 
Figures 4.13 (a, b, and c) depict chromatograms of vicenin-2 (Fig. 4.13 a), crude extract 
of G. lotoides (Fig. 4.13 b) and tablet formulation of the extract (Fig. 4.13 c). The 
flavonoids at retention time of 8 and 10.7 minutes were identified as vicenin-2 and 
vitexin-2″-O-glucoside, respectively. The concentration the total flavonoids of the seeds 
of G. lotoides were calculated from total peak area of the chromatogram (Fig. 4.13 b 
and c) and expressed as vicenin-2 equivalent. 
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Figure 4.13: Chromatograms of a) vicenin-2 standard, b) crude extract of the seeds of G. 
lotoides and c) tablet formulation of the extract separated by RP-18 HPLC. 
[Column: CC 250/4.6 Nucleosil 100-5 C18; mobile phase: see under flow 
rate 1.0 mL/min; detection: 360 nm; injected sample volume: 20 µL].  
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Six tablets were analyzed and the content of the flavonoids was determined. As shown 
in Figure 4.13 c, the HPLC chromatogram of the tablets showed similar flavonoids 
pattern compared to the crude extract (Fig. 4.13 b) indicating that the HPLC method 
was not affected by the tablet excipients and manufacturing processes (Chapter 6). 
 
4.3.4  Preparation and validation of the calibration curve 
Within the concentration range of 0.583 to 5.83 mg/100mL, the relationship between 
peak area of vicenin-2 (Y) and concentration in mg/100mL (X) was linear with a 
regression equation Y = 260009X – 5250.8. The linearity of the calibration curve was 
verified by the correlation coefficient (r² = 0.9997) as well as inspection of the residuals 
(Fig. 4.14 and 4.15). Table 4.3 provides the calibration data of vicenin-2.  
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Figure 4.14: HPLC calibration curve of vicenin-2  [  ■   Data points;             Linear 
regression; 95% Confidence interval (10 times)]. 
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Figure 4.15: Residual plots of the HPLC calibration curve of vicenin-2 
 
Table 4.3: Calibration data and statistical validation of the HPLC quantitative 
determination of vicenin-2 
Parameter Vicenin-2 
Concentration range  [mg/100ml] 0.583 – 5.830 
Number of concentration 6 
Average values x = 3.012          y = 777 940.361 
Correlation coefficient 0.9997 
Relative standard deviation 1.01% 
Calibration equation f(x) = 260009x – 5250.8 
 
The LOD and LOQ were calculated according to Gottwald (2000) and were found to be 
0.075 and 0.225 mg/100mL, respectively. Similar LOD and LOQ results were obtained 
using serial dilution of the standard solution. Reproducibility of the methods was 
verified by determining six extracts with relative standard deviations of 0.95% and the 
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intra-day variations (n = 9) were found to be 1.86%. The values are in good agreement 
with USP requirements for a validated method. 
 
4.4 Preparation of secondary standard 
Characterization and utilization of a secondary standard is necessary as extraction and 
isolation of the pure standards are time consuming and expensive for routine quality 
control of the plant extracts. Hence, the purified extract of the seeds of G. lotoides 
(extract F) was prepared and characterized. The extraction and purification of extract F 
have been described in Scheme 7.1 under Experimental section. The contents of total 
flavonoids and saponins in extract F were determined using the HPLC methods detailed 
above. 
 
Accordingly, the secondary standard was found to contain 10% vicenin-2 and 21.3% 
total flavonoids calculated as vicenin-2 equivalent. The amount of saponins in the 
secondary standard was 6.3% mollugogenol B and 12.4% total aglycons calculated as 
mollugogenol B, 14.2% glinuside G and 25.4% total saponins calculated as glinuside G 
equivalent.  
 
4.4.1  Preparation of calibration curve using the secondary standard 
Figures 4.16 and 4.17 depict the calibration curve of extract F for the saponins and 
flavonoids, respectively. The HPLC quantitative methods described above were 
adopted. The peak areas of mollugogenol B and vicenin-2 were taken to calculate the 
calibration equation. These equations were then used to determine the total saponins and 
flavonoids from the total peak area of the respective chromatogram. Table 4.4 shows the 
calibration data of extract F as a secondary standard for the saponins and flavonoids of 
the seeds of G. lotoides. The total saponins and flavonoids in extract F were calculated 
as glinuside G and vincenin-2, respectively.  
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Figure 4.16: HPLC calibration curve of extract F, as secondary standard for the 
determination of saponins. [ ■  Data points;                    Linear regression;    
                                 95% Confidence interval (10 times)]. Data points represent the 
peak area of mollugogenol B in extract F. 
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Figure 4.17: HPLC calibration curve of extract F, as secondary standard for the 
determination of flavonoids. [ ■  Data points;                 Linear regression; 
                                95% Confidence interval (10 times)]. Data points represent the peak 
area of vicenin-2 in extract F. 
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Table 4.4: Calibration data of quantitative determination of extract F using 
mollugogenol B and vicenin-2  
Parameter Mollugogenol B Vicenin-2 
Concentration range  [mg/100ml] 4.95 – 49.98 4.96 – 49.49 
Number of concentration 6 6 
Average values x = 25.812 
y = 673230.75  
x = 26.327  
y = 694350.722 
Correlation coefficient 0.9999 0.9997 
Relative standard deviation 0.53% 0.98% 
Calibration equation f(x) = 26117x – 880.48 f(x) = 26097x + 7316.3 
LOD [mg/100ml] 0.339 0.635 
LOQ [mg/100ml] 1.017 1.906 
 
Accuracy of the analytical method was determined by spiking 32.8 mg of extract F with 
standard solutions to produce 50, 75, 100, 125 and 150%. The recovery of vicenin-2 
was found to be between 98.8 and 101.6% (Table 4.5). 
 
Table 4.5: Statistical data for validation of the HPLC quantitative method using extract 
F as secondary standard. 
Parameter Theoretical 
value [%] 
Concentration 
[mg/100ml] 
RSD [%] Recovery 
[%] 
System precision  4.96 – 49.49 0.95 (n = 6)  
Method precision  33.51 (n = 9) 1.86   
Recovery 50 16.4 1.85 (n = 3) 99.0
 75 24.6 0.68 (n = 3) 99.2
 100 32.8 0.50 (n = 3)  98.8
 125 41.0 1.26 (n = 3) 101.6
 150 49.2 1.94 (n = 3) 99.8
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Table 4.6: The contents of vicenin-2 and mollugogenol B standards, total flavonoids 
and saponins of G. lotoides in the crude extract, secondary standard and 
tablet formulation. 
Compound(s) Crude extract Secondary 
standard 
Tablet 
formulationc 
Vicenin-2 4.4% 10.0% 4.3% 
Total flavonoidsa  9.3% 21.3% 9.1% 
Mollugogenol B 3.1% 14.2% 3.0% 
Total saponinsb  10.8% 25.4% 10.4% 
acalculated as vicenin-2 equivalent 
bcalculated as glinuside G equivalent 
c1.4 g oblong tables containing 650 mg extract of the seeds of G. lotoides 
 
4.5  Determination of the traditional dose 
The traditional dose of G. lotoides was determined by HPLC analysis of the contents of 
the saponins and flavonoids in the 5% ethanol extract. Extraction of 20 g powdered 
seeds of G. lotoides (traditionally recommended quantity) with 500 ml of 5% EtOH 
yielded 1.06 g dry extract.  
As shown in Table 4.7, the traditional dose contains 3.35% vicenin-2 and 4.99% total 
flavonoids of G. lotoides calculated as vicenin-2 equivalent. Similarly, the contents of 
mollugogenol B, mollugogenol A, glinuside G and total saponins of G. lotoides as 
glinuside G were found to be 2.16, 3.83. 4.40 and 7.83%, respectively. 
 The traditional dry extract and the crude extract (extract A) were then compared with 
respect to the contents of saponins and flavonoids and it was found that 650 mg of 
extract A was equivalent to 1060 mg of the 5% EtOH dry extract, i.e., the traditional 
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dose. Accordingly, a dry extract preparation containing 650 mg of extract A was used 
for the tablet formulation.   
Table 4.7: The contents of vicenin-2 and total flavonoids in the traditional dose 
5% EtOH extract 
(mg/100ml) 
Vicenin-2 
%, (RSD) 
Total flavonoidsa 
10.54 3.35 (0.73) 4.95 
39.79 3.34 (1.42) 5.20 
60.20 3.37 (1.54) 4.85 
89.25 3.36 (0.85) 4.98 
Average 3.35 4.99 
acalculated as vicenin-2 equivalent from the total peak area of the HPLC chromatogram 
 
 
Chapter 5 
 
PREPARATION AND PHYSICOCHEMICAL CHARACTERIZATION OF 
THE DRY EXTRACT PREPARATION FOR TABLET FORMULATIONS 
 
5.1 General introduction 
The preparation of a dry extract by adsorption of liquid plant extract on an inert excipient, 
such as fumed silica has been described by Palma et al. (1999). In this, the performance of 
some common excipients to be used as support for the extractive products, such as lactose, 
starch, dicalcium phosphate and fumed silica have been evaluated. Diluting dry extract with 
starch yielded materials with poor flow properties indicating that the selection of suitable inert 
material for adsorption is fundamental (Palma et al., 1999).  
 
The crude extracts (extract A) of the seeds of G. lotoides have been reported to be highly 
hygroscopic liquefying at higher relative humidity (65% and above). Dry extract preparations 
containing various concentrations of Aeroperl® 300 Pharma were prepared to improve the 
hygroscopicity and poor flow property of the crude extract of the seeds of G. lotoides.  
 
Aeroperl® 300 Pharma is a granulated high purity colloidal silicon dioxide for use in 
pharmaceutical products. Aeroperl® 300 Pharma is highly porous, spherical, dust free and 
easy in handling. It has high purity and safety which is tested according to Ph. Eur. and 
USP/NF. Aeroperl® 300 Pharma has been effectively utilized as carrier for liquid and pasty 
active ingredients and covert them into free-flowing powders. It has huge surface area and 
cavities for adsorption. Aeroperl® 300 Pharma shows an excellent flow both loaded and 
unloaded. 
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Aeroperl® 300 Pharma is white, odorless powder and 40 g/l suspension has pH value between 
3.5 and 5.5. The bulk density of Aeroperl® 300 Pharma is 280 g/l and true density of 2.2 
g/cm³ at 20 °C. It is practically stable with decomposition temperature above 2000 °C. 
 
This chapter described the preparation and physicochemical characterization of the dry extract 
preparation using Aeroperl® 300 Pharma as inert sorption material which, later on, was 
formulated into enteric coated tablets. 
 
5.2 Preparation of the dry extract preparation 
The seeds were defatted three times with n-hexane. The presence of fats in the starting plant 
materials not only interferes with the extraction and drying process but also with 
formulations. The amount of fat removed at three successive defatting steps was found to be 
62.5%, 23.6% and 9.7%, respectively, with a total yield of 95.8% of the fats (Endale et al., 
2004). The total fat content was determined by exhaustive defatting of the seeds (10 
successive defatting with n-hexane) and was reported to be 14% (Biftu et al., 1979, Endale et 
al., 2004). 
 
The solvent system, 60% methanol in water, has provided the maximum amount of saponin-
containing extract (Endale et al., 2004). Previous extraction works conducted on the seeds of 
G. lotoides have utilized 80% methanol in water (Djote, 1978; Endale et al., 1997; 1998) 
which yields less than 60% of the total saponins. 
 
Admixing of the liquid extract with Aeroperl® 300 Pharma as an inert carrier material and 
drying the mixture subsequently provided a non-adherent and free-flowing powder. The 
amount of Aeroperl® 300 Pharma required was optimized to 30% after investigation of the 
scanning electron micrographs and water-sorption properties of the dry extract preparations 
containing 10, 20, 30, 40, 50 and 60% w/w Aeroperl® 300 Pharma.  An excess amount of 
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Aeroperl® 300 Pharma increases the bulk volume and the tablet weight, whereas an 
insufficient amount leads to extract preparations with unacceptable physical properties. 
5.3 Physicochemical characterization of the dry extract preparations  
Assessment of the physicochemical properties of drug powder whether it is a pure chemical or 
an extract is a primary task during preformulation studies (Wells, 1988). Physicochemical 
properties can be related to the pharmaceutical and pharmacological properties of a drug. 
Particle size may influence number of important factors that can relate to the manufacturing 
of pharmaceuticals (Pitkin and Carstensen, 1973). Hygroscopicity contributes to poor fluidity 
and adversely influences both physical and chemical stability of many powders particularly 
plant dry extracts. Hence, investigation of some physicochemical properties of the dry extract 
preparation is imperative before commencing the formulation. 
 
In this respect, physical properties of the dry extract preparations of G. lotoides which are 
useful for the formulation of tablets, such as particle size and size distribution, morphology, 
water sorption pattern, bulk, tapped and true densities, flow properties (angle of repose and 
flow rate) and compaction profiles were investigated. Based on the density results, physical 
properties like porosity, Carr’s consolidation index and Hausner ratio were calculated.  
 
5.3.1  Particle size distribution  
Figure 5.1 depicts the particle size distribution of the dry extract preparations (DEP) 
containing 10 – 60% Aeroperl® 300 Pharma. As shown in Table 5.1, the average particle sizes 
(d50) of the particle sizes of the dry extract preparations decreased with increasing the amount 
of Aeroperl® 300 Pharma.  
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Figure 5.1: Cumulative particle size distribution of the dry extract preparations of G. lotoides 
containing 10 – 60% Aeroperl® 300 Pharma. 
 
Table 5.1: Average cumulative particle size (d10, d50 and d90) of the dry extract preparations of 
G. lotoides containing 10 – 60% Aeroperl® 300 Pharma. 
DEPs d10 μm (rel. S.D., %) d50 μm (rel. S.D., %) d90 μm (rel. S.D., %) 
10% Aeroperl 4.4 (2.22) 46.4 (2.20) 194.2 (4.43) 
20% Aeroperl 3.9 (0.57) 38,7 (1.30) 170.2 (2.67) 
30% Aeroperl 3.5 (0.82) 30.1 (1.06) 90.3 (2.08) 
40% Aeroperl 4.1 (1.23) 27.4 (0.54) 69.8 (0.58) 
50% Aeroperl 3.5 (1.97) 25.8 (0.44) 67.3 (0.57) 
60% Aeroperl 3.2 (1.24) 23.1 (1.20) 63.7 (1.61) 
 
The average particle size the crude extract (extract A) has been reported to be 68.39 μm 
(Endale et al., 2004). Hence, the dry extract preparations provided smaller particles. 
 
5.3.2  Scanning electron microscopy 
Surface structures of the crude extract (extract A), Aeroperl® 300 Pharma, and the DEPs 
containing 10 – 60% Aeroperl® 300 Pharma were visualized using a scanning electron 
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microscope (Fig. 5.2 a – m). The accelerating voltage and the magnification are shown on the 
micrographs.  Figures 5.2 (a) and (b) show the scanning electron micrographs of the vacuum 
oven dried crude extracts of the seeds of G. lotoides at magnifications of 500 and 2000 times, 
respectively. The particles are irregular in shape and relatively compact masses with sharp 
edges.  
 
On the other hand, the surface of Aeroperl® 300 Pharma particles appeared relatively uniform, 
smooth and regular. Figures 5.2 (c) and (d) showed the micrographs at magnifications of 100 
and 3000 times, respectively. The cavities shown in Fig 5.2 (d) depicted the porosity 
Aeroperl® 300 Pharma, indicating the enormous free surface area for the adsorption of liquid 
extracts. 
 
Scanning electron micrographs of the dry extract preparations revealed that the morphology 
of extract A as well as Aeroperl® 300 Pharma were changed, due to the adsorption of the 
extract onto Aeroperl® 300 Pharma (Fig. 5.2 e-m). Mixing the crude extract with Aeroperl® 
300 Pharma had improved the irregularities of the particles of the crude extracts. Moreover, 
the formation of compact masses with sharp edges was decreased when the extract is dried 
together with Aeroperl® 300 Pharma. These improvements of the surface properties of the 
extract were found to be a function of the amount of Aeroperl® 300 Pharma added.  
 
Dry extract preparation (DEP) containing 10% Aeroperl® 300 Pharma (Fig. 5.2 e and f) 
showed surface structure similar to the crude extract, indicating that the amount of Aeroperl® 
300 Pharma added was not enough to alter the surface structure of the extract completely. 
Figure 5.2 f (high resolution, 1000 times) shows the formation of aggregates of the extract 
and the Aeroperl® 300 Pharma particles. 
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Figure 5.2: Scanning electron micrographs of the crude extract of the seeds of G. lotoides at 
magnifications of a) 500 times and b) 2000 times. 
 
  
 
Figure 5.2: Scanning electron micrographs of Aeroperl® 300 Pharma at c) 100X and d) 3000X. 
 
  
 
Figure 5.2: Micrographs of the dry extract preparation (DEP) containing 10% Aeroperl® 300 
Pharma at e) 200X and f) 1000X. 
c) d)
e) f)
a) b)
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Figure 5.2: Micrographs of the dry extract preparation (DEP) containing 20% Aeroperl® 300 
Pharma at g) 200X and h) 2000X. 
 
  
 
Figure 5.2: Micrographs of the dry extract preparation (DEP) containing 30% Aeroperl® 300 
Pharma at i) 500X and j) 2000X. 
 
  
 
Figure 5.2: Micrographs of the dry extract preparation (DEP) k) containing 40% Aeroperl® 
300 Pharma at 200X and l) containing 50% Aeroperl® 300 Pharma at 200X. 
g) h)
i) j)
k) l)
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Figure 5.2: Micrographs of the dry extract preparation (DEP) m) containing 60% Aeroperl® 
300 Pharma at 200X  
 
Figures 5.2 (g) and (h) depict the SEM of the DEP containing 20% Aeroperl® 300 Pharma at 
magnifications of 200 and 2000, respectively. As shown in the figures, some proportion of the 
crude extract particles were not adsorbed on Aeroperl® 300 Pharma. However, the particle 
size of the extract in the DEP were smaller than the corresponding crude extract particles (Fig 
5.2 a) as well as that of DEP containing 10% Aeroperl® 300 Pharma (Fig 5.2 e). This 
indicates, even though, the particle size and shape of the crude extract had improved with the 
addition of 20% Aeroperl® 300 Pharma, it was not sufficient to adsorb all the extract particles.  
 
Dry extract preparation containing 30% Aeroperl® 300 Pharma showed an aggregation of 
particles (Fig. 5.2 i and j) where the crude extract was adsorbed on the surface of Aeroperl® 
300 Pharma as small particles. The typical compact and sharp edged particles of extract A 
(Fig. 5.2 a and b) were not formed.  
 
Figures 5.2 (k), (l) and (m) show the SEM of DEPs containing 40, 50 and 60% Aeroperl® 300 
Pharma, respectively. As shown in the figures, the proportion of the Aeroperl® 300 Pharma 
increased with maximum for the DEP containing 60% Aeroperl® 300 Pharma. Hence, in these 
m)
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preparations the amount of the Aeroperl® 300 Pharma was more than required. Based on the 
comparison of the SEM, the optimum amount of Aeroperl® 300 Pharma for the dry extract 
preparation was set to 30%. The result obtained was further supported by the water uptake 
studies of the various dry extract preparations as described below.  
 
5.3.3  Water uptake study 
Many drug substances, particularly plant extracts, have a tendency to adsorb moisture. The 
adsorption and equilibrium moisture content can depend upon different factors such as the 
atmospheric humidity, temperature, surface area, exposure time and the mechanism for 
moisture uptake.  
 
With most hygroscopic materials, changes in moisture level can greatly influence many 
important parameters, including chemical stability, flow properties and compatibility (Van 
Campen, et al., 1983).  The effects of moisture on various physical properties such as angle of 
repose, bulk and true densities, porosity and compression properties of various plant extracts 
have been reported with different authors (Rai and Kumar, 1995; Mishra, et al., 1996; Murthy 
and Bhattacharya, 1998). 
 
The water sorption pattern of the dry extract preparations (DEP) containing 10 – 60% 
Aeroperl® 300 Pharma was investigated in humidity chambers (desiccator method) as well as 
using a Krüss, Processor Tensiometer K12 (Krüss GmbH). In these methods, various relative 
humidity levels were realized using saturated salt solutions as described under experimental 
section (Table 7.9). Water uptake of Aeroperl® 300 Pharma alone was determined at various 
relative humidity and the water uptake due to the extract was calculated. 
 
Figures 5.3 a – g show the kinetic moisture sorption profiles of the dry extract preparations 
(DEPs) containing 10 – 60% Aeroperl® 300 Pharma. 
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Figure 5.3: Water uptake profiles of the dry extract preparations containing Aeroperl® 300 
Pharma a) 10%; b) 20%; c)30%; d) 40%; e) 50%; f) 60% and g) 100% Aeroperl® 
300 Pharma at 33, 44, 56, 75 and 85% relative humidity levels at 20°C. 
a) b)
c) d)
e) f)
g)
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As shown in the figures, the percent water uptake by the DEPs increased with increasing the 
relative humidity. Moreover, the DEPs required longer time to reach a maximum and 
equilibrium water uptake at higher relative humidity levels. 
 
Similar water uptake profiles were obtained using the desiccator method. A typical profile for 
DEP containing 30% Aeroperl® 300 Pharma is depicted in Figure 5.4.   
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Figure 5.4: Water uptake profiles of the dry extract preparation containing 30% Aeroperl® 
300 Pharma at 33, 44, 56, 75 and 85% relative humidity levels at 20°C [desiccator 
method]. 
 
The water uptake profiles of the DEP containing 30% Aeroperl® 300 Pharma were compared 
using the two methods (Figure 5.5.) A higher water uptake were observed using the desiccator 
method indicating that the DEPs require longer time to reach equilibrium than the ones 
determined by the Krüss Tensiometer. 
 
Figure 5.6 depicts the water sorption isotherms of the DEPs at 20° C. The values were taken 
from the equilibrium moisture uptake from Fig. 5.3. The addition of Aeroperl® 300 Pharma to 
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the crude extract decreases the hygroscopicity. Moreover, the sorption isotherms of the crude 
extract show a marked water uptake increase above 65% relative humidity, indicating that, the 
hygroscopicity of the DEPs are manageable at lower relative humidity.  
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Figure 5.5: Water uptake profiles of the dry extract preparation containing 30% Aeroperl® 
300 Pharma (     ⁬     desiccator method; other symbols: Krüss Tensiometer) 
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Figure 5.6: Water sorption isotherm of the DEPs containing 10 – 60% Aeroperl® 300 Pharma 
[using a Krüss Tensiometer K12]. 
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Powder beds of 1 g of the dry extract preparations containing 10 – 60% Aeroperl® 300 
Pharma were prepared in petri dishes and stored at 20° C over the saturated salt solutions. The 
moisture content of the various extract preparations was measured gravimetrically at 24 hrs 
intervals for 15 days. Dry extract preparations containing 10% and 20% Aeroperl® 300 
Pharma were deliquesced at relative humidity levels of 65% and above (Fig. 5.7). However, 
as shown in the picture, even though DEP containing 30% Aeroperl® 300 Pharma adsorbed 
20% water at 85% relative humidity (Fig. 5.3c, 5.4, 5.5 and 5.6), the preparation remained 
powder.  
 
 
 
Figure 5.7: Physical appearance of the DEPs containing 10%, 20% and 30% Aeroperl® 300 
Pharma after 15 days in 33, 44, 65, 75 and 85% relative humidity chambers. 
 
5.3.4  Water content determination 
Table 5.2 shows the water content of the DEPs containing 10 – 60% Aeroperl® 300 Pharma 
which were determined using Karl Fischer titration. The results indicate that, the water 
content of the dry extract preparations varies with the content of Aeroperl® 300 Pharma. 
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Increase in Aeroperl® 300 Pharma decreases the water content of the dry extract preparations. 
 
Table 5.2: Water content of the dry extract preparations  
DEPs containing Water content (%) SD 
10% Aeroperl® 300 Pharma 5.1 0.54 
20% Aeroperl® 300 Pharma 4.8 0.43 
30% Aeroperl® 300 Pharma 3.5 0.23 
40% Aeroperl® 300 Pharma 3.3 0.15 
50% Aeroperl® 300 Pharma 3.3 0.28 
60% Aeroperl® 300 Pharma 3.1 0.12 
 
Based on the results of the SEM and water uptake studies, the dry extract preparation 
containing 30% Aeroperl® 300 Pharma was selected for tablet formulation. Hence, density, 
flow property and compactability of this DEP were further investigated. The term dry extract 
preparation (DEP) refers to the dry extract preparation containing 30% Aeroperl® 300 
Pharma. 
 
5.3.5  Density  
The bulk, tapped and true densities of the dry extract preparation containing 30% Aeroperl® 
300 Pharma were found to be 0.697, 0.870 and 1.547 gm/ml, respectively. The crude extract 
of the seeds of G. lotoides (extract A) showed a bulk, tapped and true densities of 0.66, 0.94 
and 1.51 g/ml, respectively. Hence, due to the addition of Aeroperl® 300 Pharma, the bulk 
density increased while the tapped density decreased. The true density had also showed a 
tendency of increasing. 
 
Porosity, consolidation index (Carr compressibility index) CC % = [(tapped density – bulk 
density)/bulk density]*100 and Hausner ratio, HR = [tapped density/bulk density] which are 
measures of compressibility of powders were calculated from the density results. Table 5.3 
summarizes the results of porosity, consolidation index and Hausner ratio of the dry extract 
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preparation and the crude extract of the seeds of G. lotoides (extract A).  
 
Compressibility indices less than 15% are indicative of free-flowing powders; indices greater 
than 40% usually correspond to very poor flow (Carr, 1965). As shown in the table, the 
consolidation index had decreased form 29.8 to 19.9 indicating the improvement of the flow 
properties due to the formulation of the crude extract in to dry extract preparation using 
Aeroperl® 300 Pharma.  
 
Table 5.3: Porosity, consolidation index and Hausner ratio of the dry extract preparation 
(DEP) as well as the crude extracts of the seeds of G. lotoides (extract A). 
 Porosity (%) Consolidation (Carr’s) 
index (%) 
Hausner ratio 
DEP 55.0 19.9 1.25 
Extract A 56.0 29.8 1.42 
 
The HR is a simple test usually used to evaluate fluidity, where values less than 1.25 indicate 
good flow properties and values greater than 1.5 indicate poor flow properties (Fonner et al., 
1966). As shown in the table, the dry extract preparation decreased the HR from 1.42 to 1.25, 
indicating the improvement of flowability after mixing with Aeroperl® 300 Pharma. 
 
5.3.6  Powder flow properties 
Angle of repose and flow rate (timed delivery through an orifice) are the most simple and 
commonly used methods to evaluate powder flow properties. The flow properties of powders 
vary considerably, ranging from those that flow readily and uniformly to those that resist free 
flow. Particulate solids resist flow because of the frictional and cohesive forces in powders 
which are usually reflected in the angle of repose. 
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The values of angle of repose obtained may be used as a guide to the type of flow expected. 
Angle of repose less than 25° indicates the powder has excellent flow properties, whereas 
25°-30° good, 30°-40° passable (fair) and greater than 40° very poor (Wells and Aulton, 
1988). 
 
Dry plant extracts usually show poor flowability. The poor flow property of the crude extract 
of the seeds of G. lotoides has been reported earlier. The crude extract of G. lotoides did not 
flow through a funnel with a 10-mm aperture under gravitational force and showed an angle 
of repose of 43.7° (Endale et al., 2004). A number of reasons have been postulated for the 
poor flow properties of the crude extract including the rough and irregular particle shape, 
hygroscopicity and the very fine particles which lead powder packing and densification 
(Endale et al., 2004).  
 
The dry extract preparation showed an angle of repose 36.2° which is classified as passable 
(fair) flow according to Wells and Aulton (1988) and the flow rate was found to be 7.9 
gm/sec. Scanning electron micrographs of the DEP (Fig. 5.2 i and j) showed that the rough 
and irregular particle shape of the crude extract have been improved when the liquid extract 
was adsorbed on the surface of Aeroperl® 300 Pharma. DEP was found as aggregated 
spherical particles with less contact angle and hence less frictional force.  
 
5.3.7  Compactability study of the dry extract preparation 
The relationships between the compression pressure and the radial tensile strength as well as 
the porosity of the tablets prepared from the dry extract preparation alone are depicted in 
Figure 5.8. The radial tensile strength was calculated from the thickness, diameter and 
crushing strength of the tablets, whereas the porosity of the tablets was calculated from the 
true and apparent densities of the extract. The apparent density was calculated form the 
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thickness out of die, weight and diameter of the tablets.  
 
As shown in the figure, the tensile strength of the tablets increased with increase in 
compression pressure up to 260 Mpa. The radial tensile strength of the tablets increased 
minimal with increase in compression pressure beyond 260 Mpa. The tablets showed no sign 
of capping and lamination at higher compression pressures indicating the high plastic 
deformation of the dry extract preparation.  
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Figure 5.8: Radial tensile strength and porosity of the dry extract preparation at various 
compression pressures. 
 
On the other hand, the porosity decreased with compression pressure which remained 
constant at 0.05% after the compression pressure of 260 MPa.  
 
The Heckel plots of the dry extract preparation at compression pressures of 118, 262 and 515 
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Mpa are depicted in Figure 5.9. The mean yield pressures (reciprocal of the slope), which 
show the minimum pressure required to cause deformation, were found to be 661, 808 and 
874 at compaction pressure of 118, 262 and 515 MPa, respectively. Large values of the 
Heckel constant indicate the susceptibility of the dry extract preparation to plastic 
deformation at low pressures.  
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Figure 5.9: Heckel plots of the dry extract preparation at compression pressure of 118, 262 
and 515 MPa.  
 
Paronen and Ilkka (1996) described the process of volume reduction of a powder mass under 
pressure and enumerated different stages: die filling, rearrangement of particles, deformation 
by elastic changes, permanent deformation by plastic flow or particle failure by brittle 
fracturing. Numerous mathematical expressions dealing with the characterization of tablet 
dimensions and changes involved in the densification process including Heckel, Kawatika and 
Cooper Eaton methods have been suggested. 
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5.4 Stability of the saponins and flavonoids in the dry extract preparation 
The stability of the saponins and flavonoids in the dry extract preparation was determined at 
25 and 40° C for a period of 6 months. Figure 5.10 depicts the data. The amounts of vicenin-2 
as well as the total flavonoids were determined by HPLC using the method described under 
4.3. The measurements were done in triplicate and the percent recovery was calculated form 
the amount of flavonoids in the dry extract preparation at the beginning of the stability study. 
 
As shown in the figure, the amount of flavonoids under both storage conditions was more 
than 95% during the six months indicating a good stability at the specified storage conditions. 
The phytochemical profiles of the HPLC figureprints of the dry extract preparation stored at 
25 and 40° C were not altered significantly during the 6 months.  
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Figure 5.10: Stability of the flavonoids of G. lotoides in dry extract preparation stored at 25 
and 40°C for six months.  
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The stability of the saponins in the dry extract preparations during the storage conditions was 
confirmed by TLC comparison. A freshly prepared dry extract preparation was used as a 
standard (Figure 5.11). As shown in the figures, the major figureprints of the TLC plates were 
not altered significantly.   
 
                
 
Figure 5.11: TLC of the dry extract preparation a) freshly prepared b) stored at 25°C for 6 
months and c) stored at 40 °C for 6 months.   
 
Moreover, the amount of saponins in the dry extract preparation stored at 25 and 40°C was 
analyzed by HPLC after acid hydrolysis. Mollugogenol B was determined and the total 
saponins of G. lotoides were calculated as glinuside G as described under 4.2. Figure 5.12 
shows the data of the saponins. As shown in the figure, the amount of saponins remaining 
after 6 months were found to be 97 and 94% at 25 and 40°C, respectively. Hence, the 
saponins were found to be stable and compatible with Aeroperl® 300 Pharma in the dry 
extract preparation at the specified storage conditions.  
 
a) b) c)
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Figure 5.12: Stability of the saponins of G. lotoides in dry extract preparation stored at 25 and 
40°C for six months. 
Chapter 6 
 
DRY GRANULATION BY ROLLER COMPACTION, TABLET 
PREPARATION AND ENTERIC COATING 
 
6.1 Dry granulation by roller compaction 
6.1.1  General introduction 
Dry plant extracts usually lack good flow properties to be processed by direct 
compression. In addition, because the active components of the extracts are diluted by 
coextracted substances, high dosages are required. This is in conflict with the limited 
proportion in which the extracts can be incorporated into the final mixture for tablet 
compression (Vennat et al., 1993). Numerous reports have addressed techniques used to 
solve these problems, such as wet granulation with non-aqueous solvents (Diaz et al., 
1996), direct compression of spray-dried extracts (Plazier-Vercamen and Bruwier, 
1986) and selection of suitable excipients for the formulation of dry plant extracts in 
direct compression tablets (Renoux et al., 1996).  
 
Processing of powders into granules or aggregates is commonly performed in order to 
modify the flowability and compactability drugs and excipients as well as the 
disintegration time of the tablets thereof (Carstensen, 1980). One of the processes of 
densification of powders is granulation by roller compaction, which improves 
flowability, compressibility and disintegration time (Parrott, 1981).  
 
Moreover, compaction-granulation of powders could have one of the following 
objectives: obtain products of the same size, volume and weight; obtain a specified and 
constant product size-range; reduce the volume of a powder; stabilize mixtures of 
powders during handling and transport, provide uniformity of density, shape and size of 
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the particles, minimize segregation, control the dispersion rate of granules; solve the 
problems of powder caking during storage and eliminate the problems of dust 
generation during handling. Granulation by roller compaction of powders usually 
requires no binder and the bonding of particles is ensured by the mechanical pressure 
exerted on the product being compacted (Gerad and Zak, 1995).  
 
The crude extract (Extract A) of the seeds of G. lotoides has shown a poor flowability 
and a prolonged disintegration time after tabletting (Endale et al., 2004). Moreover, 
large amounts of the dry extract preparation were required to achieve the traditional 
dose. These conditions necessitate the need for granulation of the dry extract 
preparation by compaction.  Rocksloh et al. (1999) have reported that granulation by 
roller compaction of plant extracts before compression had improved both 
disintegration time and crushing strength of the tablets. 
 
6.1.2       Granulation and characterization of the dry extract preparation (DEP) 
The dry extract preparation was blended with 2% magnesium stearate and compacted 
using a Gerteis Micro-Pactor® (Gerteis AG) at a compaction force of 12 kN. The 
ribbons formed were grinded into granules of the required size using a mill called 
‘Zahnscheibenmühle’ (BECO). 
 
6.1.2.1  Particle size distribution of the DEP granules 
Figure 6.1 shows the particle size distribution by sieve analysis of the granulation of the 
dry extract preparation. As shown in the figure, the majority of the particles (more than 
90%) have particle sizes between 250 and 710 µm. The amount of fine powders (less 
than 250 µm) and particles greater than 1.00 mm was found to be 6.3 and 1.4%, 
respectively. 
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Figure 6.1: Sieve analysis of the granules of the dry extract preparation prepared by 
roller compaction. 
 
6.1.2.2  Compressibility and flow properties of the DEP granules 
The flowability, as measured by the angle of repose, flow rate and compressibility 
index, was greatly improved by the granulation process due to the increase of particle 
size.  Table 6.1 depicts the angle of repose, flow rate and density results of the powders 
and granules of the dry extract preparation. 
 
The granules of the dry extract preparation exhibited relatively high bulk and tapped 
densities, and the compressibility index was 7.3%, which is considered as an excellent 
flowable material (Table 6.1). The powdered dry extract preparation showed a 
compressibility index of about 20% which is categorized as fair (passable) flow 
properties (Fonner et al., 1966). The roller compaction of the dry extract preparation 
decreased the angle of repose from 36 to 31 degrees and the Hausner ratio from 1.25 to 
1.07. It is well known that powder flowability is size-dependent, and as particle size 
increases, the total surface area decreases, resulting in reduction of frictional forces 
between particles which improves the flow properties  (Amidon 1999; Parrott, 1981; 
Arnaud et al., 1998). 
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Table 6.1: Compressibility and flow properties of the dry extract preparation and the 
granulations by roller compaction. 
Dry extract preparation  
Properties Powders Granules 
Densities (gm/ml)   
Bulk 0.697 0.742 
Tapped 0.870 0.796 
Angle of repose (°) 36.24 31.2 
Flow rate (gm/sec) 7.94 10.33 
Hausner ratio 1.25 1.07 
Carr’s compressibility index (%) 19.89 7.3 
 
6.2 Formulation and characterization of DEP tablets 
6.2.1 Formulation of tablets 
The tablets were prepared from the granulated dry extract preparation (DEP) and 
contain 947 mg of DEP per tablet. The 2% magnesium stearate, which was included 
into the dry extract preparation before compaction was sufficient to prevent sticking of 
the tablet mixture to the punch faces. Tablet hardness of the different formulations was 
maintained in the range of 70 to 80N. The tablet formulations and properties of the 
tablets are given in Table 6.2. 
 
As shown in table 6.2, tablet formulations I, II, and III compare the effect the amount of 
Avicel® PH 101 on the disintegration time of the tablets. The disintegration time of the 
tablets decreased from 8.6 to 2.4 min with increase in the amount of Avicel® PH101 
from 163 to 363 mg with comparable tablet hardness.  
 
Comparison of tablet formulation I, IV and V revealed that Kollidon® CL as 
disintegrant provides tablets with faster disintegration time (30 sec). Whereas, a 
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formulation with Explotab showed a disintegration time of 9.2 min with comparable 
tablet hardness. Ac-Di-Sol has shown a disintegration time of 2.4 min.  
 
Table 6.2: Composition and characterization of the various tablet formulations  
 Tablet formulations (mg) 
Constituents I II III IV V VI VII 
DEP (granules) 947 947 947 947 947 947 947 
Avicel® PH 101 363 263 163 363 363 - - 
Avicel® PH 200 - - - - - 363 - 
Cellactose® 80 - - - - - - 363 
Ac-Di-Sol® 90 90 90 - - 90 90 
Kollidon® CL - - - 90 - - - 
Explotab® - - - - 90 - - 
Properties        
Tablet weight (mg) 1400 1300 1200 1400 1400 1400 1400 
Tablet hardness (N) 73 81 80 77 71.3 72  78 
Disintegration time (min) 2.4 4 8.6 0.5 9.2 4 12.2 
  
However, tablets prepared with Kollidon® CL as disintegrant were unstable at relative 
humidity levels of 65% and above. The tablets prepared with Kollidon® CL adsorb 
moisture and disintegrate prematurely.  
 
On the other hand, Formulations I, VI and VII depicted the effect of filler/binder such as 
Avicel® PH 101, Avicel® PH 200 and Cellactose® 80, on the disintegration time of the 
tablets prepared with Ac-Di-Sol® as disintegrant. Tablets with disintegration times of 
2.4, 4.0 and 12.2 min were obtained with Avicel® PH 101, Avicel® PH 200 and 
Cellactose® 80, respectively. 
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Based on the preliminary investigation (Table 6.2), tablet formulations containing dry 
extract preparation (947 mg), Avicel® PH101 (363 mg) and Ac-Di-sol (90 mg) was 
selected. The effect of compression force on crushing strength, disintegration time and 
friability of the tablets was evaluated by compressing the formulation at approximately 
13.5, 16.1, 18.4, 20.6, 23.7 and 27.9 kN. 
 
6.2.2 Characterization of the DEP tablets 
Figure 6.2 depicts the effect of compression force on the crushing strength, 
disintegration time and friability of the DEP tablets. Due to the complex geometry of 
the oblong tablets, compression pressure, porosity and tensile strength were not 
calculated. 
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Figure 6.2:  Effect of the compression force on the tablet hardness, disintegration time 
and friability of DEP tablets.  
Working area
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As shown in figure 6.2, the crushing strength of the tablets increased with increasing 
compression force without any sign of capping or lamination at higher compression 
forces.  
 
On the other hand, friability decreased rapidly as the compression force increased. The 
target friability of less than 1% was obtained at a compression force of 18.4kN. This 
result confirmed that compression force of 18 kN could provide tablets, which were not 
easily broken during enteric coating. No substantial difference in friability was found 
above compression force of 23.7 kN. A disintegration time of less than 10 min was set 
as a target which together with the friability defines the working area (shaded part in 
Figure 6.2) 
 
G. lotoides tablets prepared from the crude extract have shown slow disintegration times 
irrespective of the type of disintegrants used (Endale et al., 2004). The tablets exhibited 
surface erosion (i.e., dissolution) rather than spontaneous disintegration. This 
phenomenon could be explained or attributed to the presence of hygroscopic extract in 
the formulation (Lowenthal, 1973; Erdös, 1986; Lieberman and Lachman, 1989). 
 
The delaying effect of hygroscopic ingredients on the disintegration times of tablets 
containing super disintegrants has been reported (Gordon, 1987). This is so, because the 
hygroscopic ingredients promote dissolution rather than disintegration of the tablet. The 
rate of water penetration into tablets was also shown to decrease as the solubility of the 
drug increased due to competitive inhibition of the disintegrant for locally available 
water (Graf, 1982). 
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6.2.3  HPLC analysis of the DEP tablets  
The contents of the saponins and flavonoids in the tablet formulation were determined 
by HPLC as described under 4.2 and 4.3, respectively. Six tablets were analyzed and the 
contents of the saponins and flavonoids were calculated as glinuside G and vicenin-2 
equivalents, respectively. Accordingly, the content of total saponins of the six single 
tablets was between 94 to 98% of the claimed amount. Whereas, the content of 
flavonoids of the six single tablets was found to between 95 and 103%. 
 
6.3 Enteric coating 
6.3.1  General introduction 
Enteric or sustained release coating of tablets, capsules, granules, pellets, crystals and 
other drug-loaded cores serves to ensure their physical and chemical stability, to 
enhance patient compliance and to further improve their therapeutic efficacy. The 
efficiency of a pharmaceutical dosage form depends not only on the active ingredients it 
contains but also on the formulation and processing technique (Bauer et al., 1998). 
Enteric coating of G. lotoides tablets provides an immediate release of the active 
components in the small intestine, where it acts as anthelmintic agents and it also 
protects the tablets for atmospheric humidity. 
 
Anionic acrylic polymers such as EUDRAGIT® L carry carboxyl groups. They are 
insoluble in acidic medium, i.e. resistant to gastric fluid, and dissolve only in the neutral 
to weakly alkaline medium of the small intestine. Medications that are instable in 
gastric fluid, or cause incompatibilities in the stomach, i.e. irritate the gastric mucosa or 
provokes nausea and sickness, can be coated with enteric films to pass the acid 
environment of the stomach unchanged and release the active ingredient only after 
entering the small intestine (Bauer et al., 1998).  
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Enteric coating materials should swell as little as possible in the acid environment of the 
stomach at pH 1 to 4 and remain largely impermeable for several hours, as large cores 
may take longer to pass the stomach. The film coat should form a coherent layer that is 
largely impermeable to penetrating gastric fluid and emerging active ingredients.  
  
The pharmacopoeial specifications allow some softening of enteric-coated cores. 
Testing for gastroresistance must confirm that the films remain intact and that the 
diffusion of active ingredient in gastric fluid remains within tolerable limits.  
 
Enteric polymer films are expected to dissolve between pH 5.5 and 6.5, on the one hand 
to avoid premature disintegration in the stomach and, on the other hand, to ensure rapid 
release of the active ingredients in the intestinal tract.  
 
6.3.2 Formulation of tablet cores 
Tablet cores having the necessary hardness to be coated were prepared at a compression 
force of 20 kN as described earlier. These tablets showed a crushing strength of 195 N, 
a disintegration time of 9 min and a friability of 0.4%. 
 
Placebo oblong tablets were prepared from Ludipress® (360 mg), Avicel® PH 101 (352 
mg), Aeroperl® 300 Pharma (40 mg), Ac-Di-Sol (40 mg) and magnesium stearate (8 
mg).  The composition of the placebo tablets were selected which could produce tablets 
with similar properties like the core DEP tablets. The placebo core tablets showed a 
crushing strength of 150 N, friability of 0.25% and disintegrate in less than a minute. 
The placebo tablet cores were used to increase the batch volume of the core tablets in 
the coating pan. The ratio of placebo to G. lotoides tablet cores was maintained at 4:1. 
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6.3.3 Preparation and characterization of enteric coated Glinus lotoides 
tablets 
6.3.3.1  Enteric coating of Glinus lotoides tablets 
EUDRAGIT® L 100-55 which dissolves from pH 5.5 upwards was used as enteric 
coating polymer for G. lotoides tablets. The polymer was dissolved in isopropyl alcohol 
and acetone and after the addition of plasticizer, glidant (talc), lubricants and pigment, 
the mixture was used as final enteric coat on G. lotoides core tablets. The formulation of 
the enteric coating suspension is given in Table 7.13 under experimental section. 
 
Flößer et al. (2000) have evaluated the effect of variations in plasticizer type, quantity 
and talc concentration on the preparation, processing and properties of isolated films 
and film-coated caffeine tablets. Plasticizers such as propylene glycol (PG), 
polyethylene glycol (PEG) 400, PEG 6000, PEG 1500, and triethyl citrate (TEC) were 
investigated at various concentrations. With all the plasticizers investigated, the 
minimum film-forming temperature (MFT) decreases as the amount of plasticizer 
increased. Of all the variants investigated, the formulation with 20% PG performed the 
best. 
 
EUDRAGIT® L 100-55 requires the addition of plasticizer and talc. Usually, the 
amounts of polymer required for enteric coating ranges from 4 to 6 mg/cm² of the tablet 
surface. Depending on the quality of the tablets (hardness, friability), higher amounts of 
polymers may be necessary. However, higher amounts of polymer may increase the 
disintegration time in the intestinal fluid. Incorporated pigments (TiO2, color lakes) may 
increase the permeability of the coating and require higher amounts of applied polymer. 
 
 
6 GRANULATION, TABLETTING AND ENTERIC COATING 
 
107
6.3.3.2  Characterization of the enteric coated Glinus lotoides tablets 
Disintegration time  
The enteric coated tablets resisted disintegration or softening in simulated gastric fluid 
(0.1 M HCl) for a minimum of 2 hours. The gastro-resistance test was performed in a 
tablet disintegration tester according to the EP. The tablets were then inspected for signs 
of disintegration and cracks that might lead to premature release of the active 
ingredients. 
 
Subsequently, the test fluid is replaced with phosphate buffer solution pH 6.8 as 
simulated intestinal fluid. The enteric coated tablets disintegrated within 15 min 
whereas the enteric coated placebo tablets disintegrated within 4 min, which is in 
compliance with the EP specifications. There was no significant difference observed 
between Eudragit® L 100/55 and Kollicoat® MAE 100P. Both propylene glycol and 
acetyl tributyl citrate were efficient as plasticizers at concentration of 11% in dry film. 
 
Physical assessment of the coated tablets 
Table 6.3 depicts the average specifications of the core and enteric coated G. lotoides 
tablets.  
 
Table 6.3 Average specifications of the core and enteric coated tablets. 
 Parameter 
 Dimension, mm (n = 6) 
 
Weight, mg 
(n = 10,  
RSD, %) 
Crushing 
strength, N 
(n = 6, RSD, %) 
Length 
(RSD, %) 
Width 
(RSD, %) 
Thickness 
(RSD, %) 
Core tablets 1380 (0.53) 195 (3.8) 20.29 (0.12) 8.24 (0.30) 8.43 (0.26)
Enteric coated 
tablets 
1531 (0.67) 380 (2.3) 20.49 (0.45) 8.56 (0.42) 8.81 (0.40)
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6.3.3.3  Stability of the enteric coating 
Figure 6.3 shows the increase in tablet weight due to water absorption. As shown in the 
figure, the core tablets absorb up to 10% w/w water at 26°C and 60% relative humidity. 
The adsorption equilibrium was reached within three days.  
 
On the other hand, the water uptake of the enteric coated G. lotoides tablets at 26°C and 
60% relative humidity was found to be 6% in 15 days. As shown in the figure, the 
equilibrium was not achieved during this period. Similar water adsorption pattern was 
observed at 21° C and 45% relative humidity but the water uptake was reduced to 4% 
and less than 2%, for the core and enteric coated tablets, respectively.  
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Figure 6.3: Water uptake of the core and coated tablets at 21°C in 45% relative 
humidity and at 26°C in 60% relative humidity. 
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Similar pattern was observed with the increase in tablet thickness due to water uptake 
(Figure 6.4.) In addition to the increase in tablet thickness, the color of the core tablets 
changed which is more pronounced at 26 °C and 60% relative humidity level. At a 
relative humidity of 60% at 26 °C the thickness of the enteric coated tablets increased 
continuously with time. 
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Figure 6.4: Increase in tablet thickness of the core and coated tablets at 21°C in 45% 
relative humidity and at 26°C in 60% relative humidity due to water uptake. 
 
 
Chapter 7 
EXPERIMENTAL SECTION 
7.1  Materials 
Plant Material 
Fruits of Glinus lotoides L. were purchased from a local market in Addis Ababa, 
Ethiopia, in September 2001. The identity was confirmed by the National Herbarium, 
Department of Biology, Faculty of Science, Addis Ababa University, Ethiopia. A 
voucher specimen (No. 003444) has been deposited at the National Herbarium, 
Department of Biology, Faculty of Science, Addis Ababa University, Ethiopia. 
Table 7.1: Solvents and chemicals 
Substance Charge number Manufacturer/Supplier 
Acetic acid glacial K23614063651 Merck KGaA 
Acetone 1056180 Fluka Chemie AG 
Acetonitrile 9012 J. T. Baker 
Aluminum chloride 06220 Fluka Chemie AG 
p-Anisaldehyde 53615208235 Merck KGaA 
Boric acid K25574065843 Merck KGaA  
n-Butanol 21500 Fluka Chemie AG 
Citric acid monohydrate K91649444 025 Merck KGaA 
Chloroform 442392 Fluka Chemie AG 
1,2-Dichloroethane K27929255046 Merck KGaA 
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Substance Charge number Manufacturer/Supplier 
Ethyl acetate K27290323 Merck KGaA 
Ethyl methyl ketone K13788608 Merck KGaA 
Formamide 20210 Riedel-de Haën 
Formic acid K27372532 Merck KGaA 
Hydranal composite 2 33410 Riedel-de Haën 
Hydrochloric acid K27984217 Merck KGaA 
Magnesium chloride  TA743633  Merck KGaA 
Methanol 0377501 Fischer Scientific GmbH 
PEG 400 51632267 BASF AG 
Phosphoric acid (85%) K17169073 Merck KGaA 
Potassium carbonate  A493528 Fluka Chemie AG 
Potassium chloride K24252236 Merck KGaA 
iso-Propanol K2935696 Merck KGaA 
Sodium chloride K 31900304  Merck KGaA 
Sodium nitrite S30973034 Merck KGaA 
Sodium acetate 82810 Riedel-de Haën 
Sodium bromide  K30615060 Merck KGaA 
di-Sodium hydrogen phosphate K25613676841 Merck KGaA 
Sodium tartarate dihydrate 6664 Merck KGaA 
Sulphuric acid 95-97% K27582431010 Merck KGaA 
Vanillin  K25739410840 Merck KGaA 
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Table 7.2: Standard substances 
Substance  Charge number Manufacturer/Supplier 
Arabinose  10860 Fluka Chemie AG 
Xylose   L328889 Merck KGaA 
Rhamnose  1.0736 Merck KGaA 
Vitexin 95042502 Extrasynthese 
Isovitexin 94111405 Extrasynthese 
 
Table 7.3: Excipients for extract preparation, tablet formulation and enteric coating 
 
Substance  Charge number Manufacturer/Supplier 
Aeroperl® 300 Pharma  9125063 Degussa AG 
Avicel® PH 101  6350 FMC Biopolymer 
Ac-Di-Sol®  T112C FMC Corporation 
Magnesium stearate  0266 Baerlocher GmbH 
Talc 92092223 Norwegian Talc GmbH 
Oleic acid K91145571916 Merck KGaA 
Explotab® E7094 Mendell GmbH 
Avicel® PH 200 X119 FMC Biopolymer 
Kollidon® CL 19-2143 BASF AG 
Ludipress 72-1281 BASF AG 
Kollicoat® MAE 100 P 83802009T0 BASF AG 
1,2-Propylene Glycol 50027101 BASF AG 
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Substance  Charge number Manufacturer/Supplier 
CITROFOL® B II 3002862/05.05 Jungbunzlauer GmbH 
Eudragit® L 100-55 B030804067 Röhm GmbH 
Titan dioxide 60180 Kronos Titan GmbH 
Sicovit Braun 70 E 172  68M6160 BASF AG 
Glycerol monostearate 0047064 Henkel KGaA 
 
Table 7.4: Chromatography and Miscellaneous materials 
Substance  Charge number Manufacturer/Supplier 
TLC, Silica gel 60 F254, Art. 
No. 1.0554 
940389246 Merck KGaA 
TLC, RP-18 F254s, Art. No. 
1.0559 
0B076562 Merck KGaA 
TLC plates, SIL G-100 004104 Macherey-Nagel GmbH 
Sephadex LH-20, Art. No. 17-
0090-01 
292931 Amersham Biosciences AB 
Silica gel 60, CC TA288385 715 Merck KGaA 
Wacker® antifoam emulsion  12131 EK Drawin GmbH 
Helium gas, Type 5.0 0238 Messer Griesheim GmbH 
Cellulose acetate filter, 0.2 µm 16534 Sartorius AG 
Depth filter, T 1000 D105 Pall Corporation 
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7.2 Equipment 
Table 7.5: List of equipment 
Equipment Manufacturer/Supplier 
Analytical balance, model AE 200  Mettler Toledo GmbH 
Balance, model PG 4002-S  Mettler Toledo GmbH 
Beckman air comparison pycnometer, model 930 Beckman Instruments GmbH 
Centrifuge, Megafuge 1.0R Heraeus Instruments 
Dial high gauge, model No. 192-106 Mitutoyo Messgeraete GmbH 
Ph. Eur. Settling apparatus, JEL  Engelsmann AG 
Filter Press, Type A 20 Z Seitz-Werke GmbH 
Freeze dryer, LYOVAC GT 2 FINNA-AQUA GmbH 
Gerteis Micro-Pactor® 1079/2  Gerteis AG 
Hydraulic Press  5 L Fischer & Co. KG 
Karl Fischer apparatus Deutsche Metrohm GmbH & Co. 
Korsch EK II tablet press Korsch GmbH 
Korsch EK0 tablet press Korsch GmbH 
Krüss Processor Tensiometer K12 Krüss GmbH 
Mastersizer 2000  Malvern Instruments GmbH 
Oven, model T5050 Heraeus Holding GmbH 
Ball mill Erweka GmbH 
Vacuum rota vapor  Büchi Labortechnik GmbH 
TBH-30 hardness tester  Erweka GmbH 
7 EXPERIMENTAL SECTION 115
Equipment Manufacturer/Supplier 
Turbula mixer T2C Bachofen AG 
Ultra-Turrax T 45/N IKA-Werk GmbH 
Ultra-Turrax T25 IKA-Werk GmbH 
UV-Vis Spectrophotometer 550S Perkin-Elmer GmbH 
Vacuum drying oven, VDL 53 Binder GmbH 
Water distillation apparatus Wagner & Munz GmbH 
Fraction collector, UltroRac® II LKB-Produkter AB 
 
7.3 Data processor 
Computer: AMD Athlon (TM) XP1600+, 523 MB RAM, 60 GB hard disk 
Table 7.6: List of general software 
Software Manufacturer/Supplier 
Microsoft word Microsoft  
Microsoft excel Microsoft 
Microsoft power point Microsoft 
Krüss Processor Tensiometer K12 software Krüss GmbH 
Messfix 2.3 Developed in the Institute 
Malvern system software Malvern Instruments GmbH 
Catman 3.1 Hottinger-Baldwin Messgeraete GmbH 
 
 
7 EXPERIMENTAL SECTION 116 
7.4 Extraction, isolation and structural elucidation of the saponins and 
flavonoids of the seeds of Glinus lotoides  
7.4.1 Extraction of the seeds of Glinus lotoides 
The seeds of G. lotoides were separated from the fruits, powdered and extracted as 
shown in scheme 7.1. 500 g seeds of G. lotoides were defatted three times with 5 L n-
hexane in 10-L beaker for 15 min using an Ultra-Turrax (Type T 45/N, IKA-Werk 
GmbH) at 10000 rpm. The n-hexane extracts were filtered and the solvent was removed 
under reduced pressure in a rotavapor (Büchi Labortechnik GmbH). The amount of fat 
removed was found to be 66.5 g, which is equivalent to 13.3% of the dried powdered 
seeds. The defatted powdered seeds of G. lotoides (433.5 g) were stored at -20°C and 
used as starting plant material for the isolation and quantification of the saponins and 
flavonoids. 
 
The defatted powdered seeds (5 g) were extracted three times with 50 mL 60% 
methanol in water using an ultra-turrax (IKA-Werk GmbH) at 9500 rpm for 10 min. 
The extracts were filtered, concentrated under reduced pressure and dried in a freeze-
dryer (FINNA-AQUA GmbH) using a 24-hrs drying program: -30° C for 8hrs; 0° C for 
4hrs; 10° C for 6hrs and 20° C for 6hrs. This dried extract was referred to as extract A 
and was found to be 0.9 g, which is equivalent to 18% of the defatted dry powdered 
seeds.  
 
Exhaustive extraction of the seeds of G. lotoides (10 successive extractions with 80% 
methanol) has yielded 18% crude extract (Extract A) calculated on the dry defatted 
seeds.  The extraction method used in this study has provided an extract containing 
comparable amount to the exhaustive extraction reported earlier (Endale et al. 2004). 
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0.9 g of extract A was dissolved in 30 ml water and extracted three times with an equal 
volume of n-butanol. The n-butanol fractions were combined and dried which gave 160 
mg (3.2% of the defatted dry seeds). This extract was referred to as extract D and 
contains the saponins and flavonoids of G. lotoides. The remaining aqueous part was 
freeze-dried (extract B) as described above. Between the n-butanol and the aqueous 
layer, an emulsified intermediate layer was separated and dried (extract C). The amount 
of extract C decreased significantly with repeated extraction with fresh n-butanol and 
water. 
 
Extract D (160 mg) was suspended in a relatively small volume of methanol (2 ml) and 
allowed to settle. The undissolved part was separated and dried (extract E) and the 
dissolved part was added to a large volume of diethyl ether (40 ml). The precipitate 
formed was separated by centrifugation (Megafuge 1.0R, Heraeus Instruments) at 2000 
rpm for 20 min at 5 °C and dried (120 mg, 2.4% of the defatted dry seeds). This extract 
was referred to as extract F and was used as a starting material for the isolation of the 
saponins and flavonoids and later on as a secondary standard for the routine quality 
control of the crude extract and the tablet formulations thereof. After centrifugation, the 
supernatant was dried which gave an extract G.  
 
Scheme 7.1: Extraction of the seeds of G. lotoides 
500 g Powdered seeds of 
G. lotoides 
Defatted (3 x 5 L n-hexane, Ultra-Turrax 
9500 U/min, 10 min, at room temp.)  
Filtered and dried
433.5 g Defatted powdered 
seeds of G. lotoides 
66.5 g Fat (13.3% of the 
powdered seeds of G. lotoides) 
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Scheme 7.1: Extraction of the seeds of G. lotoides (Cont’d) 
 
5 g Defatted dry powder 
seeds of G. lotoides 
Extracted (3 x 50 ml 60% MeOH, Ultra-Turrax 
9500 U/min; 10 min, at room temp.) 
Filtered 
Aqueous layer 
60% Methanol extract 
Concentrated in rota vapor at 40 °C 
Freeze dried  
Dry extract, 0.9 g (Extract A) 
Dissolved in 30 ml Water 
Partitioned between n-butanol (1:1) 
n-Butanol layer Emulsified 
intermediate layer 
Freeze dried 
Extract B Extract D (160 mg)
Concentrated 
Dried 
Extract C 
Dried 
Suspended in 2 ml MeOH 
Undissolved Part Dissolved Part
Extract E 
Added into 40 ml ether 
Precipitate 
formation
Centrifugation  
2000 rpm, 20 min, 5 °C 
Precipitate 
Extract F 
Supernatant 
Extract G 
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7.4.2   Fractionation and isolation of the saponins and flavonoids 
7.4.2.1  Column chromatography fractionation 
Sephadex LH-20 column chromatography 
100 g of Sephadex LH-20 (Amersham Biosciences AB) were packed manually into a 
column of 28 cm x 1.5 cm i.d. The specified amount of sephadex LH-20 was allowed to 
swell in MeOH overnight and cautiously filled into the column using a funnel. The gel 
was then allowed to settle and pack for 24 hrs. The entrapment of air was avoided and 
care was taken not to dry the column. 
 
Extract F (1.2 g) was dissolved in a 2 ml methanol and carefully applied on the top of 
the column. The extract was eluted with methanol at a rate of 4 ml/min and 20 fractions 
were collected using UltroRac® II (LKB-Produkter AB). The fractions were combined 
into two fractions, Fr. 1 (352 mg) and Fr. 2 (600 mg) after controlling on analytical TLC 
plates (pre-coated RP-18 F254s aluminum sheets, Merck KGaA) using a mixture of 
MeOH:H2O (4:1) as eluent and 5% vanillin-H2SO4 reagent for detection. The solvent 
system composed of CHCl3-MeOH-H2O (70:50:4) was used for the flavonoids with 
fluorescence detection after spraying with Natural Products Reagent (5 mL of solution I 
(1% diphenylboryloxyethylamine in MeOH) followed by 5 mL of solution II (5% PEG 
400 in EtOH). 
 
Silica gel 60 and RP-18 column chromatography 
Similarly, silica gel 60 (Merck KGaA) and RP-18 (Merck KGaA) column were utilized 
for fractionation of the purified extract (extract F). The experimental conditions of the 
RP-18 column chromatography are given in Table 7.7. Up to 280 fractions were 
collected which were combined into 14 fractions after TLC examination. 
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Table 7.7: RP-18 column chromatography conditions of extract F 
Parameter  
Column size 18 cm x 1.5 cm i.d. 
Mobile phase H2O:MeOH in the following order  
[(100:0); (95:5); (85:15); (70:30); (50:50); (30:70)(0:100)] 
Fractions volume 6 mL (200 drops) 
Flow rate  6 mL/ 30min 
Number of fraction collected 280 
Fractions analysis RP-18 TLC plate, MeOH:H2O (4:1), 5%vanillin/H2SO4 
 
 
7.4.2.2  High Performance Liquid Chromatography (HPLC) 
Fractions collected from sephadex LH-20 column chromatography were further purified 
on HPLC to isolate saponins and flavonoids. Fraction 1 (256 mg) containing mainly 
flavonoids was separated by reversed-phase HPLC using 15% CH3CN in water as a 
mobile phase to provide two flavonoids, F. 1/1 (18.3 mg) and F. 1/2 (10.8 mg) which 
later on the structures were elucidated using spectral analysis as vicenin-2 and vitexin-
2"-O-glucoside, respectively.   
 
Fraction 2 (480 mg) containing mixtures of saponins, was separated by RP-18 HPLC 
using 75% MeOH in water as a mobile phase. Refractive index detector was employed 
for the saponins due to the lack of a suitable chromophore for UV detection. The RP-
HPLC provided two fractions, S1 (24 mg) and S2 (29 mg) which are composed of at 
least two major components as identified using TLC. Preparative TLC of S1 and S2 
provided five saponins. 
 
 
7 EXPERIMENTAL SECTION 121
HPLC conditions for the isolation of flavonoids and saponins 
Equipment: 
Pump:  LC-10AD, Shimadzu Liquid Chromatography, Shimadzu Co.  
Injector: Rheodyne, 7021, Rohnert Park, CA.  
Detector: For flavonoids: LC Spectrophotometer, MILLPORE® 
Waters, Model 481, Milford. 
For saponins  Shimadzu RID-10A refractive index 
Integrator: Chromato-Integrator, D-2000, Merck. 
Column: CC 250/4 Nucleosil 100-7 C18 Cat. No. 721609.40, Ser. No. 
1096117, Charge/Batch 21401011, Macherey-Nagel 
Guard column: LichroCART® 4-4, Lichrospher® 100 RP-18, 5 µm, Merck 
Mobile phase: For flavonoids: 15% CH3CN in water, Isocratic 
For saponins:  75% MeOH in water, Isocratic 
Injection volume: 150 µL  
Flow rate:  1 mL/min 
 
7.4.2.3  Preparative Thin Layer Chromatography (TLC)  
Preparative silica gel TLC (Sil G-100, 1.0 mm, Macherey-Nagel GmbH) with solvent 
system of CHCl3-MeOH-H2O (70:50:4) was used to isolate saponins from S1 and S2 
HPLC fractions. One small edge of the TLC plates was sprayed with vanillin reagent 
and the regions containing the saponins were scratched. The saponins were then 
extracted with MeOH. S1 afforded two saponins, S1/1 (2.2 mg) and S1/2 (1.9 mg). 
Similarly, S2 gave two fractions S2/1 (2.4 mg) and S2/2 (3.0 mg). The structures of the 
isolated compounds were elucidated as described below. 
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7.4.3  Structural elucidation of the saponins and flavonoids 
7.4.3.1  Structure analysis of flavonoids by Ultraviolet Spectroscopy 
UV-Vis spectra of the flavonoids were recorded in methanol and after the addition of 
various diagnostic reagents into the methanol solutions using Perkin-Elmer Lambda 16 
UV/Vis spectrometer (Perkin-Elmer GmbH).  
 
Preparation of diagnostic reagents 
I. Sodium methoxide (NaOMe): 2.5 g freshly cut metallic sodium were added 
cautiously in small portions to 100 mL dry spectroscopic methanol.  
II. Aluminum chloride (AlCl3):  5 g fresh anhydrous AlCl3 were added cautiously 
to 100 mL spectroscopic methanol. 
III. Hydrochloric acid (HCl): 50 ml concentrated HCl was mixed with 100 mL 
distilled water. 
IV. Sodium acetate (NaOAc): Anhydrous powdered reagent grade NaOAc was used. 
V. Boric acid (H3BO3): Anhydrous powdered reagent grade H3BO3 was used. 
 
Measurements of the spectra 
Stock solutions of the isolated flavonoids (F 1/1 and F 1/2) were prepared by dissolving 
0.5 mg in 50 ml MeOH. The concentration was then adjusted so that the optical density 
of the major absorption peak between 250 and 400 nm gave an optical density reading 
in the region 0.6 to 0.8. The methanol spectrum was measured using 3 ml of the stock 
solution of the flavonoid. The NaOMe spectrum was measured immediately after the 
addition of three drops of the NaOMe stock solution to the methanol solution. After 5 
min, the spectrum was re- recorded to check the stability of the flavonoids. The AlCl3 
spectrum was measured immediately after the addition of six drops of the AlCl3 stock 
solution to 3 ml of fresh methanol solution of the flavonoid. The AlCl3/HCl spectrum 
was then recorded after the addition of three drops of HCl solution to the AlCl3 solution. 
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The NaOAc spectrum of the flavonoid was determined as follows. Excess coarsely 
powdered, anhydrous reagent grade NaOAc was added with shaking to a cuvette 
containing 3 ml of fresh MeOH solution of the flavonoids. About 2 mm layer of NaOAc 
remained on the bottom of the cuvette. A second spectrum was run after 10 min to 
check for decomposition. The NaOAc/H3BO3 spectrum was determined immediately 
after the addition of sufficient powdered anhydrous reagent grade H3BO3 to the cuvette 
containing the NaOAc to give a saturated solution. 
 
7.4.3.2  Mass Spectrometry1 
The mass spectra of the substances were obtained using a Thermo Finnigan TSQ 
Quantum triple quadrupole mass spectrometer (Thermo Finnigan) equipped with an 
electrospray interface coupled to an integrated syringe pump system working with a 
flow rate of 10-20 µl/min. The electrospray interface was locked in a 90° position 
toward the orifice and operated at 3.8 kV in positive ionization mode and at 2.6 kV in 
negative ionization mode. Capillary temperature and sheath gas were optimized at 
280°C and 30 (arbitrary) units, respectively. Auxiliary gas was not used. The collision 
induced dissociation spectra (CID-spectra) were recorded with collision energy 20 and 
35 eV for positive and negative modes, respectively. Source CID voltage was set to a 
constant value of 10V for both Q1 and Q3 full scan and CID spectra, and the argon 
collision gas for MS/MS experiments was maintained at a pressure of 1.3 X 10-6 bar.  
 
7.4.3.3  Nuclear Magnetic Resonance (NMR)2 
1D (1H, 13C and DEPT-135) and 2D (1H COSY, HMQC and HMBC) NMR spectra 
were obtained at 300 °K on Bruker AVANCE DMX-600 or ARX-400 NMR 
                                                 
1 Measurement was conducted at the Institute of Pharmacology and Toxicology, Division of Clinical 
Pharmacology, University Hospital of Tübingen, by Dr. Bernd Kammerer 
 
2 NMR Spectra were measured at the Institut für Pharmazeutische Wissenschaften, Universität Freiburg, 
by Prof. Irmgard Merfort und GBF-Gesellschaft für Biotechnologische Forschung, Braunschweig, by 
Dr. Victor Wray 
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spectrometers (Bruker) locked to the major deuterium signal of the solvent, CD3OD. 
Chemical shifts are reported in δ ppm and coupling constants in Hz.  
 
7.4.3.4  Sugar analysis of the saponins of G. lotoides 
Acid hydrolysis on TLC plate 
Glinuside solutions (5 µL of 0.08 mg/mL corresponding to 0.4 µg glinuside) were 
applied on pre-coated silica gel 60 F254 aluminum sheet TLC plates and left in a 
hydrochloric acid atmosphere at 100 °C for 1 h HCl vapor was then eliminated under 
hot ventilation and the authentic sugars, namely arabinose (Fluka Chemie AG), xylose 
(Merck KGaA), and rhamnose (Merck KGaA) were applied. The TLC plate was 
developed with H2O-MeOH-CH3COOH-C2H4Cl2 (10:15:25:50) and visualized after 
spraying with p-anisaldehyde-H2SO4 reagent followed by heating at 110 °C for 10 min. 
Arabinose, xylose and rhamnose were observed at Rf values of 0.55, 0.65 and 0.68, 
respectively. 
 
 Methylation analysis of the sugar constituents3 
Sugar-linkages were analyzed with GC-MS system of the partially methylated alditol 
acetates as described by Plock et al (2001). 
7.5 Quantitative determination of the saponins and flavonoids for routine 
quality control purposes 
7.5.1  Quantitative determination of the saponins 
7.5.1.1  Preparation of a standard 
Isolation of mollugogenol B 
500 mg of extract F were hydrolyzed with 3M HCl at 100°C for 1 h and the aglycons of 
the saponins were extracted with diethyl ether. The major hydrolysis product (A1, 30 
                                                 
3 Analysis was conducted at the GBF-Gesellschaft für Biotechnologische Forschung, Braunschweig, by  
Dr. Victor Wray 
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mg) was isolated using RP-HPLC (CC250/4 Nucleosil 100-7 C18 Macherey-Nagel, 
GmbH & Co. KG) with a guard column (ChroCART 4-4 Lichrospher 100 RP-18, 5 µm, 
Merck KGaA) using acetonitrile as a mobile phase and UV detection at 254 nm.  
 
Structural confirmation of mollugogenol B 
The structure of the isolated aglycon was elucidated by NMR spectral analysis as 
mollugogenol B. The NMR analyses were performed as described under section 7.4.3.3. 
 
Determination of the purity of mollugogenol B 
The purity of mollugogenol B was determined using HPLC, TLC and UV-
spectrophotometry. The pre-coated RP-18 TLC plates were loaded with 5, 10, 15 and 20 
µL of mollugogenol B solutions which were equivalent to 11.85, 23.70, 35.55 and 47.40 
µg of mollugogenol B, respectively. The TLC plates were then developed with various 
solvent systems. The appearance of minor spots in high concentrations was noted. 
Similarly, 23.7 mg/100 mL mollugogenol B was injected into HPLC and the percentage 
of the mollugogenol B peak was calculated as 98%. Stock solutions of mollugogenol B 
in MeOH (2.37 mg/100 mL) were prepared and the absorbance was measured at λmax 
244, 251 and 261 nm. The molar absorptivity (log ε) was calculated and compared with 
literature values. 
 
7.5.1.2  Optimization of the acid hydrolysis of the saponins 
Optimal hydrolysis conditions were investigated using various acid concentrations (0.5 
– 5.0 M HCl), hydrolysis temperature (25 – 100°C) and hydrolysis duration (0.5 – 8 h) 
and a method was selected that provided the maximum amount of mollugogenol B with 
minimum artifacts. 
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7.5.1.3  Sample preparation for HPLC analysis 
 
Analysis of the crude extract 
G. lotoides saponins were analyzed after extract A (the crude extract) was hydrolyzed 
with 3M HCl at 100°C for 1 h. The hydrolysis products were cooled and the aglycons 
were extracted three times with diethyl ether. The ether layers were combined, dried and 
dissolved in methanol. The solution was filtered through a 0.2 µm cellulose acetate 
filter (Sartorius AG) and injected into HPLC. Calculation of the total saponins was 
based on glinuside G (mol. Wt., 900), which possesses an average molecular weight of 
G. lotoides saponins. 
 
Analysis of tablet formulation  
Oblong tablets (1.4 g) containing 650 mg extract A were crushed using mortar and 
pestle and 215.4 mg of the tablet powder, equivalent to 100 mg of extract A, were 
hydrolyzed with 100 mL of 3M HCl at 100 °C for 1 h. The aglycons were extracted 
three times with 100 mL diethyl ether. The ether layers were combined, dried and 
dissolved in 100 mL methanol. The solution was filtered and injected into HPLC. Six 
tablets were analyzed and the content of the saponins was determined.   
 
7.5.1.4  Preparation of the calibration curve 
An amount of 2.37 mg mollugogenol B was accurately weighed and dissolved in 100 
mL of methanol (stock solution [2.37 mg/100mL]). Five additional calibration levels 
(1.896; 1.422; 0.948; 0.474 and 0.237 mg/100mL) were prepared by dilution of the 
stock solution with methanol. The standard solutions, stored at 4 °C, were stable for at 
least 3 months, as confirmed by re-assaying the solutions.  
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7.5.1.5  HPLC conditions for the analysis of aglycons of the saponins 
Equipment: 
Pump:  LC-10AD, Shimadzu Liquid Chromatography, Shimadzu Co.  
Injector: Rheodyne, 7021, Rohnert Park. 
Detector: LC Spectrophotometer, MILLPORE® Waters, Model 481, Milford. 
Integrator: Chromato-Integrator, D-2000, Merck  
Column: CC 250/4.6 Nucleosil 100-5 C18 Cat. No. 721662.46, Ser. No. 
4056737, Charge/Batch 21304011 Macherey-Nagel 
Guard column: CC 8/4 Nucleosil 100-5 C18, Cat. No.: 721602.40, Ser No., 
2035906, Batch 2019 Macherey-Nagel  
Mobile phase: 25 minutes gradient flow of methanol -water solvent system as 
indicated in Table 7.8 
 
Table 7.8: Gradient flow for the aglycons 
Time (min) Solvent system Condition 
0 – 15  95% MeOH to 100% MeOH Linear  
15 – 20  100% MeOH to 95% MeOH Linear  
20 – 25  95% MeOH Isocratic 
 
The solvents were degassed with helium (Type 5.0, Messer Griesheim GmbH). The 
injection volume and the flow rate were adjusted to 20 µL and 1 mL/min, respectively. 
The detection was UV at 254 nm.   
 
7.5.1.6  Method validation 
Linearity 
The calibration curves were analyzed using a linear regression model and correlation 
coefficients. The calibration curves, residuals and standardized residuals were inspected 
to assess linearity.  
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Repeatability  
The intra- and inter-day repeatability of the method was evaluated using multiple 
preparations of the sample.   
 
Limits of detection (LOD) and limits of quantification (LOQ) 
The LOD and LOQ were determined from serial dilution and were calculated according 
Gottwald (2000).   
 
7.5.2  Quantitative determination of the flavonoids 
7.5.2.1  Preparation of standard 
Isolation of vicenin-2  
Vicenin-2 was isolated from the purified extract of the seeds of G. lotoides as 
mentioned under section 7.4.2. 
 
Structural confirmation of vicenin-2  
The structural elucidation of vicenin-2 was performed as mentioned under section 7.4.3. 
 
Determination of the purity of vicenin-2 
The purity of the isolated vicenin-2 was determined using HPLC and TLC methods. In 
this, the TLC plates were loaded with 1, 2, 5, 15 and 30 μL of vicenin-2 standard 
solutions which corresponds to 1.3, 2.6, 6.5, 19.5 and 39.0 μg, respectively. The TLC 
plates were then developed with various solvent systems.  Similarly, 130 mg/100ml of 
vicenin-2 was injected into HPLC and the percentage of vicenin-2 was calculated as 
97%. 
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7.5.2.2  Sample preparation for HPLC analysis 
Analysis of the crude extract 
The extract of the seeds of G. lotoides (extract A) was dissolved in water and filtered 
through a 0.2 µm cellulose acetate filter (Sartorius AG) before injection into HPLC. 
Total flavonoids were calculated as vicenin-2 equivalent. 
 
Analysis of the tablet formulation  
Oblong tablets (1.4 g) containing 650 mg extract A were crushed using mortar and 
pestle and 120 mg of the tablet powder were suspended in a 100 mL volumetric flask 
with water. The mixture was sonicated for 30 min and a portion of the supernatant was 
filtered through a 0.2 µm cellulose acetate filter before injection into HPLC. Six tablets 
were analyzed and the content of the flavonoids was determined.  
 
7.5.2.3  Preparation of calibration curve 
An amount of 5.83 mg vicenin-2 was accurately weighed and dissolved in 100 mL of 
water (stock solution [5.83 mg/100mL]). Five additional calibration levels (4.664; 
3.489; 2.332; 1.166 and 0.583 mg/100mL) were prepared by dilution of the stock 
solution with water. The standard solutions, stored at 4 °C, were stable for at least 3 
months, as confirmed be re-assaying the solutions.  
 
7.5.2.4  HPLC conditions for the analysis of flavonoids 
Equipment: 
Pump:  LC-10AD, Shimadzu Liquid Chromatography, Shimadzu Co.  
Injector: Rheodyne, 7021, Rohnert Park. 
Detector: LC Spectrophotometer, MILLPORE® Waters, Model 481, Milford. 
Integrator: Chromato-Integrator, D-2000, Merck  
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Column:  CC 250/4.6 Nucleosil 100-5 C18 Cat. No. 721662.46, Ser. No. 
2017025, Charge/Batch 21301173 Macherey-Nagel  
Guard column: CC 8/4 Nucleosil 100-5 C18, Cat. No.: 721602.40, Ser No., 
2035906, Batch 2019 Macherey-Nagel 
Mobile phase: 30 min gradient flow (Table 7.9) composed of two solvent 
mixtures  
 
Mixture A:   Acetonitrile:   130 
 0.1 M Phosphoric acid:  24  
 Water:    825 
 Mixture B:   Acetonitrile:   120 
 0.1 M Phosphoric acid:  6  
 Water:    187 
Table 7.9: Gradient flow for flavonoids 
Time (min) Solvent system Condition 
0 – 20.0 Mixture A to Mixture B Linear 
20.0 – 25.0 Mixture B to Mixture A Linear 
25.0 – 30.0 Mixture A Isocratic 
 
The solvents were degassed with helium (Type 5.0, Messer Griesheim GmbH). The 
sample volume and the flow rate were adjusted to 20 µL and 1 mL/min, respectively.  
LC-UV at 360 nm was used for the detection of the flavonoids. 
 
7.5.2.5  Method validation 
Accuracy 
Accuracy of the analytical method was determined by spiking 32.8 mg of extract F with 
vicenin-2 standard solutions to produce 50, 75, 125 and 150%. The samples were 
analyzed with HPLC as described above and the recovery of vicenin-2 was determined. 
 
7 EXPERIMENTAL SECTION 131
Linearity 
The calibration curves were analyzed using a linear regression model and correlation 
coefficients. The calibration curves, residuals and standardized residuals were inspected 
to assess linearity.  
 
Repeatability  
The intra- and inter-day repeatability of the method was evaluated using multiple 
preparations of the sample.   
Limits of detection (LOD) and limits of quantification (LOQ) 
The LOD and LOQ were determined from serial dilution and were calculated according 
Gottwald (2000).  
 
7.6 Preparation and physicochemical characterization of the dry extract 
preparation for tablet formulations 
7.6.1  Preparation of the dry extract preparation 
500 g of defatted powder seeds of G. lotoides were extracted with 5 L 60% MeOH in a 
10-L beaker for 15 min using an Ultra-Turrax (Type T 45/N, IKA-Werk GmbH) at 
10000 rpm. The mixture was passed through a cotton bed and the residue was 
compressed using a hydraulic press 5-L (HAFICO, Fischer & Co KG). The extract was 
filtered using a filter press (A-20Z, Seitz-Werke GmbH) through filter sheets (T 1000, 
Pall Co.) and concentrated using a rotavapor at 50 °C to a volume of 2-L. The amount 
of the dry extract was determined and the specified amount of Aeroperl® 300 Pharma 
was added. The mixture was further concentrated to a viscous mass and dried in a 
vacuum oven (VDL 53, Binder GmbH) at 40 °C and 125 mbar for 24 hours. Various 
concentrations of Aeroperl® 300 Pharma (10, 20, 30, 40, 50 and 60% (w/w)) were 
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utilized as an inert adsorbent to prepare the dry extract. The dry extract preparations 
were pulverized in a ball-mill and passed through a sieve size of 250 μm. The 
physicochemical properties of these dry extract preparations were characterized as 
described below.  
7.6.2  Physicochemical characterization of the dry extract preparations  
7.6.2.1  Particle size distribution  
The particle size distribution of the dry extract preparations (10-60% (W/W) Aeroperl® 
300 Pharma) were measured by laser diffraction spectrometry (Mastersizer 2000, 
Malvern Instruments GmbH) using the dry-dispersing system Scirocco 2000 (Malvern 
Instruments GmbH). Extract preparations were measured using a dispersing air pressure 
of 4 bars. Data were collected directly by means of the system software (Malvern 
Instruments GmbH). The particle sizes were analyzed according to Mie-theory at 
particle refractive index and absorption of 1.300 and 0.1, respectively. The mean values 
of five measurements were calculated. 
 
7.6.2.2  Scanning electron microscopy 
Surface structures of the dry extract preparations were determined using a scanning 
electron microscope Zeiss DSM 940 A (Carl Zeiss). The pictures were taken with a 
camera (model Contax M 167 MT, Yashica-Kyocera) and were digitalized using the 
Orion system (Orion 5, E.L.I. sprl). The dry extract preparations were fixed on an 
aluminum pin using double-adhesive tape (Tempfix) and then coated with a thin gold 
layer using a Sputter Coater (model E 1500, Bio-Rad). The samples were sputtered four 
times for 60 sec and exposed to 20 mA current and 2.1 kV acceleration voltages in a 
vacuum of 0.02-0.03 mbar. The micrographs were taken at various magnifications using 
5 and 10 kV. 
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7.6.2.3  Water uptake study 
Moisture sorption study in humidity chambers 
Pyrex desiccators containing appropriate saturated salt solutions (Table 7.10) in distilled 
water were prepared to create chambers with different levels of relative humidity. All 
desiccators were kept at 20 ± 0.5°C in an oven (model T5050, Heraeus Holding GmbH) 
to maintain the desired relative humidity level. 
 
Table 7.10: Saturated salt solutions used for different relative humidity levels  
Saturated salt solution Relative Humidity at 20°C (%) 
Magnesium chloride 33
Potassium carbonate 44
Sodium nitrite 65
Sodium chloride 75
Potassium chloride 85
 
Powder beds of 1 g of the dry extract preparations (10-60% W/W Aeroperl® 300 
Pharma in extract) were prepared in petri dish and stored at 20° C over the saturated salt 
solutions. The moisture content of the various extract preparations was measured 
gravimetrically at 24 hrs intervals for 15 days.  
 
Kinetic moisture sorption study using a Krüss Tensiometer K12 
The kinetics of the water sorption of the dry extract preparations was determined using 
a Krüss, Processor Tensiometer K12 (Krüss GmbH). Various relative humidity levels 
were realized in the chamber using saturated salt solutions as shown in Table 7.10. A 
powder bed of 1 g of the extract preparations was placed on a balance hanged in the 
humidity chamber. The weight gain per unit time was recorded and analyzed with the 
processor. Prior to the measurements, the extract preparations were stored in a 
desiccator over activated silica gel for one week. Water uptake of Aeroperl® 300 
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Pharma was determined at various relative humidity and the water uptake due to the 
extract was calculated. 
 
7.6.2.4  Water content determination 
The moisture content of the various extract preparations was measured using a Karl 
Fischer water-titration set-up (702 SM Titrino, Deutsche Metrohm, GmbH & Co.). In 
this, 35 mg of the extract preparations were dissolved in methanol:formamide (2:1) and 
titrated with Hydranal® composite 2, (one component reagent for volumetric Karl 
Fischer titration). The amount of Hydranal® composite 2 consumed was noted and the 
water contents of the extract preparations were calculated using a program called “702 
SM Tritrion”. Standard sodium tartarate dihydrate, which contains 15.66% water, was 
used as standard. 
 
Based on the results of the water uptake and SEM studies, the dry extract preparation 
containing 30% Aeroperl® 300 Pharma was selected for tablet formulation. Hence, 
density, flow property and compactability were investigated only for this extract 
preparation which is referred to as dry extract preparation. 
 
7.6.2.5  Density  
Bulk (poured) density 
Bulk density was measured according to the European Pharmacopoeia 5th Edition. 150 g 
of dry extract preparation were filled without compacting into a 250 mL graduated 
cylinder using a powder funnel and was weighed to ± 0.1 g (m) (model PG 4002-S, 
Mettler Toledo GmbH). The unsettled volume (V0) was read to ± 1 mL and the bulk 
density was calculated as the quotient m/V0. Measurements were performed in triplicate 
and the mean value was calculated.  
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Tapped density 
A settling apparatus (model STAV 2003, J. Engelsmann AG) was used to measure the 
tapped density. The settled volume was read after 500 (V500) and 1250 taps (V1250). 
Another 1250 taps were carried out when the difference between V500 and V1250 was 
greater than 2 mL. The tapped density (g/mL) was expressed as the quotient of m/V1250 
or m/V2500. Measurements were performed in triplicate and the mean value was 
calculated.  
 
Carr compressibility index, CC % = [(tapped density – bulk density)/bulk density]*100 
and Hausner ratio, HR = [tapped density/bulk density] were calculated from the bulk 
and tapped density results. 
 
True density 
The true density was determined using a Beckman air comparison pycnometer (model 
930, Beckman Instruments) at room temperature. Atmospheric air was used as a 
comparison gas. An amount of powder representing 80% (V/V) of the sample cup was 
weighed exactly (model AE 200, Mettler Toledo GmbH) and the volume was measured. 
The starting number and the zero measurement were checked before measurements. The 
true density [g/mL] was calculated as the quotient of weighed substance to true volume. 
The mean value of three measurements was taken.  
 
7.6.2.6  Powder flow properties 
Angle of repose 
Angle of repose was determined by pouring 150 ml of the dry extract preparation 
though a funnel of 10 mm pore size, adjusted at 75 mm height from the base, into 10 cm 
diameter plate placed below the tip of the funnel. The height (h) of the powder cone was 
measured with a dial high gauge (model No. 192-106, Mitutoyo Messgeraete GmbH). 
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The angle of repose (α) was calculated using the following equation: 
 tan α = h/r 
The mean value of three measurements was taken. 
 
Flow rate 
The flow rate of the dry extract preparation was determined by pouring 100 gm of the 
extract preparation though a funnel of pore size 10 mm with closing end. The amount of 
the extract preparation passing per unit of time under gravitational force was recorded. 
 
7.6.2.7  Compactibility study of the dry extract preparation 
The dry extract preparation was compressed on an instrumented single punch tablet 
press Korsch EK II (Korsch Pressen,) using round flat tooling of 10 mm in diameter. 
Compaction pressure was measured by a full Wheatstone bridge circuit of strain gauges 
(type 6/120 LY 11, Hottinger Baldwin Messtechnik (HBM)) at the upper punch holder 
and by a piezo-electric load washer (type 9041, Kistler) mounted directly below the 
lower punch (Herzog 1991). For the measurement of residual and ejection forces, a 
camshaft switch was installed on the drive shaft of the tablet press. The camshaft 
switched on, as soon as the lower punch started to eject the tablet and allowed a precise 
measurement of the force in Newton range.  
 
Data were acquired using the MGC Plus system including a ML 10 B voltage amplifier 
(HBM) and the Catman software. The filling height of the die was determined and the 
Heckel plots were calculated using the corrected upper punch displacement data. The 
slope of the linear compression part of each Heckel plot and the yield pressure (its 
reciprocal value) were determined using a stepwise linear regression from 300 data 
points, which gave the best fit for the linear part of the curve. The residual force was 
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measured by the lower punch sensor and the ejection force was determined as the 
highest value measured by the lower punch sensor (Dressler 2002).  
 
The radial tensile strength (S) of the tablets was calculated from the thickness (H), 
diameter (D), and crushing strength (Fc) using the equation   
 S = 2Fc/πDH 
The porosity of the tablets was calculated from the true density (ρt) and the apparent 
density (ρa) of the extract. The apparent density was calculated form the thickness out of 
die, weight and diameter of the tablets 
 ε = 1- (ρa/ρt)          
 
7.6.3 Stability of the saponins and flavonoids in the dry extract preparation 
The stability of the saponins and flavonoids in the dry extract preparation was 
determined at 25 and 40° C for a period of 6 months. 10 gm of the dry extract 
preparation were filled and sealed in vials of 25 mL. The vials were stored in an oven at 
25 and 40° C. One vial was taken every month from both ovens and the amount of 
saponins and flavonoids were analyzed according to the methods described under 7.5. 
The phytochemical profiles of the dry extract preparation were compared with the 
corresponding TLC and HPLC-profiles of the freshly prepared extract. 
 
7.7 Dry granulation by roller compaction, tablet preparation and enteric 
coating  
7.7.1  Dry granulation by roller compaction 
7.7.1.1   Mode of operation of Gerteis Micro-Pactor® 
The dry extract preparation was granulated by roller compaction using Gerteis Micro-
Pactor® (Gerteis AG) before tablet formulation. Micro-Pactor® is a small scale 
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compactor which allows predicting, if a given substance, or a blend can be granulated 
with the roller compaction technology. Minimum quantity (2 – 5 g) is required for the 
compaction study. The mode of operation of the machine is shown schematically in 
Figure 7.1.  
 
Dry extract preparation 
Cover
Die 
Support Bar 
Roller 
Gap
Hydraulic 
Cylinders 
 
Figure 7.1:  Mode of operation of Gerteis Micro-Pactor® 
 
The filling depth, the roller speed, force and the gap of the machine is given in Table 
7.11.  
 
Table 7.11: Parameters of the Micro-Pactor® 
Parameter Minimum* Maximum* Normal*  
Roller speed 0.001 m/s 0.1 m/s 0.05 m/s 
Press force 2 kN 20 kN 10 kN 
Hydraulic pressure 15 bar 160 bar 70 bar 
Gap 0.5 mm 5 mm 2.5 mm 
Filling depth 4 mm 8 mm 6 mm 
*These values are given by the company. 
7 EXPERIMENTAL SECTION 139
7.7.1.2  Compaction with Gerteis Micro-Pactor® 
Preparation of mixture for compaction 
The dry extract preparation was mixed with magnesium stearate (2%) in Turbula mixer 
T2C (Bachofen AG) at 42 rpm for 5 min. Before mixing, the magnesium stearate was 
passed through a sieve size 315 µm on the dry extract preparation.                                                        
 
Compaction 
The 8-mm die was filled with 7-8 g the mixture for compaction (dry extract preparation 
containing 2% magnesium stearate) at the horizontal position. The die with the cover 
was shifted into its guidance and the die was inserted into the machine (Figure 7.1). The 
compaction force and the roller speed were adjusted to 12 kN and 0.05 m/s, 
respectively. After having passed the roller, the die falls down and the roller stops 
automatically. The ribbon was taken out of the die and stored in desiccator over 
activated silica gel. 
 
Preparation of granules 
 The ribbons were crushed into granules using a hand driven mill called 
‘Zahnscheibenmühle’ (BECO). The mill was previously adjusted to produce granules 
less than 1.000 mm. The granule size and distribution were analyzed by sieve analysis 
method. 
 
7.7.2  Tablet preparation 
Granules prepared from the dry extract preparation by roller compaction were 
formulated into tablets using an instrumented eccentric tablet machine Korsch EK0 
(Korsch GmbH) fitted with oblong punches (20 x 8.25 mm). The lower punch holder 
was instrumented with strain gauges (3/120 Ly11, Hottinger Baldwin Meßtechnik). 
Signal transfer was achieved by a carrier frequency bridge (PR 9307, Philips GmbH). 
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Compression data were collected and analyzed using a program called ‘messfix’ 
(Herzog 1991). A calibration factor of 3.444 kN/V was used with a sensitivity of 2 
mV/V. 
 
7.7.2.1  Determination of the traditional dose 
20 g of the powdered seeds were extracted with 500 ml of 5% EtOH by maceration for 
24 hrs. The extract was filtered, concentrated in rota-vapor and dried to constant weight. 
The yield and the contents of saponins and flavonoids in the dry extract were 
determined by HPLC.  
 
7.7.2.2  Tablet formulation 
Direct compression excipients such as Avicel® PH101, Avicel® PH 200, Cellactose® 80 
and disintegrants (Ac-Di-Sol®, Kollidon® CL and Explotab®) were investigated and 
tablet formulation was developed as shown in Table 7.12.  
 
Table 7.12: Tablet formulation of the dry extract preparation 
Substance Mass in mg/tablet Percentage 
Dry extract preparation (granules) 947 67.64 
Avicel® PH 101 363 25.93 
Ac-Di-Sol® 90  6.43 
Total weight 1400 mg  
 
7.7.2.3  Compression of tablets 
The tablet mixture was weighed and mixed in a turbula mixer T2C (Bachofen  AG) at 
42 rpm for 5 min. Formulations were compressed into oblong tablets at various 
compression forces (13.5, 16.1, 18.4, 20.6, 23.7 and 27.9 kN) using an instrumented 
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eccentric tablet machine EK0 (Korsch GmbH).  Batch sizes of 500 g were used. The 
compression force-tablet hardness and compression force-disintegration time profiles 
were evaluated. For formulation of enteric-coated tablets a compression force of 20 kN 
was used which provide tablets with the required strength (150-200 N) for coating. Due 
to the relatively complex geometric shapes of the oblong tablets, the compression 
pressure was not calculated.  
 
7.7.2.4  Characterization of the tablet formulations 
The following characteristics of the tablets were determined 24 hours after tablet 
compression. 
 
Tablet mass 
The tablet mass, as a parameter for weight uniformity, was determined from 10 
randomly selected tablets. The tablets were weighed on an analytical balance (AE 200, 
Mettler Toledo GmbH) and the mean, standard deviation and relative standard deviation 
were calculated. 
 
Crushing strength 
The crushing strength of the tablets was determined according to the European 
Pharmacopoeia 5th Edition using a crushing strength tester TBH-30 (Erweka GmbH). 
The crushing strength was measured after 24 hrs to allow for completion of elastic 
deformation and particle rearrangement (consolidation). Tablets fragments were 
removed from the jaws before the next measurement. Mean, standard deviation and 
relative standard deviation were calculated. 
 
Friability 
The tablet friability was measured according to the European Pharmacopoeia 5th 
Edition. In this, 10 tablets were tested using a friability tester (Type PTF 1, Pharmatest 
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Apparatebau) for 4 minutes at 25 rpm. Loose dust particles were removed from the 
tablets with air pressure before and after the test. The tablet friability was calculated 
from the loss of mass and expressed as the percentage of the initial mass.   
 
Disintegration time 
The disintegration time of the tablets was determined with disintegration tester (Type 
PTZ 1, Pharmatest) according to the European Pharmacopoeia 5th Edition. In 1-liter 
beaker, the temperature of the distilled water was maintained at 36-38° C and the 
disintegration of 6 tablets was measured. The disintegration time was defined as the 
time required for the tablets to disintegrate and pass through the sieve openings. 
 
7.7.3  Enteric coating of G. lotoides tablets 
7.7.3.1  Enteric coating formulation 
Tablets were enteric coated in a pan coater (15-L) with the coating suspension as shown 
in Table 7.13.  
 
Table 7.13: Formulation of enteric coating suspension 
Substance Amount in g Percentage Percent in dry film* 
Eudragit® L 100-55 125   8.33 % 55.5 % 
1,2-Propylene glycol  25   1.67 % 11.1 % 
i-PrOH 637.5 42.5 % - 
Acetone 637.5 42.5 % - 
Talc 42  2.8 % 18.7 % 
Titan dioxide 10  0.67 % 4.4 % 
Iron oxide (brown) 15 1.0 % 6.7 % 
Magnesium stearate   8  0.53 % 3.6 % 
Total 1500g 100%  
*Calculated from the total dry weight of the coating suspension. 
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Eudragit® L 100-55 (125 g) was dissolved in the mixture of the solvent system (i-
propanol and acetone) and 1,2-propylene glycol (25 g) was dissolved in the polymer 
solution.  
 
The insoluble ingredients (talc, titan dioxide, iron oxide and magnesium stearate) were 
mixed with i-propanol and grinded in a ball mill (Erweka GmbH) for 24 hrs. The 
required amount of the pigment suspension was then added to the polymer solution and 
stirred for 2 hrs before coating. 
 
A batch of 1.5 kg tablets composed of G. lotoides and placebo core tablets (Table 7.14) 
was used. The cores were prewarmed to about 25 °C and the coating solution was 
sprayed on the core with a pressure of 1.2 bar using a two-substance nozzle (1.2 mm 
diameter, Schlick GmbH). The drying temperature was set at 40 °C and the 1.5 kg 
coating solution was sprayed within 90 min (Schiller 2002).  
 
After coating the tablets were dried at 30 °C for 24 hrs in hot air oven (Memmert 
GmbH). The effects of plasticizers (propylene glycol and acetyl tributyl citrate) and 
lubricants (talc, glycerol monostearate with and without magnesium stearate) were 
evaluated. Two commercial products namely, Eudragit® L 100/55 (Röhm) and 
Kollicoat® MAE 100P (BASF) were compared. 
 
Compression of placebo core tablets 
Due to shortage of extract, Ludipress placebo core tablets were prepared using the 
formulation shown in Table 7.14. The placebo formulation was compressed into oblong 
tablets (19 x 7 mm) with one sided breaking notch which was used to identify the 
tablets after coating. Compression force of 8 kN was used after investigation of the 
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tablet hardness and friability. The tablets mass was adjusted to 800 mg which provide 
tablets with less problem of sticking and twins formation during coating. 
 
Table 7.14: Formulation of the placebo tablet cores 
Substance Mass in mg/tablet Percentage 
Ludipress 360 45 % 
Avicel PH 101 352 44 % 
Aeroperl® 300 Pharma 40 5 % 
Ac-Di-Sol 40 5 % 
Magnesium stearate 8 1 % 
Total weight 800 mg  
 
7.7.3.2  Disintegration time of the enteric coated tablets 
The disintegration time of the enteric coated tablets was determined with disintegration 
tester (Type PTZ 1, Pharmatest) according to the European Pharmacopoeia 5th Edition. 
Six coated tablets were first tested in 0.1 M HCl medium for 2 hours without disks. 
Then the rigid rack of the apparatus was removed and the tablets are inspected for signs 
of disintegration. 
Subsequently, the test fluid was replaced with phosphate buffer solution pH 6.8 and a 
loading disk was placed on top of each tablet in the tube. The apparatus was then started 
and the disintegration time of the tablets was noted. The temperature of the fluids was 
maintained at 36 to 38 °C. 
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7.7.3.3  Stability of the enteric coating 
The enteric coated tablets were stored at 21° C in 45% rel. humidity and 26° C in 60% 
rel. humidity which approximate the various climate zones. Six enteric coated tablets 
were placed in each desiccator containing potassium carbonate and ammonium nitrate 
saturated salt solutions to create relative humidity of 45 and 60 %, respectively. The 
weight and thickness of the coated-tablets were measured accurately every 24 hrs for 15 
days. The changes in weight were calculated and expressed as percentages.  
 
 
Chapter 8 
CONCLUSION 
 
Suitable extraction methods for the seeds of Glinus lotoides have been developed and 
the major saponins and flavonoids have been isolated. In this, four new hopane-type 
saponins, glinusides F, G, H and K, and the known succulentoside B as well as the two 
known flavones, 5,7,4’-trihydroxyflavone-6,8-di-C-glucoside (vicenin-2) and 5,7,4’-
trihydroxy-flavone-8-C-sophoroside (vitexin-2″-O-glucoside), have been isolated from 
the seeds of the plant. Based on the spectral analyses including 2D NMR and HRESI 
mass spectroscopy, the new structures have been characterized as 3β-O-β-D-
xylopyranosyl-6α-O-β-D-xylopyranosyl-16β-O-β-D-xylopyranosyl-22-hydroxy-hopane 
(glinuside F), 3β-O-α-L-rhamnopyranosyl-(1→2)-β-D-xylopyranosyl-6α,16β-
dihydroxy-22-O-α-L-rhamnopyranosyl-hopane (glinuside G), 3β-O-α-L-
rhamnopyranosyl-(1→2)-β-D-xylopyranosyl-6α-O-β-D-xylopyranosyl-16β-hydroxy-22-
O-α-L-rhamnopyranosyl-hopane (glinuside H) and 3β-O-α-L-rhamnopyranosyl-(1→2)-
β-D-xylopyranosyl-6α-O-β-D-xylopyranosyl-16β-O-β-D-xylopyranosyl-22-hopane 
(glinuside I). 
 
The total flavonoids and saponins of the seeds of G. lotoides in the crude extracts and 
tablet formulations thereof have been quantified by reversed-phase high performance 
liquid chromatographic (RP-HPLC) methods with UV detection. The saponins were 
analyzed after acid hydrolysis in 3M HCl at 100°C for 1 hour. Vicenin-2 and 
mollugogenol B have been isolated and used as reference substances for the 
quantification of total flavonoids and saponins, respectively. The identities of vicenin-2 
and mollugogenol B have been confirmed using UV, MS and NMR spectral analyses 
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and comparison with respective published data. The purity of the isolated mollugogenol 
B has been determined by TLC, HPLC and UV spectrophotometry as 98%, calculated 
from HPLC peak area. The molar absorptivity of the methanol solution of mollugogenol 
B at a concentration of 0.948 mg/100ml was found to be 3.98, 4.16 and 4.12 at λmax of 
260sh, 251 and 243 nm, respectively, which is in good agreement with literature values, 
indicating the purity of mollugogenol B. Similarly, the purity of vicenin-2 has been 
determined as 97% using HPLC, which is confirmed by TLC and UV methods.  
 
Satisfactory separation of the components of the flavonoids and saponins compounds 
has been obtained in less than 30 and 25 min, for the flavonoids and saponins, 
respectively. The HPLC methods were validated for linearity, repeatability, limits of 
detection (LOD) and quantification (LOQ). Repeatability (inter- and intra-day, n = 6 
and 9, respectively) showed less than 2% relative standard deviation (RSD). The LOD 
and LOQ were found to be 0.075 and 0.225 mg/mL, respectively, for vicenin-2 and 
0.027 and 0.082 mg/100mL, respectively, for mollugogenol B.  
 
The total amounts of saponins of the crude extract and tablet formulation have been 
determined as glinuside G equivalent (mol. Wt. 900) which approximates the average 
molecular weight of the saponins of G. lotoides.  
 
The content of flavonoids and saponins of six single tablets has been found to be 
between 95 and 103% for flavonoids and 94 to 98% for saponins. The validated HPLC 
methods could be employed to standardize a laboratory produced purified extract, 
which could be used as a secondary standard for the routine quality control. 
Accordingly, the secondary standard (extract F) has been found to contain 10% vicenin-
2 and 21.3% total flavonoids calculated as vicenin-2 equivalent. The amount of 
saponins in the secondary standard was 6.3% mollugogenol B and 12.4% total aglycons 
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calculated as mollugogenol B, 14.2% glinuside G and 25.4% total saponins calculated 
as glinuside G equivalent. 
 
Admixing of the crude liquid extract of the seeds of G. lotoides with Aeroperl® 300 
Pharma, as an inert carrier material, and subsequent drying the mixture has provided a 
non-adherent and free-flowing powder. The required amount of Aeroperl® 300 Pharma 
has been optimized as 30%, based on the physicochemical properties such as particle 
size distribution, surface morphology, moisture content and sorption kinetics of the dry 
extract preparations containing 10, 20, 30, 40, 50 and 60% w/w Aeroperl® 300 Pharma. 
 
A tablet formulation containing granules of the dry extract preparation (947 mg), 
Avicel® PH101 (363 mg) and Ac-Di-sol (90 mg) provided the best tablet properties 
such as disintegration time of 2.4 min at a tablet hardness of 73 N. Granulation by roller 
compaction of the dry extract preparation has improved the disintegration time of the 
tablets. Oblong tablets which could administer the traditional dose as a single tablet 
have been developed and enteric coated. 
 
Enteric coated tablets of G. lotoides with pharmacopoeial requirements could be 
prepared using methacrylic acid/ ethylacrylate co-polymer (Eudragit® L 100/55 or 
Kollicoat® MAE 100P). Propylene glycol and acetyl tributyl citrate could be used as 
plasticizers at concentrations of about 11% in the dry film. 
 
Chapter 9 
 
REFERENCES 
 
Abegaz, B. and Tecle, B.  
“A new triterpenoid glycoside from the seeds of Glinus lotoides” 
Phytochemistry, 19: 1553-1554 (1980). 
 
Agrawal, P. K. 
“NMR spectroscopy in the structural elucidation of oligosaccharides and glycosides” 
Phytochemistry, 31: 3307-3330 (1992). 
 
Agrawal, P. K. 
“Carbon-13 NMR of flavonoids” 
ELSEVIER Science Publishers B.V., Amsterdam, 41-94 (1989) 
 
Amidon, G. E.; Ausburger, L. L.; Brittain, H. G.;  Byrn, S. R.; Fox, C. D.;  Peck, G. E. 
and Wurster D. E. 
“Physical test methods for powder flow characterization of pharmaceutical materials: 
A review of methods” 
Pharmacopeial Forum 25: 8298-8308 (1999). 
 
Arnaud, Ph.; Brossard, D. and Chaumeil, J. C. 
“Effect of the granulation process on nitrofurantoin granule characteristics” 
Drug Dev. Ind. Pharm., 24: 57-66 (1998). 
 
Arragie, M. and Chernishov, G.  
“Preliminary pharmacological studies on mettere (Glinus lotoides) I: Effects upon the 
central nervous system”  
Ethiop. Med. J., 15: 147-153 (1977). 
 
Bader, G. and Hiller, K. 
“Neue Ergebnisse zur Struktur und Wirkungsweise von Triterpensaponinen” 
Pharmazie 42: 577-597 (1987). 
 
9 REFERENCES 
 
150 
Bader, G.; Wary, V. and Hiller, K. 
“The main saponins from the aerial parts and the roots of Solidago virgaurea subsp. 
Virgaurea” 
Planta Med. 61: 158-161 (1995). 
 
Barua, A. K.; Chakravarti, S.; Basak, A.; Ghosh, A. and Chakrabarti, P. 
“The structure of mollugocin A.  A new triterpene glycoside from Mollugo hirta”      
J. Indian Chem. Soc., 53: 598-601 (1976a).   
 
Barua, A. K.; Chakravarti, S.; Basak, A.; Ghosh, A. and Chakrabarti, P. 
“A new triterpene glycoside from Mollugo hirta” 
Phytochemistry, 15: 831-832 (1976b).   
 
Barua, A. K.; Ghosh, S.; Basu, K. and Patra, A.  
“Structure and stereochemistry of Mollugogenol-G - A triterpenoid sapogenin from 
Mollugo hirta” 
J. Indian Chem. Soc., 66: 64-66 (1989).    
 
Bauer, K. H.; Lehmann, K.; Osterwald, H. P. and Rothgang, G. 
“Coated pharmaceutical dosage forms: Fundamentals, manufacturing techniques, 
biopharmaceutical aspects, test methods and raw materials” 
CRC Press, Scientific Publishers Stuttgart, 63-113 (1998).  
 
Besson, E. and Chopin, J. 
“Sugar ring isomerization in C-arabinosylflavones” 
Phytochemistry, 22: 2051-2056 (1983). 
 
Bialy, Z.; Jurzysta, M.; Oleszek, W.; Piacente, S. and Pizza, C. 
“Saponins in alfalfa (Medicago sativa L.) root and their structural elucidation” 
J. Agric. Food Chem., 47: 3185-3192 (1999). 
 
Biftu, T.; Abegaz, B. and Teffera, S. 
“Fatty acid composition of 'metere' (Glinus lotoides, L) seeds by Gas Liquid 
Chromatography (GLC)” 
SINET: Ethiop. J. Sci., 2: 19-22 (1979). 
 
9 REFERENCES 
 
151
Bishaw, M. 
“Promoting traditional medicine in Ethiopia: a brief historical review of government 
policy” 
Soc. Sci. Med., 33: 193-200 (1991).          
 
Biswas, T.; Gupta, M.; Achari, B. and Pal, B. C. 
“Hopane-type saponins from Glinus lotoides Linn” 
Phytochemistry, 66: 621-626 (2005). 
 
Blouin, F. A. and Zarins, Z. M. 
“High-performance liquid chromatography of cottonseed flavonoids” 
J. Chromatogr. A, 441: 443-447 (1988).   
 
Bock, K. and Pedersen, C.  
“A study of 13CH coupling constants in hexopyranoses” 
J. Chem. Soc., Perkin Trans. II, 293-297 (1974). 
 
Bock, K. and Pedersen, C. 
“Carbon-13 nuclear magnetic resonace spectroscopy of monosaccharides” 
 Adv. Carbohydr. Chem. Biochem., 41: 27-66 (1983). 
 
Bramati, L.; Minoggio, M.; Gardana, C.; Simonetti, P.; Mauri, P. and Pietta, P. 
“Quantitative characterization of flavonoid compounds in Rooibos tea (Aspalathus 
linearis) by LC-UV/DAD” 
J. Agric. Food Chem., 50: 5513-5519 (2002). 
 
Breitmaier, E.,  
“Structure Elucidation by NMR in Organic Chemistry, A Practical Guide” 
John Wiley, Chichester, U.K., 42-54 (1993). 
 
Carpani, G.; Orsini, F.; Sisti, M. and Luisella, V. 
“Saponins from Albizzia anthelmintica” 
Phytochemistry, 28: 863-866 (1989). 
 
Carr, R. L. 
“Evaluating Flow properties of Solids”  
9 REFERENCES 
 
152 
Chem. Eng. 18: 163-168 (1965). 
 
Carstensen, J. T.; Kothari, R.; Prasad, V. K. and Sheridan, J.     
“Time and temperature dependence of disintegration and correlation between 
dissolution and disintegration rate constants” 
J. Pharm. Sci.,  69: 290-294 (1980).  
 
Chakrabarti, P. 
“Structure and stereochemistry of mollugogenol A, a new sapogenin from Mollugo 
hirta” 
Tetrahedron, 25: 3301-3305 (1969).   
 
Chakrabarti, P. and Choudhury, M. K. 
“Isolation of some sterol glucosides and a triterpene from Mollugo hirta” 
J. Indian Chem. Soc., 50: 163 (1973).   
 
Chakrabarti, P. and Sanyal, P. K. 
“Constitution of mollugogenol C, a new sapogenin from Mollugo hirta” 
J. Indian Chem. Soc., 46: 1061-1062 (1969).   
 
Chakrabarti, P. and Sanyal, P. K. 
“Constitution of Mollugogenol E-new sapogenin from Mollugo hirta” 
Indian J. Chem., 8: 1042-1043 (1970).   
 
Chakrabarti, P.; Sanyal, P. K. and Barua, A. K.   
“Constitution of mollugogenol B:  a new sapogenin from Mollugo hirta” 
J. Indian Chem. Soc., 46: 96-97 (1969).   
 
Chernishov, G.; Arragaie, M. and Etana, A.  
“Preliminary Pharmacological studies on mettere (Glinus lotoides) II. Effects up on the 
cardiovascular and Gastro intestinal system” 
Ethiop. Med. J., 16: 105-110 (1978). 
 
Chopra, R. N.; Nayar, S. I. and Chopra, I. C.  
“Glossary of Indian medicinal plants” 
CSIR, New Delhi, 168 (1956). 
9 REFERENCES 
 
153
Choudhury, M. K. and Chakrabarti, P.  
“Constitution of mollugogenol-F.  New triterpenoid sapogenol from Mollugo hirta” 
Indian J. Chem., 13: 947-948 (1975).  
 
Choudhury, M. K. and Chakrabarti, P.  
“Stereochemistry of mollugogenol-A and mollugogenol-E, the triterpenoid sapogenols 
from Mollugo hirta” 
Phytochemistry, 15: 433-434 (1976). 
 
Choudhury, M. K. and Chakrabarti, P.     
“The structure of mollugogenol-F, a new triterpenoid sapogenin from Mollugo hirta” 
Phytochemistry, 18: 1363-1365 (1979).   
 
Choudhury, M. K.; Sanyal, A. K. and Chakrabarti, P.     
“The structure of mollugogenol-D: A new triterpenoid sapogenin from Mollugo hirta” 
Ghana J. Chem., 1(11): 480-483 (1995).   
 
Dressler, J. A. 
“Vergleichende Untersuchung pharmazeutischer Hilfsstoffe unter Einsatz eines 
inkrementalen Weggebers zur präzisen Wegmessung an einer Exzenter-
Tablettenpresse” 
Ph.D. Thesis, Eberhard Karls University, Tübingen, Germany 2002 
 
Diaz, L.; Souto, C.; Concheiro, A.; Gomez-Amoza, L. M. and Martinez-Pacheco, R. 
“Evaluation of Eudragit E as excipient in tablets of dry plant extracts” 
S.T.P. Pharma., 6: 105-109 (1996). 
 
Djote, M.  
“Taenicidal activity of Glinus lotoides (AIZOACEAE)” 
J. Eth. Pharma. Assoc., 3: 9-11 (1978). 
 
Edwards, S.; Tadesse, M.; Demissew, S. and Hedberg, I. 
“Flora of Ethiopia and Eriteria” 
The National Herbarium, Addis Ababa University, Uppsala, Vol. 2, Part 1, 234-237 
(2000). 
 
9 REFERENCES 
 
154 
Endale, A.; Getachew, M. and Gebre-Mariam, T.  
“In vitro taenicidal activity of the extract of the seeds of Glinus lotoides on Hymenolepis 
nana worm”  
Eth. Phar. J., 15: 45-50 (1997). 
 
Endale, A.; Kassa, M. and Gebre-Mariam, T.  
“In vivo anthelminthic activity of the extract of the seeds of Glinus lotoides in albino 
mice infested with Hymenolepis nana worms”  
Ethiop. Pharm. J., 16: 34-41 (1998). 
 
Endale, A.; Schmidt, P.C. and Gebre-Mariam, T. 
“Quantitative determination of saponins in the extracts of the seeds of Glinus lotoides 
using colorimetric and UV-spectrophotometric methods” 
Ethiop. Pharm. J., 18: 1-14 (2000). 
 
Endale, A.; Schmidt, P. C. and Gebre-Mariam, T. 
“Standardisation and physicochemical characterisation of the extracts of the seeds of 
Glinus lotoides” 
Pharmazie, 59: 34-38 (2004). 
 
Enwerem, N. M.; Okogun, J. I. and Wambebe, C. O. 
“Anthelmintic activity of the stem bark extracts of Berlina grandiflora and one of its 
active priciples, Betulinic acid” 
 Phytomedicine,  8: 112-114 (2001). 
 
Erdös, S. 
“Spontaneous disintegration” 
Pharm. Ind., 48: 503-507 (1986). 
 
European Pharmacopoeia 5th edition  
“Disintegration of tablets and capsules” 
Council of Europe, Strasbourg 225-227 (2005). 
 
European Pharmacopoeia 5th edition  
“Friability of uncoated tablets” 
Council of Europe, Strasbourg 234-235 (2005). 
9 REFERENCES 
 
155
European Pharmacopoeia 5th edition  
“Apparent volume” 
Council of Europe, Strasbourg, 241-242 (2005). 
 
Flößer, A.; Kolter, K.; Reich, H.B. and Schepky, G. 
“Variation of composition of an enteric formulation based on Kollicoat MAE 30 D” 
Drug Dev. Ind. Pharm., 26: 177-87 (2000). 
 
Fonner, D. E.; Jr. Banker, G. S. and Swarbrick, J. 
“Micromeritics of granuler pharmaceutical granules” 
J. Pharm. Sci., 55: 576-580 (1966). 
 
Frański, R.; Bednarek, P.; Wojtaszek, P. and Stobiecki, M. 
“Identification of flavonoid diglycosides in Yellow Lupin (Lupinus luteus L.) with Mass 
spectrometric techniques” 
J. Mass Spectrom., 34: 486-495 (1999). 
 
Gerad, K. B. and Zak, T. C.  
“Materials for direct compaction, in: “Pharmaceutical powder compaction technology” 
Göran, A. and Christer, N. (eds), Marcel Dekker, New York, pp. 419-500 (1995). 
 
Gedif, T. and Hahn, H.-J. 
“The use of medicinal plants in self-care in rural central Ethiopia” 
J. Ethnopharmacol., 87: 155-161 (2003).   
 
Gil, M. I.; Ferreres, F.; Ortiz, A.; Subra, E.; Tomás-Barberán, J. 
“Plant phenolic metabolites and floral origin of rosemary honey” 
J. Agric. Food Chem., 43: 2833-2838 (1995). 
 
Graf, E.; Ghanem, A. H. and Mahmoud, H. 
“Studies on the direct compression of Pharmaceuticals, Part 8: Role of liquid 
penetration and humidity on the tablets formulations” 
Pharm. Ind., 44: 200-203 (1982) 
 
Gogtay, N. J.; Bhatt, H. A.; Dalvi, S. S. and Kshirsagar, N. A.   
“The use and safety of non-allopathic Indian medicines” 
9 REFERENCES 
 
156 
Drug safety, 25: 1005-1019 (2002).   
 
Gordon, M. S. and Chowhan, Z. T. 
“Effect of tablet solubility and hygroscopicity on disintegrant efficiency in direct 
compression tablets in terms of dissolution” 
J. Pharm. Sci., 76: 907-909 (1987). 
 
Gottwald, W.  
“Statistik für Anwender”  
WILEY-VCH Verlag GmbH, Weinheim, 144-146 (2000).  
 
Gurfinkel, D. M. and Rao, A. V. 
“Determination of saponins in legumes by direct densitometry” 
J. Agric. Food Chem., 50: 426-430 (2002). 
 
Hamburger, M.; Dudan, G.; Nair, A. G.; Jayaprakasam, R. R. and Hostettmann, K. 
“An antifungal triterpenoid from Mollugo pentaphylla” 
Phytochemistry, 28: 1767-1768 (1989). 
 
Hamed, A. I., and El-Emary, N. A 
“Triterpene saponins form Glinus lotoides var dictamnoides”  
Phytochemistry, 50: 477-480 (1999). 
 
Hamed, A. I.; Springuel, I.; ElEmary, N. A.; Mitome, H. Miyaoka, H. and Yamada, Y.  
“Triterpenoidal saponin glycosides form Glinus lotoides var dictamnoides”  
Phytochemistry, 43: 183-188 (1996). 
 
Hamed, A.; Springuel, I.; El-Emary, N.; Mitome, H.; Miyaoka, H. and Yamada, Y. 
“Two phenylpropanoid glucosides from Glinus lotoides L. var. dictamnoides” 
Bull. Pharm. Sci., Assiut University  20: 23-26 (1997). 
 
Harborne, J. B. 
“The flavonoids, Advances in research since 1980” 
Chapman and Hall, London, (1988). 
 
 
9 REFERENCES 
 
157
Hertog, M. G. L.; Hollman, P. C. H.; Venema, D. P.     
“Optimization of a quantitative HPLC determination of potentially anticarcinogenic 
flavonoids in vegetables and fruits” 
 J. Agri. Food Chem., 40: 1591-1598 (1992).   
 
Herzog, R. 
“Calciumphosphate in der Tablettierung” 
Ph.D. Thesis, Eberhard Karls University, Tübingen, Germany (1991). 
 
Hollman, P. C. H.; van Trijp, J. M. P. and Buysman, M. N.C.P. 
“Fluorescence detection of flavonols in HPLC by postcolumn chelation with 
aluminium” 
Anal. Chem., 68: 3511-3515 (1996). 
 
Hostettmann, K. and Marston, A. 
“Chemistry and pharmacology of natural products: Saponins” 
Cambridge University Press, Cambridge, 1-284 (1995). 
 
Hsiao, G.; Chang, C.-Y.; Shen, M.-Y.; Chou, D.-S.; Tzeng, S.-H.; Chen, T.-F. and Sheu, 
J.-R. 
“α-Naphthoflavone, a potent antiplatelet flavonoid, Is mediated through inhibition of 
phospholipase C activity and stimulation of cyclic GMP formation” 
J. Agric. Food Chem., 53: 5179-5186 (2005). 
 
Ireland, P. A. and Dziedzic, S. Z. 
“Analysis of soybean sapogenins by high-performance liquid chromatography” 
J. Chromatogr., 325: 275-281 (1985). 
 
Ireland, P. A. and Dziedzic, S. Z. 
“Effect of hydrolysis on sapogenin release in soy” 
J. Agric. Food Chem., 34: 1037-1041 (1986).  
 
Ji, Y. B.; Xu, Q. S.; Hu, Y. Z. and Heyden, Y. V. 
“Development, optimization and validation of a fingerprint of Ginkgo biloba extracts by 
high-performance liquid chromatography” 
J. Chromatogr. A, 1066: 97-104 (2005). 
9 REFERENCES 
 
158 
Justesen, U.; Knuthsen, P. and Leth, T. 
“Quantitative analysis of flavonols, flavones, and flavanones in fruits, vegetables and 
beverages by high-performance liquid chromatography with photo-diode array and 
mass spectrometric detection” 
J. Chromatogr. A, 799: 101-110 (1998). 
 
Kavimani, S.; Manisenthilkumar, K. T.; Ilango, R. and Krishnamoorthy, G.    
“Effect of the methanolic extract of Glinus lotoides on Dalton's ascitic lymphoma” 
Biol. Pharm. Bull., 22: 1251-1252 (1999). 
 
Klitina, S. E.  
“Clinical picture and treatment of patients suffering from poisoning caused by kosso 
collection of research work of the Soviet Red Cross Hospital in Addis Ababa”, 4th issue, 
61 (1965). 
 
Kloos, H.; Tekle, A.; Yohannes, L.; Yosef, A.; and Lemma, A. 
“Preliminary studies of traditional medicinal plants in nineteen markets in Ethiopia, use 
patterns and public health aspects” 
Ethiop. Med. J., 16: 33-43 (1978). 
 
Kroll, D. J.   
“Concerns and needs for research in herbal supplement pharmacotherapy and safety” 
J. Herbal Pharmacotherapy, 1(2): 3-23 (2001).   
 
Kuti, J. O. and Konuru, H. B. 
“Antioxidant capacity and phenolic content in leaf extracts of tree spinach (Cnidoscolus 
spp.)” 
J. Agric. Food. Chem. 52: 117-121 (2004). 
 
Li, W. and Fitzloff, J. F. 
“A validated method for quantitative determination of saponins in notoginseng (Panax 
notoginseng) using high-performance liquid chromatography with evaporative light-
scattering detection” 
J. Pharm. Pharmacol., 53: 1637-1643 (2001). 
 
 
9 REFERENCES 
 
159
Lieberman H. A. and Lachman L. 
“Pharmaceutical Dosage Forms: Tablets, Vol. 1, 2nd Ed.”  
Marcel Dekker, Inc., New York, 141-143 (1989). 
 
Liou, M. and Wu, T. 
“Triterpenoids from Rubia yunnanensis” 
J. Nat. Prod. 65: 1283-1287 (2002). 
 
Lombardi-Boccia, G.; Lucarinim, M.; Lanzi, S.; Aguzzi, A. and Cappelloni, M.  
“Nutrients and antioxidant molecules in yellow plums (Prunus domestica L.) from 
conventional and organic productions: a comparative study” 
J Agric. Food Chem. 52: 90-94 (2004). 
 
Lowenthal, W.  
“Mechanism of action of tablet disintegratnts” 
Pharm. Acta. Helv., 48: 589-609 (1973). 
 
Luftensteiner, C. P. and Vierstein, H.  
“Zubereitungsformen pflanzlicher Arzneimittel” 
Wien. Med. Wochenschr., 149: 258-261 (1999). 
 
Mabry, T. J.; Markham, K. R. and Thomas, M. B. 
“The systematic identification of flavonoids” 
Springer-Verlag, Berlin, 35-164 (1970). 
 
Mahato, S. B. and Kundu, A. P.  
“13C NMR spectra of pentacyclic triterpenoids – A compilation and some salient 
features” 
Phytochemistry, 37: 1517-1575 (1994). 
 
Mahato, S. B.; Nandy, A. K. and Roy, G. 
“Triterpenoids” 
Phytochemistry, 31: 2199-2249 (1992). 
 
Markham, K. R.; Geiger, H. 
“1H nuclear magnetic resonance spectroscopy of flavonoids and their glycosides in 
9 REFERENCES 
 
160 
hexadeuterodimethylsulfoxide” 
in: Harborne, J. B. “The Flavonoids: Advance in research since 1986” 
Chapman & Hall, London, 441-497 (1994).      
 
Markham, K. R.; Webby, R. F. and Vilain, C.  
“7-O-Methyl-(2R:3R)-dihydroquercetin 5-O-ß-D-Glucoside and other flavonoids from 
Podocarpus nivalis” 
Phytochemistry, 23: 2049-2052 (1984). 
 
Mateos, R.; Espartero, J. L.; Trujillo, M.; Rios, J. J.; León-Camacho, M.; Alcudia, F. 
and Cert, A. 
“Determination of phenols, flavones, and lignans in virgin olive oils by solid-phase 
extraction and high-performance liquid chromatography with diode array ultraviolet 
detection” 
J. Agric. Food Chem., 49: 2185-2192 (2001). 
 
Mattila, P.; Astola, J. And Kumpulainen, J. 
“Determination of flavonoids in plant material by HPLC with diode-array and electro-
array detections” 
J. Agric. Food Chem., 48: 5834-5841 (2000). 
 
Maurice, J. 
“C-Glycosylflavonoids” 
in: Harborne, J. B. “The Flavonoids: Advance in research since 1986” 
Chapman & Hall, London, 57-94 (1994).   
 
Merken, H. M. and Beecher, G. R. 
“Measurement of food flavonoids by high-performance liquid chromatography: A 
review” 
J. Agric. Food Chem., 48: 576-599 (2000). 
 
Meselhy, M. R. 
“Hopane-type saponins from Polycarpon succulentum-II” 
Phytochemistry, 48: 1415-1421 (1998). 
 
 
9 REFERENCES 
 
161
Meselhy, M. R. and Aboutabl, E. A. 
“Hopane-type saponins from Polycarpon succulentum growing in Egypt” 
Phytochemistry, 44: 925-929 (1997). 
 
Mishra, V. K.; Ooraikul, B. and Temelli, F. 
“Physical characterization and water sorption of freeze dried dulse Palmaria palmata 
powder” 
J. Food Process. Pres., 20: 25-39 (1996). 
 
Mohamed, E. M.  
“Phytochemical investigation of Glinus lotoides growing in Egypt” 
Egpyptian J. Pharm. Sci., 38: 377-390 (1998). 
 
Mouly, P.; Gaydou, E. M. and Auffray, A. 
“Simultaneous separation of flavanone glycosides and polymethoxylated flavones in 
citrus juices using liquid chromatography” 
J. Chromatogr. A., 800: 171-179 (1998). 
 
Murthy, C. T. and Bhattacharya, S. 
“Moisture dependent physical and uniaxial compression properties of black pepper” 
J. of Food Eng., 37: 193-205 (1998). 
 
Nair, A.G. and Gunasegaran, R.     
“Flavone C-glycosides from Mollugo hirta” 
Curr. Sci., 52: 248-249 (1983). 
 
Oleszek, W. A. 
“Chromatographic determination of plant saponins” 
J. Chromatogr. A., 967: 147-162 (2002). 
 
Österdahl, B. G.  
“Chemical studies on Bryophytes. 22. Flavonoid C-Glycosides of Mnium undulatum” 
Acta. Chem. Scand., B 33: 400-404 (1979). 
 
Palma, S. D.; Manzo, R. H. and Allemandi, D. A. 
“Dry plant extract loaded on fumed silica for direct compression: preparation and 
9 REFERENCES 
 
162 
preformulation” 
Pharm. Dev. Technol. 4(4): 523-530 (1999). 
 
Pankhurst, R.  
“An historical examination of traditional Ethiopian medicine and surgery” 
Ethiop. Med. J., 3: 157-172 (1965). 
 
Park, I. S.; Kang, E. M. and Kim, N. 
“High-performance liquid chromatographic analysis of saponin compounds in 
Bupleurum falcatum” 
J. Chromatogr. Sci., 38: 229-233 (2000). 
 
Paronen, P. and Ilkka, J.  
“Porosity-pressure functions”  
in: Alderborn, G. and Nyström, C. “Pharmaceutical powder compaction technology” 
Marcel Dekker, New York 428-440 (1996).  
 
Parrott, E. L. 
“Densification of powders by concave-convex roller compactor” 
J. Pharm. Sci., 70: 288-291 (1981). 
 
Pitkin, C. And Carstensen, J. 
“Moisture content of granulations” 
J. Pharm. Sci., 62: 1215-1216 (1973). 
 
Plazier-Vercamen, J. A. and Bruwier, C. 
“Evaluation of excipients for direct compression of the spray-dried extract of 
Harpagophytum procumbens” 
S.T.P. Pharma., 2: 525-530 (1986) 
 
Plock, A.; Beyer, G.; Hiller, K.; Gründemann, E.; Krause, E.; Nimtz, M. and Wray, V. 
“Application of MS and NMR to the structure elucidation of complex sugar moieties of 
natural products: exemplified by the steroidal saponin from Yucca filamentosa L.” 
Phytochemistry, 57: 489-496 (2001). 
 
 
9 REFERENCES 
 
163
Potterat, O.; Hostettman, K.; Stoeckli-Evans, H. and Saadou, M. 
“Saponins with an unusual secoursene skeleton from Sesamum alatum Thonn.” 
Helv. Chim. Acta., 75: 833-841 (1992). 
 
Qimin, H.;Van Den Heuvel, O.; Delorenzo, J.; Corthout, L. A. C.; Pieters, A. J. and 
Vlietinck M. Claeys 
“Mass spectra characterization of C-glycosidic flavonoids isolated from a medicinal 
plant (Passiflora incarnata)” 
J. Chromatogr., 562: 435-446 (1991). 
 
Raffaelli, A.; Moneti, G.; Mercati, V. and Toja, E. 
“Mass spectrometric characterization of flavonoids in extracts form Passiflora 
incarnata” 
J. Chromatogr. A, 777: 223-231 (1997).  
 
Rai, D. R. and Kumar, A. 
“Some moisture dependent physical properties of Kabuli chana (Cicer arietinum L.)” 
J. of Food Sci. and Technol., 32: 150-152 (1995). 
 
Renoux, R.; Demazieres, J. A.; Cardot, J. M. and Aiache, J. M. 
“Experimentally designed optimization of direct compression tablets” 
Drug Dev. Ind. Pharm., 22: 103-105 (1996). 
 
Rocksloh, K.; Rapp, F. R.; Abed, S. Abu; Müller, W.; Reher, M.; Gauglitz, G. and 
Schmidt, P. C. 
“Optimization of crushing strength and disintegration time of a high-dose plant extract 
tablet by neutral networks” 
Drug Dev. Ind. Pharm., 25: 1015-1025 (1999). 
 
Rokos, L.  
“Eye complications in poisoning caused by ‘kosso’ (Hagenia abyssinica)” 
Ethiop. Med. J., 7: 11-16 (1969). 
 
Sakakibara, M.; Mabry, T. J.; Bouillant, M.-L. and Chopin, J. 
“6,8-Di-C-Glucosylflavones from Larrea tridentate (Zyogophyllaceae)” 
Phytochemistry, 16: 1113-1114 (1977). 
9 REFERENCES 
 
164 
Schiller, M. 
“Analytik und technologische Optimierung von Filmtabletten mit Extrakten von 
Eschscholtzia californica Cham.” 
Ph.D. Thesis, Eberhard Karls University, Tübingen, Germany (2002). 
 
Schöpke, Th.; Hiller, K.; Wary, V. and Nimtz, M. 
“Application of MS-MS for the rapid, comparative analysis of saponin mixtures as 
exemplified by the deacylated and partially deacylated triterpenoid saponins of Bellis 
annnua” 
Planta Med., 62: 336-340 (1996). 
 
Seo, S.; Tomita, Y.; Tori, K. and Yoshimura, Y. 
“Determination of the configuration of a secondary hydroxy groupin a chiral secondary 
alchol using glycosidation shifts in carbon-13 nuclear magnetic resonance 
spectroscopy” 
J. Am. Chem. Soc., 100: 3331-3339 (1978). 
 
Singh, B.P.; Jha, O.P. and Ghosh, P. K.    
“A study of wax alkanes of some Molluginaceae and Aizoaceae”   
Plant Physiol. Bioch., 9: 14-17 (1982).   
 
Singh, B.P.; Singh, R.P. and Jha, O. P.     
“Flavonoids of some Aizoaceae and Molluginaceae of Bhagalpur” 
Biol. Bull. India, 4: 157-163 (1982).   
 
The United States Pharmacopeia and the National Formulary (USP 28; NF 23) 
“Disintegration” 
United States Pharmacopeial Convention, INC. Rockville, 2411-2412 (2005). 
 
Tomczyk, M.; Gudej, J. and Sochacki, M. 
“Flavonoids form Ficaria verna huds” 
Z. Naturforsch., 57: 440-444 (2002). 
 
Tsai, W.-J.; Hsin, W.-C. and Chen, C.-C. 
"Antiplatelet flavonoids from seeds of Psoralea corylifolia” 
J. Nat. Prod., 59: 671-672 (1996). 
9 REFERENCES 
 
165
Tsega, E.; Landells, J.; Tekelehaimanot, R.; Berkassa, T.; Tessema, D. and Dagne, E.  
“Kosso toxicity in mice” 
 SINET: Ethiop. J. Sci., 1: 99-106 (1978). 
 
Van Campen, L.; Amidon, G. L. and Zografi, G. 
“Moisture sorption kinetics for water-soluble substances: III Theoretical and 
experimental studies in air” 
J. Pharm. Sci., 72: 1394-1398 (1983). 
 
Van Kamp, H. V.; Bolhuis, G. K.; De Boer, A. H.; Lerk, C. F., and Lie, A. H. 
“The role of water uptake on tablet disintegration. Design of an improved method for 
pentration measurements” 
Pharm. Acta. Helv., 61: 22-29 (1986). 
 
Vennat, B.; Gross, A.; Pourrat, A. and Pourrat, H. 
“Tablet of hammamelis dry extract by direct compression: Comparative study of natural 
starches and starch derivatives” 
Drug Dev. Ind. Pharm., 19: 1357-1368 (1993). 
 
Wagner, Von H.; Reger, H. and Bauer, R. 
“Saponinhaltige Drogen und Fertigarzneimittel” 
Dtsch. Apoth. Ztg., 30: 1513-1518 (1985). 
 
Watt, J. M. and Breyer-Bandwijk, M. D.  
“The medicinal and poisonous plants of Eastern and Southern Africa” 
E and S Livingstone Ltd., London. 2nd ed, (1962). 
 
Weast, R. C. 
“CRC Handbook of chemistry and physics” 
CRC Press, Cleveland, 5th ed, p. E-46 (1974). 
 
Wei, Feng.; Ma, S.-C.; Ma, L.-Y.; But, P.-H.; Lin, R.-C. and Khan, I. A. 
“Antiviral Flavonoids from the Seeds of Aesculus chinensis” 
J. Nat. Prod., 67: 650-653 (2004). 
 
 
9 REFERENCES 
 
166 
Wells, J. I. and Aulton, M. E. 
“Preformulation, in Pharmaceutics: The science of doasage form design” 
Churchill Livingstone, New York, pp. 223-253 (1988). 
 
Wolfender, J.-L.; Maillard, M.; Marston, A. and Hostettmann, K. 
“Mass spectrometry of underivatized naturally occurring glycosides” 
Phytochem. Anal., 3: 193-214 (1992). 
 
Zhang, Y.; Bao, B.; Lu, B.; Ren, Y.; Tie, X. and Zhang, Y. 
“Determination of flavone C-glucosides in antioxidant of bamboo leaves (AOB) fortified 
foods by reversed-phase high-performance liquid chromatography with ultraviolet 
diode array detection” 
J. Chromatogr. A, 1065: 177-185 (2005). 
 
 
Chapter 10 
 
APPENDIX 
 
10.1 Calibration and validation data of the quantitative determination of the 
saponins of Glinus lotoides by HPLC 
Table 10.1: Calibration data of Mollugogenol B.  
 Conc. 
Mollugogenol B 
[mg/100ml] 
Peak area 
 
Conc. 
Mollugogenol B 
[mg/100ml] 
Peak area 
 
 0.237 88421 0.474 180087 
 0.237 89899 0.474 177247 
 0.237 88274 0.474 180064 
 0.237 90616 0.474 177044 
 0.237 89459 0.474 177615 
 0.237 88399 0.474 176714 
Average  89178  178129 
SD  965  1536 
RSD  1.08  0.86 
 0.948 358008 1.422 540262 
 0.948 350665 1.422 528796 
 0.948 352901 1.422 535757 
 0.948 361214 1.422 533127 
 0.948 358598 1.422 534223 
 0.948 358630 1.422 533563 
Average  356669  534288 
SD  4006  3738 
RSD  1.12  0.70 
 1.896 710120 2.37 900534 
 1.896 716780 2.37 896353 
 1.896 707003 2.37 887221 
 1.896 711949 2.37 898923 
 1.896 713132 2.37 881455 
 1.896 715095 2.37 900912 
Average  712347  894233 
SD  3507  8040 
RSD  0.49  0.90 
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Table 10.2: Calibration data of Extract F as secondary standard for determination of the 
saponins of G. lotoides after acid hydrolysis as Mollugogenol B. 
 Conc. Extract F 
[mg/100ml] 
Peak area 
Mollugogenol B
Conc. Extract F 
[mg/100ml] 
Peak area 
Mollugogenol B 
 4.95 127929 9.95 262614 
 4.95 129389 9.95 259217 
 4.95 127147 9.95 258811 
 4.95 129595 9.95 258247 
 4.95 129836 9.95 256981 
 4.95 126174 9.95 258240 
Average  128345  259018 
SD  1496  1916 
RSD  1.17  0.74 
 19.81 515730 30.13 784497 
 19.81 519452 30.13 790157 
 19.81 519455 30.13 790585 
 19.81 516402 30.13 787807 
 19.81 518091 30.13 775957 
 19.81 514365 30.13 782428 
Average  517249  785239 
SD  2086  5549 
RSD  0.40  0.71 
 40.05 1044109 49.98 1303034 
 40.05 1048680 49.98 1301862 
 40.05 1048774 49.98 1315613 
 40.05 1041979 49.98 1306789 
 40.05 1043566 49.98 1302771 
 40.05 1039244 49.98 1300780 
Average  1044392  1305142 
SD  3759  5517 
RSD  0.36  0.42 
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Table 10.3: Determination of the method precision of the acid hydrolysis of Extract F. 
 Conc. Extract F 
[mg/100ml] 
Peak area 
Mollugogenol B
Conc. Extract F 
[mg/100ml] 
Peak area 
Mollugogenol B 
 24.62 637096 27.42 724586 
 24.62 637793 27.42 713016 
 24.62 639076 27.42 714585 
Average  637988  717396 
SD  1004  6276 
RSD  0.16  0.87 
 24.37 620266 23.41 580293 
 24.37 622698 23.41 581559 
 24.37 623025 23.41 584370 
Average  621996  582074 
SD  1507  2086 
RSD  0.24  0.36 
 25.93 685862 28.31 736512 
 25.93 683032 28.31 752337 
 25.93 679649 28.31 739143 
Average  682848  742664 
SD  3110  8479 
RSD  0.46  1.14 
 
Table 10.4: Data for the determination of system precision of the HPLC method. 
 Conc. Extract F 
[mg/100ml] 
Peak area 
Mollugogenol B
Conc. Extract F 
[mg/100ml] 
Peak area 
Mollugogenol B 
 25.93 685704 25.93 678448 
 25.93 682848 25.93 682231 
 25.93 683717 25.93 683533 
 25.93 682936 25.93 679044 
 25.93 675383   
Average 681678.7    
SD 3405    
RSD 0.500    
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Table 10.5: Data for the determination of saponins in 5% EtOH extract (extract to 
determine the traditional dose). 
 Conc. 5% EtOH 
extract  
[mg/100ml] 
Peak area 
Mollugogenol B 
 104.26 843856 
 104.26 842817 
 104.26 859941 
Average  848871.3 
SD  9600.7 
RSD  1.13 
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10.2 Calibration and validation data of the quantitative determination of the 
flavonoids of Glinus lotoides by HPLC 
Table 10.6: Calibration data of vicenin-2. 
 Conc. vicenin-2 
[mg/100ml] 
Peak area 
 
Conc. vicenin-2 
[mg/100ml] 
Peak area 
 
 0.583 152072 1.166 298923 
 0.583 150148 1.166 291526 
 0.583 149874 1.166 292675 
 0.583 149604 1.166 307117 
 0.583 148986 1.166 295563 
 0.583 153011 1.166 297144 
Average  150616  297158 
SD  1568  5597 
RSD  1.04  1.88 
 2.332 601820 3.498 894170 
 2.332 590096 3.498 911971 
 2.332 588314 3.498 901377 
 2.332 601289 3.498 903740 
 2.332 593381 3.498 923637 
 2.332 588699 3.498 892774 
Average  593933  904612 
SD  6169  11631 
RSD  1.04  1.29 
 4.664 1204642 5.83 1501111 
 4.664 1209573 5.83 1509448 
 4.664 1211650 5.83 1514393 
 4.664 1202719 5.83 1508848 
 4.664 1217450 5.83 1517291 
 4.664 1225890 5.83 1504927 
Average  1211987  1509336 
SD  8589  5936 
RSD  0.71  0.39 
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Table 10.7: Calibration data of Extract F as secondary standard for determination of the 
flavonoids of G. lotoides as vicenin-2. 
 Conc. Extract F 
[mg/100ml] 
Peak area 
Vicenin-2 
Conc. Extract F 
[mg/100ml] 
Peak area 
Vicenin-2 
 4.96 131487 11.88 321198 
 4.96 131078 11.88 318711 
 4.96 131071 11.88 318127 
 4.96 128474 11.88 318101 
 4.96 129827 11.88 318333 
 4.96 127980 11.88 312101 
Average  129986  317762 
SD  1238  3011 
RSD  0.95  0.95 
 20.34 549680 30.39 801647 
 20.34 546577 30.39 798251 
 20.34 545047 30.39 801146 
 20.34 546762 30.39 798879 
 20.34 540739 30.39 797558 
 20.34 544989 30.39 810210 
Average  545632  801282 
SD  2941  4662 
RSD  0.54  0.58 
 40.90 1078782 49.49 1285794 
 40.90 1084506 49.49 1294153 
 40.90 1078577 49.49 1289314 
 40.90 1085842 49.49 1296740 
 40.90 1075539 49.49 1289559 
 40.90 1079402 49.49 1290445 
Average  1080441  1291001 
SD  3925  3879 
RSD  0.36  0.30 
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Table 10.8: Data for the determination of the recovery of vicenin-2 in Extract F 
Theoretical Conc. [mg/100ml] 16.4 24.6 32.8 41.0 49.2 
Theoretical percentage [%] 50 75 100 125 150 
Peak area of vicenin-2 422640 639321 853484 1101796 1304771 
 438440 647942 852612 1086134 1272433 
 432127 645038 853213 1096232 1292048 
Average 431069.0 644100.3 853103.0 1094720.7 1289750.7
RSD [%] 1.85 0.68 0.05 0.73 1.26 
Calculated Conc. [mg/100ml] 16.2 24.4 32.4 41.67 49.1 
Recovery 99.0 99.2 98.8 101.6 99.9 
 
 
Table 10.9: Data for the determination of the method precision. 
 Conc. Extract F 
[mg/100ml] 
Peak area 
Vicenin-2 
Conc. Extract F 
[mg/100ml] 
Peak area 
Vicenin-2 
 30.42 825473 30.39 801647 
 30.42 822083 30.39 798879 
 30.42 829311 30.39 810210 
Average  825622  803579 
SD  3616  5907 
RSD  0.44  0.74 
 33.60 872794 32.43 872374 
 33.60 889188 32.43 888158 
 33.60 884407 32.43 891475 
Average  882130  884002 
SD  8430  10206 
RSD  0.96  1.15 
 31.26 832567 32.85 857985 
 31.26 825468 32.85 875648 
 31.26 849568 32.85 885264 
Average  835868  872966 
SD  12384  13835 
RSD  1.48  1.58 
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Table 10.10: Data for the determination of system precision of the HPLC method. 
 Conc. Extract F 
[mg/100ml] 
Peak area 
Vicenin-2 
Conc. Extract F 
[mg/100ml] 
Peak area 
Vicenin-2 
 33.51 875463 33.51 900913 
 33.51 905638 33.51 878016 
 33.51 884002 33.51 879046 
 33.51 877170 33.51 915387 
 33.51 901804   
Average 890325.5    
SD 16529    
RSD 1.86    
 
 
Table 10.11: Data for the determination of the amount of vicenin-2 and total flavonoids 
in the 5% EtOH extract (extract to determine the traditional dose). 
 Conc. 5% 
EtOH extract  
[mg/100ml] 
Peak area 
Vicenin-2 
Conc. 5% EtOH 
extract  
[mg/100ml] 
Peak area 
Vicenin-2 
 10.54 89015 39.79 344799 
 10.54 89937 39.79 352468 
   39.79 354085 
Average  89476  350450.7 
SD  652  4960.8 
RSD  0.73  1.42 
 60.20 547895 89.25 804698 
 60.20 534986 89.25 797965 
 60.20 532469 89.25 791072 
Average  538450  797911.7 
SD  8275.9  6813.2 
RSD  1.54  0.85 
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10.3 List of suppliers 
Amersham Biosciences AB, SE 751 84, Uppsala 
Willy A. Bachofen AG, Utengasse 15-17, CH-4002 Basel 
BASF AG, Carl-Bosch-Str. 38, D-68056 Ludwigshafen 
Bärlocher GmbH, Riesstr. 16, D-80992 München 
Beckman Instruments Inc., Frankfurter Ring 115, D-80807 München 
Binder GmbH, Bergstr. 14, D-78532 Tuttlingen 
Büchi Labortechnik GmbH, Am Porscheplatz 5, D-45127 Essen 
Degussa AG, Bennigsenplatz 1, D-40474 Düsseldorf  
Deutsche Metrohm GmbH & Co., In den Birken 3, D-70794 Filderstadt 
Drawin Vertriebs-GmbH, Rudolf-Diesel-Str. 15, D-85521 Ottobrunn 
Engelsmann AG, Frankenthaler Str. 137-141, D-67059 Ludwigshafen 
Erweka GmbH, Ottostr. 20-22, D-63150 Heusenstamm 
Extrasynthese, B.P. 62, F-69730 Genay, Frankreich 
FINNA-AQUA Santasalo-Sohlberg GmbH, Kalscheurener Str. 92, D-50354 Hürth 
Fischer Scientific GmbH, Liebigstr. 16, D-61130 Niederau 
Fluka Chemie AG, Industriestr. 25, CH-9470 Buchs, Schweiz 
FMC Biopolymer, Wallingston, Little Island, IRL-Cork  
Gerteis Maschinen + Processengineering AG, Stampfstr. 74, CH-8645 Jona, Schweiz 
Henkel KGaA, Postfach 10 1100, D-40002 Düsseldorf  
Heraeus Holding GmbH, Haraeusstr. 12-14, D-63450 Hanau 
Heraeus Instruments GmbH, Postfach 1561, D-63450 Hanau 
Hottinger-Baldwin Messgeraete GmbH, Im Tiefen See 45, D-64293 Darnstadt 
IKA-Werk GmbH & Co., Janke & Kunkel Str. 10, D-79219 Staufen 
J. T. Baker, H.-S.-Richardson Str. 1, D-64521 Groß-Gerau 
Jungbunzlauer GmbH, Dr.-Albert-Reimann-Str. 18, D-68526 Ladenburg 
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Kistler Instruments GmbH, Eulachstr. 22, CH-8408 Winterthur 
Korsch Pressen GmbH, Breitenbachstr. 1, D-13509 Berlin 
Kronos Titan GmbH & Co. OHG, Postfach 10 07 20, D-51307 Leverkusen 
Krüss GmbH, Borsteller Chaussee 85-99a, D-2000, Hamburg 
LKB-Produkter AB, S-161 26, Bromma, Sweden 
Macherey-Nagel GmbH, Valencienner Str. 11, D-52355 Düren 
Malvern Instruments GmbH, Rigipsstr. 19, D-71083 Herrenberg 
Meggle GmbH, Megglestr. 6-12, D-83512 Wasserburg 
Memmert GmbH & Co. KG, Äußere Rittersbacher Str. 38, D-91126 Schwabach 
Mendell GmbH, Röpckes Mühle 2, D-25436 Uetersen 
Merck KGaA, Frankfurter Str. 250, D-64293 Darmstadt 
Messer Griesheim GmbH, Füttingsweg 34, D-47805 Krefeld 
Mettler Toledo GmbH, Ockerweg 3, D-35396 Gießen 
Microsoft Deutschland GmbH, Konrad-Zuse-Str. 1, D-85716 Unterschleißheim 
Mitutoyo Messgeraete GmbH, Borisigstr. 8-10, D-41469 Neuss 
Norwegian Talc Deutschland GmbH, Rückmühlenweg 1, D-63628 Bad Sonden-
Salmünster 
Pall Seitschenk, Filtersystems GmbH, Planiger-Str. 137, D-55543 Bad Kreuznach 
Perkin-Elmer GmbH, Postfach 10 11, D-88662 Überlingen 
Pharmatest Apparatebau, Postrfach 11 -50, D-63512 Hainburg 
Rheodyne LLC, 600 Park Court Rohnert Park, CA 94928 USA 
Riedel-de Haën, Wunstorfer Str. 40, D-30926 Seelze 
Röhm GmbH, Kirschenallee, D-64293 Darmstadt 
Sartorius AG, Weender Landstr. 94-108, D-37075 Göttingen 
Düsen-Schlick GmbH, Hutstr. 4, D-96253 Untersiemau/Coburg 
Seitz-Werke GmbH, Bad Kreuznach, Rheinland 
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Shimadzu Europa GmbH, Albert-Hahn-Str. 6-10, D-47269 Düisburg 
Wagner & Munz GmbH, In der Rosenau 4, D-81829 München 
Waters GmbH, Hauptstr. 87, D-65760 Eschborn 
Yashica-Kyocera GmbH, Eifflerstr. 76, D-20537 Hamburg 
Carl-Zeiss GmbH, Carl-Zeiss-Str., D-72447, Aalen-Oberkochen 
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